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Proper execution of animal development requires that it be integrated with cell 
division.  In part, this is made possible due to cell cycle regulatory genes becoming 
dependent upon developmental signaling pathways that regulate their transcription.  
Cyclin D genes are important bridges linking the regulation of the cell cycle to 
development because these genes regulate the cell cycle, growth and differentiation in 
response to intercellular signaling.  In this dissertation, a cis-regulatory analysis of a 
cyclin D gene, Sp-CycD, in the sea urchin, Strongylocentrotus purpuratus, is presented.  
While the promoters of vertebrate cyclin D genes have been analyzed, the cis-regulatory 
sequences across an entire cyclin D locus that regulate its expression pattern have not.    
From conducting the cis-regulatory analysis of Sp-CycD, regulatory regions 
located within six defined regions were identified.  Two of these regions were found 
upstream of the start of transcription, but the remaining regions were found within 
introns.  Regarding their activity patterns, two intronic regions were most strongly active 
at the time of induction of Sp-CycD expression, implying they contributed to this 
induction.  The activity patterns of other regions indicated that each could have distinct 
 roles, including controlling and maintaining Sp-CycD expression as it becomes spatially 
restricted during and after gastrulation.   
The sequences of the regulatory regions were analyzed.  In three regions 
subregions containing the cis-regulatory modules responsible for activity were found, and 
in two other regions, sequences that lacked activating regulatory activity were found, 
allowing the identities of active regulatory sequences to be inferred.  The sequences of 
each region were further analyzed for bearing significantly represented potential binding 
sites for transcription factors expressed in developmental lineages of the embryo where 
Sp-CycD is expressed.  The transcription factors included those that act downstream of 
Wnt-beta catenin and Delta-Notch signaling pathways that induce the development of the 
endoderm and mesoderm; and those expressed within the Gene Regulatory Networks that 
contribute to the development of these lineages.  From this, testable linkages between 
these binding sites and transcription factors that could regulate the expression of Sp-CycD 
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CHAPTER 1:   
THE CELL CYCLE AND DEVELOPMENT, AND THE ROLE OF CYCLIN D 
GENES IN REGULATING THOSE PROCESSES 
1.1  Overview and rationale 
This dissertation describes a cis-regulatory analysis of the cyclin D gene, Sp-
CycD, in the sea urchin, Strongylocentrotus purpuratus.  Genes of the cyclin D family, 
which are primarily regulated at the level of transcription [1], are important contributing 
regulators of both the cell cycle and development.  Despite this, to date, no cyclin D gene 
has been subjected to a comprehensive cis-regulatory analysis to identify the regulatory 
sequences within its locus that allow the gene to transcriptionally respond to 
developmental signals.  As a result of the cis-regulatory analysis of Sp-CycD, cis-
regulatory regions were identified in discreet regions found both upstream of the start of 
transcription, but also, intronically.  Because, as will become apparent below, cyclin D 
family genes function within the context of both the cell cycle and development, before 
describing the results of the cis-regulatory analysis in more detail, an overview of the cell 
cycle, its link to development, and the role of cyclin D family genes in these processes is 
given. 
Please note:  A number of genes are introduced in this dissertation.  Generally, within the 
main text, the most common names are given.  For official names and Gene Identification 
numbers, provided by NCBI Gene [2] for all genes except for those derived from the sea 
urchin, Strongylocentrotus purpuratus; or by SpBase [3] for genes described in S. 
purpuratus, see Appendix A, Table A.1. 
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1.2  Overview of the cell cycle, and the discovery of cyclins and their partners 
In animal development, cells become integrated into a cooperative community.  
To do this, cells must successfully reproduce themselves, and they must do so in 
relationship to their neighbors.  At the heart of this process is the cell cycle – the means 
by which cells reproduce themselves.  The cell cycle involves a large number of 
molecular players.  The first group consists of the group of proteins, such as DNA 
helicases, polymerases, topoisomerases and associated factors that replicate the cell’s 
DNA, along with the histone proteins, acetylases and deacetylases, that regulate the 
disassembly and assembly of DNA into chromatin and chromosomes, which must be 
mitotically segregated into daughter cells following replication of the DNA.  However, 
this multitude of proteins must be set into motion in a coordinated manner, and groups of 
them must also silenced after cells have been replicated and further replication is either 
permanently, or temporarily not needed.  The involved players were discovered over 
many years [4], and will be introduced as this Introduction proceeds.    
Important regulatory drivers of the cell cycle are a family of proteins known as 
cyclins. The first cyclins were discovered in the sea urchin, Lytechinus pictus by the Hunt 
group, working at the Marine Biological Laboratory, who labeled proteins from fertilized 
eggs with [
35
S]methionine, ran the proteins on an SDS gel, and discovered  a protein in 
early cleaving embryos that abruptly was destroyed before each cleavage, then appeared 
again, in a cyclical manner [5, 6].  Proteins showing this periodic behavior were likewise 
discovered in clam [5, 6].  Due to its cyclical synthesis and destruction coinciding with 
the beginning and end of each cell cycle, this protein was called “cyclin”[5, 6]  This 
cyclin, later termed cyclin B, is a member of a larger family of cyclin proteins [1].  The 
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Hunt group hypothesized but did not prove that the cyclin protein they had discovered 
played a role in regulating the cell cycle; their evidence was purely correlative.   
Ruderman and colleagues [7] provided direct evidence that a cyclin protein in clams, 
cyclin A, when injected into G2/M arrested oocytes, could induce M phase.  Since that 
time, other cyclins were discovered, found to be expressed in all eukaryotes, from yeast 
to mammals, and together with a network of other proteins with which they interact, 
found to be fundamental players in the eukaryotic cell cycle [1, 8].  How could cyclins 
regulate the cell cycle?  In part, cyclins were found to accomplish this by interacting with 
and activating cyclin-dependent kinases (CDKs), the first characterized of which, cyclin-
dependent kinase 2 was discovered in yeast [9]. In each case, the interaction between 
each cyclin protein and its CDK partner is mediated by a 100 amino acid “cyclin box” 
within each cyclin protein.  This interaction requires the presence on the CDK of the 
amino acid motif PSTAIR [1].  The CDKs are serine/threonine protein kinases.  There are 
a number of different CDKs, each of which is involved in phosphorylating specific 
substrate proteins to allow specific stages of the cell cycle to proceed.  For example, 
CDK4 and 6 phosphorylate the retinoblastoma (RB) protein, which acts as a cell cycle 
inhibitor in the absence of such phosphorylation.  In the presence of such 
phosphorylation, RB releases E2F transcription factors needed for the progression of S 
phase [1].   
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1.3  The protein players involved in controlling the cell cycle 
A transition is now made to listing and giving some of the functions of the 
network of proteins that drive the cell cycle, focusing first on members of the cyclin 
family, the proteins with which they directly interact, and the stages of the cell cycle that 
are set in motion by those interactions.  As will become evident below, it has been shown 
that specific stages of the cell cycle are associated with the activities of specific members 
of the cyclin and CDK families.  However, it should be noted that recent work by 
Coudreuse and Nurse [10] showed that in fusion yeast, it is possible to engineer a single 
CDK to drive the entire cell cycle in this organism, without the need for the input from 
any cyclins, despite the fact that this organism possesses at least 4 different cyclins.  This 
relates to the fact that the seemingly unique roles of specific cyclin-CDK complexes may 
in part be due not to intrinsic properties of the complexes themselves, but due to where 
they are localized within a cell [1].  
Herein, a simplified overview of how the cell cycle is set in motion by 
extracellular signals [1, 8, 11, 12] is presented.  An important caveat is that many of the 
experimental findings upon which this overview is based are derived from work on 
cultured cells, especially mammalian cells [12] rather than from developing organisms.  
As this Introduction proceeds, how the cell cycle is linked to the gene regulatory 
networks within a whole developing organism will be described, but first, the discussion 
of the cell cycle overview begun above will be finished.  In a cell cycle permissive 
signaling environment, combinations of developmental signaling pathways converge to 
activate transcription of cyclin D gene(s).  Cyclin D family genes are indeed important 
integrators of multiple developmental signaling pathways and their associated 
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downstream activated transcription factors [13].  Due to this, cyclin D family genes have 
been called “signal sensors” that couple signals received by cells to progression from G1 
to S phase of the cell cycle [14], and this characterization relates to findings pertaining to 
their discovery.  Cyclin D genes were first characterized by the Sherr group [15], 
although the newly identified cyclins were not yet given the designation “cyclin D” at the 
time of this characterization. The newly identified cyclins, originally named p36
CYL
, 
based on their size of 36 kd, were required for mouse macrophages to overcome G1 and 
enter S phase in response to the growth factor Colony-Stimulating Factor 1, but, after 
this, were no longer required for the cells to complete the cell cycle, their protein levels 
falling during S phase to a low after mitosis. In the absence of such stimulation, the cells 
never entered S phase, and died.   Subsequent work provided support for the role of 
cyclin D genes as the “signal sensors” that couple signals received by cells to progression 
from G1 to S phase of the cell cycle [14].   
Cyclin D family genes may also actively prevent the cell cycle from proceeding 
forward under appropriate conditions.  This is based on work by Kozar et al [16].  These 
authors obtained fibroblasts from day 13.5 C57BL/6 mouse embryos in which all three 
mammalian cyclin D genes, Ccnd1, Ccnd2 and Ccnd3, had been knocked out.  As a 
control, fibroblasts from littermate controls were used.  When both groups of fibroblasts 
were transfected with retrovirus encoding the cell cycle inhibitor P16ink4a, the 
proliferation of control cells was inhibited, as expected.  However, the inhibition of 
proliferation by this cell cycle inhibitor was almost completely prevented in the cyclin D-
null fibroblasts.  
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An explanation of how the cell cycle is driven forward will now be presented.  
Cyclin D  mRNA levels are low in the absence of inducing signals, and, in addition, 
cyclin D proteins are unstable, exhibiting half lives of about 20 minutes [1].  The 
instability of cyclin D proteins is due in part to the presence of C-terminal PEST 
sequences, which signal for these proteins to be destroyed by ubiquitination [1].    Once 
transcribed and translated, cyclin D proteins bind to and activate serine/threonine protein 
kinases, termed cyclin-dependent kinases (CDKs), such as CDKs 4 and 6.  CDK4 and 
CDK6 phosphorylate proteins of the RB family.   The path to discovery of the first 
described gene of this family, RB, was begun in 1971 by Knudson [17], who discussed  
how retinoblastoma tumors of the eye were brought about in patients who had inherited a 
mutated version of a gene.  This one mutant copy could not by itself elicit cancer, but if 
the second copy became mutated somatically, retinoblastoma tumors would result.  
Ultimately, the RB gene was cloned by Friend et al. in 1986 [18].   
Proteins of the RB family are termed “pocket proteins” [19, 20], because they 
share a conserved “pocket domain” which binds to target proteins that bear the motif 
LXCXE [21].  Besides RB, the family also contains the proteins P107 and P130 [22] .  
All three of these proteins play primarily inhibitory functions at the gene promoters that 
are regulated by the E2F transcription factor family, with P107 and P130 acting as a 
complex at such promoters [22].  There is also evidence that RB and P107 + P130 differ 
in terms of the E2F target genes they regulate.  This was shown in 1997 by Hurford et al 
[23]. These authors demonstrated that deletion of either Rb, or both P107 + P130 (but not 
either of the latter singly) in mice led to either the upregulation or downregulation of 
different cell cycle regulatory genes in cell cultures derived from these mice.  For 
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example, the cell cycle regulators B-MYB, CDK2, and E2F1, and cyclin A2 were de-
repressed by deletion of P107 + P130, whereas cyclin E was derepressed by deletion of 
Rb.  Another way that proteins of the RB family carry out their regulatory function is by, 
in their hypo-phosphorylated state, recruiting transcriptional repressors, such as histone 
deacetylases to the promoters of E2F-regulated genes [21, 24, 25]. 
As introduced above, the activity of cyclin-CDK and RB family proteins regulates 
the transcription of genes in part by regulating the interaction of proteins of the E2F 
family with these genes’ promoters.  The E2F genes have multiple family members, 
which regulate the transcription of different genes.  They carry out their transcriptional 
regulation through forming heterodimers with proteins termed DP proteins.  By carrying 
out this transcriptional regulation, E2F family genes can affect cell proliferation, and also 
developmental fate (reviewed in [26]).  The target genes of E2F family genes have been 
queried by genome wide analysis of binding sites [27, 28] .  This has shown that E2F 
family genes regulate a variety of genes, including those involved in the regulation of 
chromatin, DNA replication, DNA repair, the cell cycle, and development.  The fact that 
E2F family genes undertake such diverse processes is of relation to cyclin D family 
genes, which, as described later in this Chapter, regulate developmental processes as well 
as the cell cycle.  
Among the genes that are transcribed by activated E2F transcription factors is a 
second group of cyclins, of which focus is made on cyclins of the cyclin E family [12].  
Cyclin E proteins interact with CDK2 family proteins, leading to their activation.  This 
has at least two consequences.  First, the cyclin E-CDK2 complexes further 
phosphorylate RB family proteins, which have already been phosphorylated by cyclin D-
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CDK4.  Therefore, the actions of signal-sensing cyclin D-CDK4 ultimately set in motion 
a positive feedback loop that contributes to making a single cell cycle irreversible. 
Because of this, the state through which cells pass to reach this irreversible status is 
known as the “restriction point.” However, because each subsequent cell cycle includes 
another G1 stage, these subsequent cell cycles depend on the continued presence of 
induction signals, in the absence of which, these cycles will cease [12, 14, 29].  
Continuing with the discussion of the activation of cyclin E-CDK2 complexes and its 
relationship to cell cycle progression, the second consequence of the activation of cyclin 
E-CDK2 complexes is the activation by phosphorylation of various transcription factors, 
which ultimately leads to the transcription of genes critical for progression through the 
cell cycle.  These include genes necessary for DNA synthesis, along with those needed 
for mitosis [4, 12].   
It is in part through the above mechanisms that cells progress from the first gap 
phase, G1, to the DNA synthesis stage, S, of the cell cycle.  After this, if conditions are 
favorable, cells will then prepare for and undergo mitosis, as described herein [8, 12].  
The commencement of mitosis is brought about through passage through another 
restriction point, the G2-M phase.  Key players involved in this progression include the A 
type cyclins, which associate with CDK1 and CDK2, and are active first, followed by the 
B type cyclins, which become active as the A type cyclins are ubiquitinated and 
degraded.  At least 70 proteins involved in mitosis are phosphorylated through cyclin B-
induced CDK activity.  Another of several important players includes CDC25 
phosphatase proteins.  The role of these proteins only becomes clear in light of the fact 
that not all phosphorylation events that occur during the cell cycle are activating; some 
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are inhibitory, and these inhibitory phosphorylations relate to the negative regulation of 
the cell cycle, discussed further below.  These inhibitory phosphorylations are carried out 
by kinases of the WEE and MYT families [8, 12].  These inhibitory phosphorylations, 
which act as another safeguard gate to prevent the cell cycle from proceeding 
inappropriately, occur on cyclin-dependent kinases involved in both the G1 to S phase 
and G2 to M phase of the cell cycle.  Proteins of the CDC25 phosphatase family act as 
positive regulators of the cell cycle by removing these inhibitory phosphates, thus 
allowing the cell cycle to proceed.  After the completion of mitosis, cells face another 
decision, to either continue cycling or to enter a resting stage termed G0 [8, 12].  Cycling 
cells may enter G0 for a number of reasons, of which focus is given to developmental 
ones. Cells may find themselves at a stage of development where they must differentiate, 
a process often referred to as terminal differentiation.  An important theme arises with 
respect to this fact:  development and the cell cycle must somehow be linked in order for 
cells to behave in a manner that relates to their temporal and spatial position within a 
developing organism.  As signal-responsive cyclins that play a role in the decision of 
cells to cycle or not to cycle in response to extracellular signals, cyclin D genes play 
important contributory roles in this process.  Further expansion on the relationship of the 
cell cycle to development is described in the section of this Introduction, “How regulation 
of the cell cycle relates to development.” 
1.4  Regulation of the cell cycle by the availability of nutrients 
Besides being regulated by developmental signaling pathways, the cell cycle is 
also regulated by the availability of nutrients.  An important pathway that cells use to 
couple the availability or lack of nutrients, along with the presence of growth factors to 
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the decision about whether to proceed with the cell cycle is the mTOR pathway [30].  It 
has been shown that this pathway exerts its effect, at least in part, by regulation of the 
cyclin D1 gene (in a human cell line), both at the level of transcription [31], and also by 
controlling the levels of both cyclin D1 mRNA and cyclin D1 protein (in a 3T3 mouse 
cell line).  It should be noted that animal cells are not unique in becoming dependent on 
extrinsic cues for their cell cycles to proceed.  For example, in the plant Arabidopsis, 
evidence suggests that cyclin D type genes couple development from juvenile to adult 
plant by the availability of sugar [32].  Polymenis and Schmidt showed that in the 
unicellular yeasts, the cyclin protein involved in the G1 to S phase transition, CLN3, is 
translationally regulated by a 5’ sequence in its mRNA that senses the level of translation 
in the yeast [33].  The theme that arises from these observations is that the eukaryotic cell 
cycle is not solely autonomous – its passage is coupled to the availability of nutrients 
and/or developmental signals, depending on the the identity of the organism in which the 
cell cycle is taking place.  The next section explores this theme further – by describing 
how the the cell cycle and development are related 
1.5  How regulation of the cell cycle relates to development 
Up until now, most of the discussion has focused on how the cell cycle is driven 
forward.  However, in order to better understand how the cell cycle is linked to 
development, it is critical to understand how the cell cycle can be negatively regulated [8, 
34, 35].  Both driving the cell cycle forward and inhibition of the cell cycle must be 
properly coordinated with an organism’s developmental status.  This importance will 
become evident as some of the mechanisms for inhibiting the cell cycle are discussed.   
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In acting as cell cycle inhibitors, proteins of the RB family play important roles in 
allowing cells to differentiate [21].  For example, RB contributes to the differentiation of 
adipocytes by at least two mechanisms.  First, in line with its aforementioned role, RB, 
inhibits cell cycle in adipocytes in part by inhibiting cell cycle promoting transcription 
factors, such as those of the E2F family.  In concert with this, RB family proteins induce 
differentiation in this system by activating the differentiation promoting transcription 
factor C/EBPα, thus exhibiting a transcriptional activation as well as inhibitory role.   
Results from work in knockout strains of mice demonstrate that members of the 
Rb family are needed for normal development, due in part to the necessity for their cell 
cycle inhibitory and differentiation-inducing properties. This is shown by the fact that 
knockout of these genes in mice is embryonic lethal, due to defects in the erythrocyte 
lineage and over-cell proliferation in the liver [20].  Of interest, cyclin D triple knockout 
C57BL/6 mice likewise die in utero, but due to under-production of hematopoietic cells 
rather than due to over-production [16].  This is not surprising given that, as explained 
above, RB family proteins function downstream of signal-activated cyclin D proteins 
[14].  
The relationship between cyclin D, cyclin E and E2F is likely not simply linear.  
This was shown through work in Drosophila by Buttitta et al [36].  Given that E2F acts 
downstream of cyclin D-CDK4 and cyclin E-CDK2, a reasonable hypothesis would be 
that simply activating E2F, irrespective of either cyclin D or cyclin E, could prevent cells 
from exiting the cell cycle.  However, these authors showed that, at least in Drosophila, it 
is necessary to activate both E2F, plus either cyclin D or cyclin E to prevent cells from 
exiting the cell cycle before completing differentiation. 
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Given that cells exit the cell cycle and enter G0 when they differentiate, it might 
be hypothesized that the states of cycling through the cell cycle and differentiation are 
mutually exclusive.  Is this a developmental rule?  Related to this question, Korzelius et 
al. showed that in C. elegans, artificially activating cyclin D-CDK4 or cyclin E-CDK2 
could cause differentiated muscle cells enter S phase or mitosis, respectively [37].  In a 
related study, Sage et al. [38] showed that targeted deletion of Rb genes in mammalian 
hair cells of the ear causes those cells to undergo the cell cycle but still maintain 
functions such as the abilities to respond to mechanosensation and express at least some 
markers of differentiation.  Similarly, Ajioka et al.[39] characterized, in vivo, 
differentiated interneurons in mice (strain not provided) lacking two of the Rb family 
members, Rb and P130, but not P107.  These authors found that after several weeks, 
differentiated interneurons bearing this genotype would re-enter the cell cycle.  However, 
these cells maintained various phenotypes of differentiation, such as the ability to form 
neurites and synapses.  Whether these interneurons were fully differentiated was not 
clear, because the authors did not compare the gene expression pattern of these 
interneurons to differentiated interneurons in wildtype mice.   
These findings relate to another aspect of the cell cycle– that it can be modulated 
during development, as the two processes are linked [40].   During the earliest cleavage 
stages in vertebrates and sea urchins, the fertilized egg divides a number of times in 
preparation for subsequent rearrangements that begin with gastrulation.  These earliest 
cell divisions are driven by maternal factors that are stored in the egg cytoplasm [41, 42].  
During these earliest divisions, the cell cycle is essentially intrinsic, moving forward 
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without the cues of extracellular signals.  At this stage, the cell cycle consists of just two 
phases, S, where the DNA is synthesized, followed rapidly by M, mitosis.   
However, even during these earliest divisions in animals, cells are not found 
within a developmental void:  their position within the developing embryo will dictate 
their eventual developmental fate.  For example, in the sea urchin, cells that will become 
various developmental lineages are formed in distinct parts of the cleaving embryo [42, 
43].  This is due to exposure of the cells in different embryonic territories, initially, to 
maternally stored factors that will subsequently set in motion specific developmental 
programs for each uniquely located group of cells [41, 43].  Maternal factors also include 
mRNAs that encode cyclins A and B, which can play a role in the transition from S to M 
phase by activating cyclin A and B dependent kinases [41].   
There then arrives an important transition termed the maternal to zygotic 
transition [44].  At this stage, two critical events occur to set the developing embryo on 
its independent trajectory.  First, maternal regulators of the cell cycle are degraded.  
Second, transcription of the embryo’s own genes that regulate the cell cycle and 
development is commenced.    Degradation of maternal RNAs is triggered by the 
presence of sequences within the maternal RNAs that signal for the binding of factors, 
such as enzymes that remove the polyA tails.  Maternal RNAs with different functions 
are degraded at different rates, with those that code for factors that regulate the cell cycle 
among the first to be eliminated [44].  This allows the cell cycle to begin to be regulated 
by external rather than maternal cues. 
As maternal transcripts become degraded, activation of transcription of the 
zygotic genome begins.  A combination of factors may induce transcription of zygotic 
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genes.  These factors include changes in the nuclear to cytoplasmic ratio with successive 
cell divisions, during which cells become successively smaller during cleavage; presence 
of a molecular clock, for which the molecular components are being elucidated; and 
changes to chromatin within the embryo’s nuclei [44].  The timing of the onset of 
transcription from the zygotic genome varies between animals [44].  In sea urchin, 
transcripts synthesized by the embryo itself are detected at the zygote stage [44].  These 
include transcripts of genes that comprise the Gene Regulatory Networks (GRNs), 
introduced more fully below, that control sea urchin embryogenesis [45].   However, 
these development-regulating GRNs are activated by maternal factors that are stored in 
the egg cytoplasm.  For example, the GRN that controls the development of the lineage 
comprising the endoderm and mesoderm, that is, the endomesoderm, requires maternal 
Wnt6 transcripts in order to be activated [46].   
An important event for which the timing coincides with the maternal to zygotic 
transition is the introduction of gap phases in the cell cycle.  The introduction of these 
gap phases, G1 and G2 [41] is important for a number of reasons.  First, as noted, their 
terminal boundaries serve as cell cycle checkpoints whereby cells will not commit to 
replicating their DNA or undergoing mitosis if errors are present.  Second, and related to 
the theme being developed for this dissertation, the checkpoints are important from a 
developmental perspective: after completion of M, there exists another gap phase G0, 
during which cells can decide to exit the cell cycle and differentiate.  Cells make this 
decision based in part on the developmental context in which they find themselves.  In 
short, cells sense and respond to developmental signaling factors.  The maternal factors 
that cells encounter differ upon their position in the embryo [42, 43].  Cells respond to 
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these factors by activating the transcription of a specific subset of genes [45].  Some of 
these genes code for other transcription factors, and others code for specific terminal 
differentiation factors that do not themselves activate other genes, but impart on a cell a 
specific phenotype related to its temporal and spatial position within the developing 
embryo [43]. Ultimately, what is set in motion within a specified cell type is a network of 
transcriptional-regulatory interactions between specific genes within the organism’s 
developmental program [45].  This relates to gene regulatory networks (GRNs), which 
are explained more below.   
1.6  Strongylocentrotus purpuratus – a useful system for studying development 
 The purple sea urchin, Strongylocentrotus purpuratus is an ideal system for 
studying questions relating to development and the cell cycle, due to a number of recent 
developments.   These include the fact that the genome of this organism has been 
sequenced, and its genes have been annotated [47], revealing that most of the gene 
families found in vertebrates are also found in S. purpuratus.  These include, for example, 
most transcription factor family members, developmental signaling pathways, genes 
involved in the immune and complement systems, ABC transporters, genes involved in 
adhesion, such as integrins and cadherins, and genes expressed in the nervous and 
sensory systems [47].    With respect to transcription factor families, the members of 
various families have been well annotated, including, for example, Fox genes [48], Ets 
genes [49], Zinc finger genes [50], and Homeobox genes [51].  In addition, the 
transcriptome of the sea urchin embryo was studied by Samanta et al. [52].  These 
investigators identified thousands of genes across many functional classes that were 
transcribed during embryogenesis.  Of interest, the Samanta et al. study described 
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transcription from intergenic regions.  Although the function of these latter transcripts 
was not determined by Samanta et al.[52], this study has not been the only one to identify 
such entities.  For example, Kim et al. [53] identified RNA species they termed enhancer 
RNAs that were transcribed from neuronal enhancers.  Likewise, the functions of these 
species remained unknown, but it was speculated that they might play a role in gene 
regulation.  The existence of these newly characterized RNAs is of interest, because it 
relates somewhat to the project described in this dissertation, which identifies and 
characterizes conserved non-exon regions within a cyclin D gene that regulate its 
expression, although it does not address whether any RNAs are transcribed from these 
regions.   An update on the status of the transcriptome of S. purpuratus was published in 
2012 [48].  Although that study focused on protein coding genes, the knowledge obtained 
in that project allowed gene models postulated in the previous work of Sodergren et al. 
[47] to be revised based on the identity and pattern of transcription of genes that are 
expressed from early embryo through juvenile stages. 
Of relevance to this project, in S. purpuratus, the genes involved in regulating the 
cell cycle in this organism have been annotated [54].  This annotation showed that with 
the exception of the INK4 and ARF tumor repressor families, all family members 
involved in both positive and negative control of the cell cycle were present, although 
often with fewer representative members than found in vertebrates.   
As noted earlier, the cell cycle is linked to development [40, 41].  In this 
Introduction, an attempt has also been made to show specific examples of how the cell 
cycle and developmental signaling and environmental factors related to nutrition are 
linked.  To date, the role of cell cycle regulatory genes in controlling developmentally 
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important transcriptional networks has been largely neglected in the field of animal 
development.  For example, in S. purpuratus, cell cycle regulatory genes have not yet 
been linked to the developmental GRNs in this organism [55].  The relationship of cell 
cycle regulatory genes to the transcriptional regulatory networks of which they are part 
has been studied in systems such as yeast [56, 57] but not so much in the development of 
animals, except as pertains to the study of cancer, and in such studies, the techniques used 
are largely computational methods that make predictions that have yet to be 
experimentally verified [58].  As alluded to above and will become further evident below, 
genes of the cyclin D family, could play an important role in linking the cell cycle to the 
GRN.  With this in mind, this project focuses on a cis-regulatory analysis of the cyclin D 
gene, Sp-CycD, of S. purpuratus.  Cyclin D genes are now described in more detail. 
1.7  Cyclin D genes --  overview of roles in the cell cycle and development   
As described above, the eukaryotic cell cycle is regulated by the cyclins [59].  As 
described earlier, cyclins were first identified in sea urchin embryos as proteins that 
accumulated and then were destroyed with different phases of the cell cycle [5].  While 
the cyclins expressed during early development before the maternal to zygotic transition 
are byproducts primarily of maternal mRNAs, as noted, the D-type cyclins become active 
at the maternal to zygotic transition.  Linked to this fact, analysis of cyclin D promoters, 
generally in vitro, and primarily with the vertebrate cyclin D1 gene, has shown the 
existence of binding sites for dozens of transcription factors that act downstream from 
most of the developmentally important signaling pathways, giving further evidence for 
roles of cyclin D genes as developmental sensors that contribute to the regulation of 
development by linking receipt of extracellular signals to downstream developmental 
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responses [13].  This is related to the fact that the well characterized role of cyclin D 
genes in bringing about the G1 to S transition in the cell cycle is triggered by receipt by 
the cell of mitogenic signals, stemming from virtually all the developmental signaling 
pathways [59].    
Driving the G1 to S phase of the cell cycle may be one of many roles for cyclin D 
genes, and in fact, in certain developmental contexts, cyclin D genes may not be needed 
for the G1 to S phase transition.   For example, work carried out by the Sicinski lab has 
shown that knockout mice lacking all three of the mammalian cyclin D genes are viable 
throughout much of embryogenesis, before dying due to deficits in the hematopoietic 
lineages [16].  It is possible that these findings could be due to functional redundancy 
with other cyclin genes.  For example, in 1999, Geng et al. [60] showed that in a mouse 
strain where the cyclin D coding sequence had been replaced with that of cyclin E, cyclin 
E rescued the phenotypes caused by cyclin D loss.  Further support of this came from 
Keenan et al. in 2004 [61]. These authors showed that if cyclin D1 synthesis was blocked 
in Chinese hamster embryonic fibroblasts, progression through G1 to S phase of the cell 
cycle was blocked.  However, this block was overcome by expression of cyclin E-CDK2.  
Moreover, cyclin E-CDK2 carried out this rescue through inactivation of RB via 
phosphorylation, and concomitant activation of E2F. Moore et al.[62] showed that 
depletion of cyclin D in developing sea urchin embryos did not affect total cell number in 
late gastrula stage embryos. However,  Robertson et al. [63] examining the effect of 
cyclin D knockdown on cell numbers in blastula stage embryos, showed that depletion of 
cyclin D did reduce cell numbers at that stage of development.   
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In addition to their important role in regulating the cell cycle in response to 
developmental signals, genes of the cyclin D family also play other developmental roles.  
For example, Datar et al.[64] showed that in Drosophila, cyclin D and its partner CDK4 
induce cellular growth (increase in cell size) but not cell proliferation.  Related to its role 
in regulating cell growth, cyclin D genes have also been shown to down-regulate 
catabolic genes [37].  Moore et al. [62] showed that cyclin D in the developing sea urchin 
embryo is not expressed until blastula stage, and that this expression is required for 
development of normal larval morphology.  Inducing cyclin D expression during 
cleavage caused death.  Similar findings were reported by Tanaka et al. [65] who, 
working in a different developmental system, Xenopus laevis, showed that cyclin D1 
RNA in that organism was not detected until the midblastula stage.  Both Moore et al. 
and Tanaka et al. showed that cyclin D expression became successively restricted as 
development proceeded, to dividing cells of the gut and ectoderm in the sea urchin, and 
to neural plate and eye vesicles in Xenopus [62, 65].   
A point of contention has been the role of cyclin D genes in differentiation.  The 
most common view has been that cyclin D cells are cell cycle regulators, and that it is 
their down-regulation that allows cells to exit the cell cycle and differentiate [66].  This 
view is supported by studies, such as that of Adachi et al. [67] who demonstrate that 
degradation of cyclin D1 and D2 caused by switching growth factor medium is associated 
with ceasing of the cell cycle in immature myeloid cells and their differentiation into 
neutrophils.  In developing mouse spermatogonia, cyclins D1 and D3 appear to regulate 
the cell cycle, whereas the expression cyclin D2 appears to be required for differentiation 
into A1 spermatogonia [68].  The complexity of this situation is further revealed by the 
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fact that cyclin D3’s role may be context dependent, regulating the G1 to S transition in 
spermatogonia, but perhaps regulating differentiation in Sertoli and Leydig cells [68].  In 
skeletal muscle,  cyclin D3 and its associated CDK4 has been shown to repress 
differentiation by directly inhibiting the association of the transcriptional regulators 
MEF2C and GRIP-1 required for the muscle cell differentiation program to be activated 
[69].      
Understanding the mechanisms through which the expression of cyclin D family 
genes is regulated is also medically pertinent, with cyclin D genes, particularly cyclin D1, 
being commonly mis-regulated in various cancers, with  the cyclin D1 gene being the 
second most amplified gene in human cancers [70, 71], and its mis-regulation being 
associated with the development of a variety of these diseases [72-74].  Moreover, this 
gene could be an important chemotherapeutic target, based on a recent finding that 
expression of this gene may be required for the viability of certain cancers, but may not 
be needed in adult tissues that have completed development [75].  Also of medical 
relevance, cyclin D and its partners have been shown to regulate the activity of 
telomerase [76-78], findings which are pertinent to better understanding both cancer and 
aging [79].  
Clearly genes of the cyclin D family play important roles in development, and in 
both normal and disease-compromised biological processes.  Of interest, recent work has 
provided evidence that cyclin D proteins may carry out some of their functions by 
pathways distinct from the best characterized activation of CDKs.  In particular, recent 
work has shown that cyclin D proteins may act directly as transcription factors, perhaps 
in concert with other transcription factors.  For example, the Sicinski group [80] showed 
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that during mouse embryogenesis, the cyclin D1 protein was found associated with 
promoters of developmentally active genes, and, in particular, was shown to recruit 
CREB binding protein histone acetyltransferase to the Notch1 gene.  Moreover, if the 
cyclin D1 gene was ablated in retinas, NOTCH1 activation was lessened, leading to 
decreased cell proliferation in that organ, an effect that could be rescued by introduction 
of an artificially activated Notch1 gene.  In related work, Lukaszewicz and Anderson [81] 
showed that the cyclin D1 protein promotes neurogenesis in the developing mouse spinal 
cord by inducing expression of  the transcription factor Hes6.  As described near the end 
of Chapter 3, the weight of the evidence indicates that cyclin D genes carry out their 
transcriptional roles indirectly, via protein-protein interactions with sequence-specific 
DNA binding transcription factors. 
How are levels in the cell of the developmentally important cyclin D genes 
regulated?  Due to its instability as a protein, cyclin D is primarily regulated at the level 
of transcription [1].  Work from numerous groups has provided evidence in support of 
this by describing how developmentally important signaling pathways and their 
associated transcription factors regulate the transcription of cyclin D genes.  For example, 
transcription factors of the TCF family that are the effectors of the Wnt-β-catenin 
pathway regulate the expression of cyclin D genes.  Shtutman et al. [82] and Tetsu and 
McCormick [83] showed that activation of β-catenin, working through the TCF 
homologue LEF1, increased transcription of cyclin D1 via LEF1 binding sites in the 
promoter.  Pradeep et al. demonstrated that cyclin D1 activation depended primarily on 
activation in its promoter of a CRE responsive element, but that a TCF4 site contributed 
to a lesser extent [84].   Baek et al. [85], working on a mouse cell line, showed that LEF1, 
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along with histone deacetylase 1 and a complex of E2F4 and P130, repress the cyclin D1  
promoter until repression is lifted by activation of the Wnt-β catenin pathway.  
The regulation of cyclin D expression has also been linked to Runx transcription 
factors.  For example, Bernardin-Fried et al. [86] found that levels of the Runx protein 
AML1 varied during the cell cycle in a pattern similar to that displayed by cyclin D3.  
Inhibition of AML1 lead to loss of cyclin D3 expression, and AML1 was shown to 
interact with and activate the cyclin D3 promoter.  Knockdown of the sea urchin Runx 
gene Runt1 caused a decrease in cyclin D RNA expression, as well as decrease in 
expression of several Wnt genes, such as Wnt4, Wnt7, Wnt8, Wnt6, Wnt7 and Wnt9 [63].  
Further, Robertson et al. [63] showed that blocking Runt1, Wnt8, or cyclin D expression 
caused a decrease in cell numbers in blastula stage embryos, and that Runt1 bound the 5’ 
flanking regions of CycD, Wnt6 and Wnt8.   
The regulation of cyclin D genes by other developmentally important signaling 
pathways and associated transcription factors has also been examined.  Examples include 
the MAPK cascade [87]; heat shock proteins [88]; E2F (of interest since E2F 
transcription factors are themselves regulated by cyclin D genes during the G1 to S phase 
transition of the cell cycle) [89]; G proteins, steroid hormones and nuclear receptors [90]; 
Sp1 [91]; STAT5 [92]; STAT3 [93]; and TGFα [94].  
Transcription factors mediate their effects, in part, by binding to gene promoters.  
Related to this, the cyclin D1 promoter has been extensively analyzed, although the work 
involved has focused mostly on in vitro systems [13].  Examples of specific papers 
analyzing cyclin D promoters include Kitazawa et al. [95] and Matsumura et al [92].   To 
date, cyclin D promoters have not been subjected to a great deal of analysis in an in vivo 
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context.  An exception concerns work done by Tanaka et al. working with Xenopus [65].  
After examining the in vivo expression profile of endogenous cyclin D1, these authors 
created reporter constructs with specified deletions of the cyclin D1 promoter, and 
analyzed the effect on reporter gene activity.   These authors found that the regulatory 
elements identified in the promoter were not sufficient to explain the full expression 
profile of cyclin D1, so they suggested that other sequence elements might be involved.  
This finding also provides an impetus for undertaking the project described in this 
dissertation – a comprehensive cis-regulatory analysis of a cyclin D gene. 
1.8  The rationale for performing a cis-regulatory analysis on a cyclin D gene 
 Focus is now made on the main subject of this dissertation – a cis-regulatory 
analysis of the Sp-CycD gene in the sea urchin Strongylocentrotus purpuratus. To 
understand how the expression of a gene is regulated during development requires a cis-
regulatory analysis of that gene.  Typically, developmentally regulated genes contain 
multiple DNA sequence regions, up to several hundred basepairs in length, that bind 
groups of transcription factors that play a role in regulating a gene’s pattern of expression 
[45].  These regulatory regions are termed cis-regulatory modules (CRMs).  Some of 
these regions play stimulatory roles in specific cells, others have inhibitory roles, and still 
others act as boosters or inhibitors of other cis-regulatory modules [45]. The function of 
cis-regulatory modules can be examined by incorporating them into reporter constructs, 
injecting the latter into developing embryos, and observing the spatial and temporal 
expression pattern of the reporter genes.  Such cis-regulatory analyses have been 
successfully applied in S. purpuratus to numerous genes, such as CyIIIa [96], SM50 [97], 
Endo16 [98, 99], CyIIa [100], Wnt8 [101], Nodal [102], and Delta [103].   
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The efficiency with which potential CRM-containing regions of a gene are 
identified can be increased using a number of computational approaches.  One such 
method is to identify regions of sequence conservation.  This method, termed 
“phylogenetic footprinting,” is based on the premise that sequences within the same gene 
that are evolutionarily conserved between different species of sufficient evolutionary 
distance may exhibit this conservation because they are functional [104, 105].  With 
respect to this, sequence comparisons between the genes of S. purpuratus and the sea 
urchin L. variegatus have been shown to reliably predict CRMs [106, 107]. A  
comprehensive program for identifying conserved and potentially functional regulatory 
sequences is FamilyRelationsII [106].  This program has been demonstrated to accurately 
predict cis-regulatory regions ([106] and references therein).  The identification of 
regions containing potential cis-regulatory modules can also be facilitated by identifying 
sequence regions that have clusters of binding sites for known transcription factors, as 
such regions have been shown to often be regulatory in nature [108].   
Performing a cis-regulatory analysis of a gene is the only way to definitively, by 
experiment, link that gene to the gene regulatory network (GRN) of which it is a part, 
because such an analysis is required to identify the transcription factors of a gene 
regulatory network that directly regulate the expression of the gene being studied [45].   
1.9  Overview of developmental GRNs 
Gene regulatory networks (GRNs) are important “drivers” of development [45, 
55, 109].  Gene regulatory networks prescribe how the information encoded in the 
genome is to be used during development of an organism.  Visualized in diagrammatic 
form [55] GRNs consist of networks of all regulatory genes known to be active in 
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development.  Among the best worked-out lineages in developing embryonic S. 
purpuratus are the endomesoderm lineages, and, to a lesser extent, the lineage specifying 
the ectoderm [55].  GRNs show not only the genes involved in specifying a 
developmental lineage or structure, but, more importantly, the regulatory interactions 
between those genes.  These interactions can range from simple, as for example, when a 
transcription factor activates a gene that produces an end product, such as a skeletal 
protein that is expressed in and characteristic of a particular cell type, or complex, as in 
circuits where transcription factors can successively activate or inhibit other transcription 
factors through negative and/or positive feedback loops [45].  
 Development is best described as a system property that results from the 
interactions between genes.  Developmental GRNs present these interactions, and explain 
how they lead to specific phenotypes at specific times and specific places within a 
developing embryo [45, 109-112].  Developmental GRNs are modular, being composed 
of individual subcircuits of interacting genes.  These subcircuits, which can be classified 
based on their function, have been described as the “building blocks” of developmental 
GRNs.   The genes within these subcircuits can be classified based on whether they only 
receive signals from other genes, but do not themselves communicate with other genes; 
or both receive input from other genes, but respond with an output that regulates the 
transcription of other genes.   An example of the former would be a gene that encodes a 
structural product but does not transcriptionally regulate any other genes [111].  
Examples of the latter would be transcription factors, and signaling genes that lead to the 
transcriptional expression of such transcription factors [45].  
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 The subcircuits within developmental GRNs can be classified into a number of 
different types [45].  Among developmental questions that can be answered by study of 
subcircuits are:  what causes a particular transcription factor to be expressed in a 
particular spatial domain but not in others; what causes a particular gene to be activated 
at a particular time and place, and then have its expression become extinguished; is a 
particular gene activated by binding of one transcription factor, or does it require binding 
of more than one specific transcription factor to become activated; how is “community 
effect” signaling, in which all cells within a given spatial territory express the same 
assortment of genes, maintained? Developmental GRNs ultimately consist of all the 
subcircuits that are active in all regions of an embryo, and how they change over time to 
bring about developmental phenotypes.  A goal of researchers who decipher GRNs is to 
eventually construct global GRNs that encompass all regulatory genes expressed during 
development.  Progress toward this goal is being made by analyzing the entire 
transcriptome during sea urchin embryonic development [113].   
 Despite the fact that their structures are still being deciphered, the 
developmental GRNs of S. purpuratus that regulate the development of specific tissue 
lineages within embryos are complete enough to allow them to be used to explain how 
certain regulatory genes that are active in specific developmental lineages communicate 
and cooperate with each other to bring about specific phenotypes in terms of expressed 
genes and resultant developmental morphology and behavior, within those lineages.  This 
knowledge was gained by either individually perturbing expression, generally by 
knockdown using morpholino antisense oligonucleotides but sometimes by over-
expression, of each regulatory gene in the regulatory network, followed by cataloging the 
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effect on expression of every other gene in the network.  From this analysis, it can be 
determined which genes are regulated by each gene whose expression was 
experimentally perturbed.  To determine whether each gene whose expression is affected 
by the experimental perturbation of the each regulatory gene is direct or indirect, cis-
regulatory analyses of genes whose expression profiles were affected by perturbation of 
each regulatory gene were, and are being conducted.  Therefore, direct transcriptional 
regulatory interactions between genes in the network can be deduced, verified by direct 
experimental evidence [45].  
1.10  Gaps in our understanding of the developmental role of cyclin D family genes 
At least two gaps in understanding exist with respect to cyclin D family genes.  
First, to date, the cyclin D gene of S. purpuratus (Sp-CycD) has not been linked to sea 
urchin developmental GRNs.  GRNs of strongest interest include that specifying the 
endomesoderm, the precursor to the endoderm and mesoderm lineages; and that 
specifying the ectoderm.  This is because Sp-CycD becomes confined to the 
endomesoderm and oral ectoderm as development proceeds [62], and this pattern of 
expression is likely controlled by the genes expressed in those territories, which is in turn 
controlled by the respective GRNs.  Second,  as noted above, Wnt signaling has been 
shown to regulate expression of cyclin D genes, and Wnt8 is a key gene in the 
endomesoderm GRN, showing multiple linkages [55].  Runt1, which is required for both 
Wnt8 and cyclin D expression in the blastula [63], is also ultimately expressed in the 
endomesoderm, as well as in oral and ciliated band ectoderm, in an overall pattern that is 
similar to Sp-CycD’s pattern of expression [114].   
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A second gap in understanding with respect to cyclin D family genes is that none 
has been subjected to a comprehensive cis-regulatory analysis, the experimental method 
needed to verify linkages between a gene and the developmental GRNs of which it is a 
part.  Evidence has also been provided in this Introduction that cyclin D genes, due to 
their transcriptional regulation by numerous developmentally important pathways, and 
due to their ability to in turn regulate aspects of both the cell cycle and development, play 
important developmental roles.  Due to the above noted gaps in understanding, a cis-
regulatory analysis of the entire Sp-CycD gene has been undertaken, as described in the 
following chapters, based on the premise that genes of the cyclin D family are an 
important bridge linking the cell cycle to development [40].   A cis-regulatory analysis of 
Sp-CycD in S. purpuratus would identify the DNA sequence modules that control its 
expression pattern.  Since cis-regulatory elements control expression by interacting with 
transcription factors from developmental pathways, they can link a gene to a GRN of 
which it is a part.  Indeed, a gene is confirmed to be part of a GRN by just such an 
analysis [45].  Therefore, as described in Chapter 2, a developmental cis-regulatory 




DEVELOPMENTAL CIS-REGULATORY ANALYSIS OF THE CYCLIN D 
GENE IN THE SEA URCHIN STRONGYLOCENTROTUS PURPURATUS 
Herein, a developmental cis-regulatory analysis of the cyclin D gene, Sp-CycD, in 
S. purpuratus is presented. As explained in Chapter 1, it is proposed that this work can 
serve as the basis for incorporation of this developmentally important gene into the GRNs 
that regulate embryonic development in S. purpuratus.  The methods used to carry out 
this work are first described.  Subsequently, the results, and the interpretation of those 
results are presented.  It should be noted that the material presented in this Chapter is 
taken, essentially in whole, with only slight modifications, from a recently published 
paper [115]. 
2.1  Materials and methods 
2.1.1  Rearing and maintenance of Strongylocentrotus purpuratus, and obtaining 
gametes 
Strongylocentrotus purpuratus adults were obtained from the Pt. Loma Marine 
Invertebrate Lab (Lakeside, CA), and kept in a seawater aquarium at ~12
o
C.  Sperm and 
eggs were obtained by shaking, or by injection with 0.55 M KCl using established 
methods [116].  Embryos were cultured in artificial sea water. 
2.1.2  Sequence comparisons between Sp-CycD and Lv-CycD 
The cyclin D sequence from Lytechinus variegatus (Lv-CycD) used for 
comparison to Sp-CycD sequence was obtained from two sources, a BAC containing 17 
kb of sequence upstream of exon 1, and as a series of isotigs from an Lv-CycD draft 
sequence available at SpBase [3].   Sequence comparisons were made using Family 
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Relations II [106, 117]. FamilyRelationsII compares sequences using a “sliding window,” 
so that conserved sequences found in the genes being tested will be identified irrespective 
of their location or orientation in each gene.   Sequences in Sp-CycD of at least 20 bp that 
shared at least 90% similarity with Lv-CycD were selected for further analysis.      
2.1.3  Generation of reporter constructs 
To generate EpGFPII-linked reporter constructs [118], regions of interest were 
amplified by PCR using high fidelity DNA polymerases purchased from Roche or New 
England BioLabs.  For template, either BAC DNA bearing the Sp-CycD locus, or if PCR 
from that template was unsuccessful, sea urchin genomic DNA, was used.  Primers were 
modified on their 5’ and 3’ ends to have KpnI and SmaI sites, plus 15 bp homology with 
the multiple cloning site of EpGFPII cut with those enzymes.  The primer modifications 
were 5’-CTATCGATAGGTACC and 5’-ACAGTTTAACCCGGG, for the forward and 
reverse primers, respectively.  Primers were designed using Primer 3, available online 
[119].   For regions to be incorporated into 13-tag vectors rather than EpGFPII, the 
forward primer was not modified, while the reverse primer was modified by the addition 
of 5’-TTGAAGTAGCTGGCAGTGACGT at its 5’ end to enable linkage by fusion PCR 
to 13 tag-bearing reporters as described below.  The sequences of primers used to amplify 
all regions used for analysis are shown in Appendix B Table B.1.   
Amplified regions of interest were ligated to EpGFPII reporter vectors using 
conventional methods.  Reporter constructs were then linearized with KpnI followed by 
purification with a PCR purification kit (Nucleospin Gel and PCR Cleanup, Clontech) 
before being used for injecting embryos.   
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13-tag-linked reporter constructs were made as follows.  Bacterial cultures 
bearing each 13 tag reporter were grown up from stab cultures (provided by J. Nam, 
Davidson lab, California Institute of Techology) as follows.  First, derivatives of each 
stab culture were individually streaked onto LB agar plates containing chloramphenicol 
(12.5 μg/ml).  Colonies from each plate were then placed into 5 ml LB + 
chloramphenicol (12.5 μg/ml) and grown overnight at 37oC, with shaking.  200 μl of each 
overnight culture was then used to inoculate 1 ml LB + chloramphenicol (12.5 μg/ml) + 1 
μl Copy Control Induction Solution (epicentre).  These cultures were then incubated at 
37
o
C, shaking at 290 rpm for 5 hours before being subjected to miniprepping (Spin 
Miniprep Kit, Qiagen).  The resultant minipreps were then used as templates for PCR that 
would be used to modify their structure somewhat from that presented in the original 
Nam et al. paper [120] (J. Nam, personal communication).  These modifications involved 
replacing, on each 13 tag reporter, the Sp-gatae basal promoter given in the Nam and 




TGAGGGCTCACGGGCACCTTCtcatcttacaagtgaatcacaa), bearing the Sp-nodal basal 
promoter annealed just 3’ to the Sp-gatae promoter on each original 13 tag vector.  In this 
primer, the non-underlined nucleotides in red font on the 5’ end were for subsequent 
linking by fusion PCR to the 3’ end of a regulatory region to be tested bearing the 
complementary sequence, 5’-TTGAAGTAGCTGGCAGTGACGT; the underlined 
sequence corresponded to a disarmed nodal basal promoter; and the lowercase part 
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annealed to the 5’ end of each 13 tag vector being amplified (J. Nam, personal 
communication).  The reverse primer, end_core-polyA, (5’-
CACAAACCACAACTAGAATGCA) annealed ~23 nucleotides downstream of the 13 
tag basic unit unique on each reporter (J. Nam, personal communication, May, 2011).  
Minipreps of each of the 13 tag vectors were then used as templates in PCR reactions 
containing the two above primers.   For these reactions, Phusion DNA polymerase (New 
England BioLabs) and the following cycling conditions were used:  98
o
C x 30 sec; 35 
cycles of 98
o
C x 7 sec, 60.8
o
C x 20 sec, 72
o
C x 20 sec; 72
o
C x 10 min.  PCR products of 
the 13 tag reporters, which now bore the Sp-nodal basal promoter instead of the Sp-gatae 
promoter, were subjected to PCR purification (Nucleospin Gel and PCR Cleanup, 
Clontech).  At this point, these PCR products could be used for subsequent linking by 
fusion PCR to amplified potential regulatory regions of interest from Sp-CycD.   
Potential regulatory regions in Sp-CycD were amplified with either Expand High 
Fidelity DNA polymerase (Roche) or Expand Long Template PCR System (Roche) and 
purified as described in Nam et al [120].  Amplified regions were linked by fusion PCR 
to 13-tag reporter constructs using Expand High Fidelity DNA polymerase (Roche) as 
described in Nam et al [120].  If fusion PCR products could not be generated using 
Expand High Fidelity DNA polymerase (Roche), then Expand Long Template PCR 
System (Roche) was used.   Fusion PCR products were run on a gel and subjected to gel 
purification (Nucleospin Gel and PCR Cleanup, Clontech).  PCR products run on the gel 
were visualized by blue light from a Safe Imager (Invitrogen) rather than ultraviolet 
illumination to limit damage to the DNA.  By comparing the activity of reporter 
constructs bearing known active regions that had been purified by either gel purification 
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with the aid of blue light or by PCR purification, it was determined that gel purification 
with the aid of blue light did not prevent the detection of active regulatory regions (data 
not shown).  All PCR products were sequenced to ensure generation of desired products.  
From analysis of these sequences, it was determined that gel purification was successful 
in removing the majority of contaminating PCR side products for all 13 tag-linked 
regions except for 13 tag-linked region 3, for which sequencing showed a roughly 1:1 
mixture of 13-tag linked region 3 and non-specific amplification products (data not 
shown).  Despite multiple attempts at optimization, it was not possible to remove these 
non-specific amplification products from 13-tag linked region 3.   
The sequences for upstream regions 2 and 4 presented in this dissertation are from 
the full sequencing of clones bearing these regions used in this study.  The sequences of 
all of the other regions, for which the correct identity in each case was confirmed by 
partial sequencing and by running 13 tag-linked reporters of each on a gel to check sizes, 
are taken directly from Sp-CycD sequence accessed using GBrowse V3.1, located at the 
SpBase website [3, 121]. 
Each region was attached to a specific 13 tag reporter, X-13Y, where X denotes 
the region and Y denotes the tag, as indicated in Appendix C, Table C.1.   
2.1.4  Microinjection of fertilized eggs 
For reporter constructs containing region(s) linked to the reporter vector EpGFPII 
[118], a 10 μl injection solution contained ~10 nmols of reporter construct along with 165 
to 200 ng of HindIII digested then purified genomic DNA; and 0.12 M KCl.  Injection 
solutions comprising potential CRM-containing regions linked to 13-tag vectors were 
made based on Nam and colleagues’ paper [120], but with some modifications.  First, a 
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Master Pool containing ~10-12 13-tag linked reporter constructs was made as directed 
[120].  However, for the final injection solution of 10 μl, the volume of Master Pool mix 
used was increased form 0.5 μl to 1 μl.  The final mix also contained ~200-270 ng 
HindIII digested then purified genomic DNA, plus 0.12 M KCl. Microinjection was done 
using established methods [122], with ~100-150 embryos being injected with injection 
solution containing EpGFPII-linked reporters and > 200 embryos being injected with 
injection solution containing 13-tag-linked reporters.  For this study, a BAC (BAC 4013 
F-18 mCherry, prepared by the Sp Genome Research Resource at Caltech) bearing the 
Sp-CycD gene plus ~90 kb upstream and ~13 kb downstream sequence was also utilized.  
BAC DNA was prepared using a BACMAX DNA Purification Kit (epicentre) from 
bacterial stab cultures that were grown up under selection from chloramphenicol (12.5 
μg/ml).  BAC DNA was dialyzed and microinjected based on previous methods [123] . 
Injection needles were pulled from capillary tubing (FHC, catalog number 30-30-0) using 
a Flaming/Brown Micropipette Puller (Sutter Instrument Co, Model P-97). 
2.1.5  Procurement of RNA, and cDNA synthesis 
For assays of endogenous Sp-CycD expression, embryos were cultured at a 
concentration of ~1200 embryos per 4 ml at 15
o
C in 4 ml each in 6 well plates.  At 
specified time points, embryos were harvested by centrifugation and RNA was obtained 
using an Rneasy Plus mini kit (Qiagen).  Lysates were first passed through a 
QIAshredder (Qiagen) before processing to obtain RNA.  DNA was removed from 
lysates as described in the kit’s instructions.  For each time point, RNA equivalent to 30 
ng per 20 μl reaction was converted to cDNA using random hexamers and the FirstStrand 
cDNA Synthesis kit (Invitrogen Life Technologies).  For embryos injected with 
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EpGFPII-based reporter vectors, RNAs and DNAs were obtained with a DNA/RNA ALL 
Prep kit (Qiagen).  cDNA synthesis was carried out using random hexamers as directed 
by the manufacturer, with 3 μl RNA used for each 20 μl reaction.  For embryos injected 
with 13-tag-linked reporter vectors, RNAs and DNAs were extracted for each time point 
using the DNA/RNA ALL Prep kit (Qiagen).  Before cDNA synthesis, RNAs were 
treated with DNAse as directed by the DNA/RNA ALL Prep kit instructions.  cDNA 
synthesis was conducted using the FirstStrand Synthesis kit on RNA equivalent to 3 μl 
per 20 μl reaction using a gene specific primer, that is, one specific for the 13 tag vectors, 
5'-ATGCTTTATTTGTTC [120].   The exception for this was the experiment for 
biological replicate #5 (Fig. 2.4), for which random hexamers were used. 
2.1.6  Real-Time PCR procedure and analysis 
Real-Time PCR experiments were conducted using Perfecta SYBR Green Fast 
Mix (Quanta BioSciences) and a LightCycler 480 II instrument (Roche).  cDNA and 
DNA equivalent to 1.3 μl and 1.6 μl per 12 μl reaction were used.  Unless indicated 
otherwise, all reactions were done in duplicate.   The reaction profile used was 95
o
C for 
10 minutes, followed by 40 cycles of 95
o
C for 30 seconds, 60
o
C for 1 minute.  The 
relative quantification setting was used.   All reactions were subjected to melt curve 
analysis as well.   
To determine endogenous Sp-CycD expression, primers specific for exon 1 of 
cyclin D were used (5’-TTTGTTGTGCTTTGAGCAAGA and 5’-
CGAACATCCAATCCACGACT).  Ct values were obtained for each time point and 
compared to those derived from expression of ubiquitin in the same samples.  Sp-CycD 
expression levels for each time point were determined by finding the difference in Ct 
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values between the Real-Time PCR reactions conducted for Sp-CycD expression and 
ubiquitin expression. The primers used to detect ubiquitin expression were: 5’-
CACAGGCAAGACCATCACAC and 5’-GAGAGAGTGCGACCATCCTC.  Next, the 
Ct value difference between Sp-CycD and ubiquitin from each time point was compared 
to this difference at the first time point, generally 10 hours post-fertilization (hpf), 
yielding a ΔΔCt value for each time point.  Relative expression values at each time point 
were then computed using the formula Expression = 1/2
ΔΔCt
.  These Ct values were 
derived from cDNA samples subjected to Real-Time PCR. 
 To calculate expression of GFP derived from injection of embryos with 
EpGFPII-region of interest-linked reporter vectors, Ct values derived from expression of 
GFP were determined using GFP specific primers (5’-AGGGCTATGTGCAGGAGAGA 
and 5’-CTTGTGGCCGAGAATGTTTC).  Ct values derived from GFP expression were 
then normalized to Ct values derived from expression of ubiquitin by finding the 
difference between Ct values of GFP and ubiquitin at each time point.   These Ct values 
were derived from cDNA samples subjected to Real-Time PCR.  To account for how 
much GFP-linked construct was injected for each time point, Ct values were likewise 
obtained using the same GFP specific primers on DNA samples derived from each time 
point.  The difference between each ubiquitin normalized Ct value and the corresponding 
value derived from Real-Time PCR with GFP primers on the corresponding DNA sample 
for that time point was determined for each time point.  All such ubiquitin- and amount-
injected-normalized values were then further normalized to that of the first time point by 
finding the difference between the former and each of the latter.  The resultant ΔΔCt 
values were used to calculate the relative expression of GFP at each time point as above.  
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Activity levels of microinjected mcherry-bearing BAC (BAC 4013 F-18 mCherry) were 
determined as for microinjected GFP-bearing constructs, except that primers specific for 
mcherry (5’-AAGGGCGAGGAGGATAACAT + 5’-ACATGAACTGAGGGGCAGG) 
replaced those specific for GFP.   
 To determine the activity of each 13-tag-linked reporter derived from embryos 
co-injected with these, each linked to a potential regulatory region of Sp-CycD, a primer 
pair unique for each 13 tag reporter being assayed was used to obtain a Ct value for that 
reporter.  Primers used to detect 13 tag reporters are provided in Nam and colleagues’ 
Supplemental Data [120]. Ct values were derived from both the cDNA samples, to 
determine how much reporter was expressed, and for the corresponding DNA samples, to 
determine how much of each was injected.    For each 13-tag reporter linked to a specific 
potential regulatory region, activity was first determined in the same manner as for GFP 
from EpGFPII-based reporter.  However, for each time point, Ct data for co-injected 
empty 13 tag reporter 1302 were also collected, enabling relative expression of both 
empty reporter and reporters linked to regions of interest to be determined at each time 
point.  As a final step, the relative activity value determined for each region-linked 
reporter was divided by that of empty 1302 for each time point.  These calculations led to 
the relative expression values for each region reported in the Results and Discussion.  
 Some deviations from these procedures were made for some of the experiments 
presented in Fig. 2.4, as follows. 1. The graph for Experiment #8 is a composite of three 
individual biological replicates, for which Real-Time PCRs were conducted one time 
each.  This graph also contains one region, 13_orig, for which the final boundaries had 
not been finalized to account for conservation with Lv-CycD, because this latter sequence 
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was unavailable when Experiment #8 was done.  2. In Experiment #7, region 18, not 
discussed, showed significant activity.  This region was considered to be of interest 
before the boundaries of regions 5 and 6, which were also shown to be active, as 
discussed in the Results, had been finalized.  Since the termini of region 18 overlap with 
regions 5 and 6 (see Fig. 2.3A), and since regions 5 and 6 contain all of the conserved 
sequence found in region 18 (Fig. 2.3A), region 18 was not further studied. 
2.1.7  Examination of injected embryos by fluorescence microscopy 
Eggs were arrayed on 50 mm glass bottom dishes (MatTek), and fertilized and 
injected as described above.  At time points of interest, injected embryos were visualized 
with an Axiovert 200 fluorescence microscope (Zeiss).   
2.2  Results 
2.2.1  Temporal expression of Sp-CycD  
The temporal profile of embryonic Sp-CycD expression was assayed by 
quantitative RT-PCR.  As reported previously by others [62], expression commenced 
~10-12 hpf (early blastula), then increased at least up to pluteus stage (72 hpf) (Fig. 2.1).  




Fig. 2.1 Endogenous Sp-CycD expression from different embryo cultures, as 
determined by quantitative RT-PCR. Expression values are of relative expression with 
respect to that at the first time point. A. Temporal expression patterns of Sp-CycD in 
experiments derived from embryo cultures 1-3. Each experiment shown in panel A 
consisted of one technical replicate on a unique embryo culture. B. Graph of experiments 
derived from embryo cultures 4 and 5. In this case, each graph represents the mean of two 
technical replicates done on one embryo culture each. 
 
The temporal activities of endogenous Sp-CycD and a bacterial artificial 
chromosome (BAC) bearing Sp-CycD with mCherry knocked into exon 1 were co-
assayed.  This BAC encompassed sequence from ~90 kb upstream of the gene to ~13 kb 
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downstream.  Both endogenous Sp-CycD and the injected BAC exhibited similar 
temporal activities (Fig. 2.2, panel A), suggesting the information needed to regulate 
embryonic Sp-CycD expression is within this BAC.  It should also be noted that the 
expression profiles of endogenous Sp-CycD and the Sp-CycD-mcherry BAC were similar 
to that of Sp-CycD derived from the transcriptome analysis of S. purpuratus, worked out 
by the Davidson lab (Fig. 2.2, panel B, [3]). 
 
Fig. 2.2. A. Expression of endogenous Sp-CycD and microinjected mcherry-linked 
BAC bearing Sp-CycD plus 90 kb and 13 kb of up and downstream sequence. 
Relative levels of Sp-CycD mRNA were measured at each indicated time point by qRT-
PCR as described in the text. Each graph represents two technical replicates done on one 
biological replicate.  B. Transcription profile of Sp-CycD as taken from SpBase [3].  The 




 The cis-regulatory analysis conducted for this project encompassed from ~13 kb 






Fig. 2.3. Identifying cis-regulatory sequences. A. Regions tested for CRM-containing 
activity. Sp-CycD, plus 13 kb upstream and 7 kb downstream sequence is shown. Exons: 
black; potential CRM-containing regions: blue; sequences 
with > 90% similarity to Lv-CycD: red; active regions: boxed. B. Representative 
activity profiles. Each panel is from the indicated experiment 1, 2 or 6. Asterisks denote 




Fig. 2.4 Results of additional experiments showing the activities of tested regions.   
Notes:  1. The fact that region 21 showed significant activity at 10 hpf in Experiment #7 
was attributed to the low background expression level in that experiment. Region 21 did 
not show significant activity in other experiments.   2. In at least two additional 
experiments assaying each, regions 12 and 13 showed only background activity; and in 
one additional experiment, region 22 showed only background activity (data not shown) 




Fig 2.4 continued.   
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2.2.2  Identification of cis-regulatory regions 
 
Twenty-two regions spanning upstream and intronic sequence of Sp-CycD were 
selected to assay for regulatory activity (Fig. 2.3A).  The boundaries of most were chosen 
based on the presence of sequences of > 20 bp with > 90% similarity to Lv-CycD from L. 
variegatus (Fig. 2.3A) [3]. This criterion was based on the fact that sequence 
comparisons between genes in S. purpuratus and L. variegatus reliably predict S. 
purpuratus CRMs [106, 107].  This analysis was comprehensive: all non-exonic 
sequence except 1 bp between the 3’ end of region 10 and the 5’ end of exon 5, and 2 bp 
between the 3’ end of region 11 and the 5’ end of region 21 was tested.  
Candidate cis-regulatory regions were assayed for activity using the ‘13-tag’ 
reporters developed by Nam and colleagues [120].  Representative results are in Fig. 2.3B 
and Fig. 2.4.  In each experiment, a region was classified as significantly active if activity 
at one or more time points was > 2.5 times that of the mean activity of regions in the 
middle 40% of the distribution [120].  
Several active regions were identified.  Region 5, (2.4 kb) in the first half of 
intron 2 (Fig. 2.3A) showed the strongest activity, with significant activity at all tested 
time points from ~10-60 hpf.  This activity was ~15 times greater than that of empty 
reporter at its peak, and at least 2 times higher than those of the next most active regions.  
The next most active regions were region 2 (~3.6 kb), located ~4.6 kb upstream from the 
beginning of exon 1; region 6 (2.7 kb), comprising the 3’ half of intron 2; region 19 (4.6 
kb), in intron 4; followed by region 4 (2.1 kb), which abuts exon 1; and region 17 (2.1 kb) 
in intron 1 (Fig. 2.3 and 2.4).  Regions 2 and 6 always showed significant activity for at 
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least one time point when injected without region 5-linked reporter, but not always in its 
presence (Fig. 2.4).   
2.2.3  Temporal activity profiles of cis-regulatory regions 
To gain further insight into the roles of each active region, temporal activity 
profiles were extracted from experiments in Fig. 2.3B and Fig. 2.4, and are presented in 
Fig. 2.5.  This analysis reveals substantial inter-experimental variation in the temporal 
activity profiles of each region.  An exception concerned region 19, as discussed below. 
Possible sources of this variation include biological variability, the fact that injection 
solutions contained different mixtures of 13-tag-linked regions, and the fact that each 
time point was from a separate injection plate because it was technically not possible to 




Fig. 2.5. Comparison of the temporal activities of regulatory regions of Sp-CycD, 
with the results of individual experiments for the temporal activity of each region 
shown. Temporal activity profiles are derived from embryos injected with regions linked 
to 13-tag reporters. Experiments shown in the key for each graph each correspond to a 
unique experiment corresponding to a unique embryo culture. Experiment “X” in a given 
panel utilized the same embryo culture as Experiment “X” in a different panel. For 
example, Experiment 1 in the graphs for regions 2, 4 and 6 corresponds to the same 
experiment. Note also that Experiments #1, #2 and #6 are extracted from panels 1, 2 and 
6, respectively, in Fig. 2.3B. The other labeled time course graphs are extracted from the 
graphs bearing the same labels in Fig. 2.4. In all cases, activity at each time point is with 





To more clearly discern canonical aspects of the temporal activity patterns, the 
activity values across experiments were averaged (Fig. 2.6).   
 
Fig. 2.6. Averaged temporal activity profiles. Grand means and standard deviations 
were calculated from the means of all experiments in Fig. 2.5. Small differences between 
time points in different experiments (for example, 45 and 47 hpf) were ignored. 
 
From this analysis, the following patterns were found.  (Please see Figs. 2.5 and 
2.6, plus other figures when indicated).  Region 5’s activity was highest at 10-12 hpf, 
when Sp-CycD is initially activated.  As other regions became active, region 5’s activity 
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declined somewhat, but remained significant (Fig. 2.3B).  Region 6 likewise showed the 
strongest activity at ~10 hpf.    During the first ~33 hours, activities of regions 5 and 6 
paralleled each other, then region 6’s stabilized, suggesting that region 6 contributes to 
maintaining Sp-CycD expression after ~33 hpf, corresponding to gastrulation and later 
stages.   
On average, region 2’s activity peaked at ~21 hpf (Fig. 2.6), although peak 
activity varied from ~12-33 hpf (Fig. 2.5).  Region 2’s activity peak occurred after that of 
regions 5 and 6.  Therefore, region 2’s primary role may be to activate transcription 
during late blastula stage.   
Region 4’s activity varied considerably (Fig. 2.5), but on average (Fig. 2.6) 
increased to low but stable levels by ~21-33 hpf.  Thus, region 4 may contribute to 
maintaining Sp-CycD expression.   
Region 17’s activity slowly increased to stability by ~21-33 hpf (Figs. 2.5 and 
2.6), indicating that this region may contribute to maintenance or lineage-specific 
activation of Sp-CycD during and after gastrulation. 
Region 19’s activity peaked at ~21 hpf, the mesenchyme blastula stage (Figs. 2.5 
and 2.6), suggesting that this region may act as a switch that regulates Sp-CycD at the 
onset of gastrulation. As noted, region 19’s activity showed much less variation than 
those of other active regions (Fig. 2.5; compare Experiments #5, 2 and 3).  Therefore, 
region 19 may be under especially strong control. 
As a control, activities of region 2-linked 13-tag vectors at 12 hpf (Fig. 2.7A), and 
13-tag vectors linked to unique regions (Fig. 2.7B) were compared.  There was 
significantly less variation between activities of 13-tag reporters linked only to region 2 
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than between those linked to different regions, indicating that differences in activity 
among regions could mostly be attributed to region-specific differences rather than 13-tag 




Fig 2.7. Testing for variations in activity attributed to differences between 13-tag 
reporters at 12 hpf. A. Testing for variation in expression between activities of the same 
region (region 2) when linked to different 13-tag reporters.  Two biological replicates, 1 
and 2, each broken down into two graphs, a and b, are presented.  In each case, “a” shows 
the activity of each individual region 2-linked reporter, whereas “b” shows the grand 
mean of the activities of all region 2-linked reporters, along with the standard deviation 
of those means. B.  The grand means and standard deviations resulting from averaging 
the activities of multiple regions (not just region 2) when linked to 13-tag reporters.  To 
construct these graphs, the average activity level and standard deviation for all regions at 
12 hpf was determined for each experiment in Fig. 2.3.  Note that the standard deviations 
are much less when all 13-tag reporters are linked to the same region (region 2) than 
when these reporters are all linked to different regions.   
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2.2.4  Identification of candidate cis-regulatory modules 
Since the sizes of the identified regulatory regions ranged from ~2-5 kb (Fig. 
2.3A), additional analysis was needed to identify CRMs, which are generally only up to 
several hundred bp [45].  By using a combination of computational approaches to analyze 
each region (Fig. 2.8; Appendix D, Fig. D.1; Appendix E, Fig. E.1), candidate CRMs 
were identified within each.  The activities of several of these were verified 
experimentally.  (Please note:  Several transcription factor binding sites highlighted in 
Appendices D and E may only be briefly introduced in this Chapter, or not mentioned at 




Fig. 2.8. Identification of cis-regulatory modules. A. Sp-CycD showing active cis-
regulatory regions. Exons: black rectangles; active regions: blue rectangles; active 
and inactive subregions: blue and tan lines, respectively; conserved sequences: red; 
Cluster-Buster-identified sequences: gray. B. Activities of 13-tag-linked regions 2, 2- 
2, 6 and 6-1. Panel 1 shows the activities of region 2 and subregion 2-2 in co-injected 
embryos (one experiment). Panel 2 shows the averaged temporal activities and 
standard deviations of region 6 and subregion 6-1 from all presented experiments 
where either region was assayed. C. Fluorescence micrographs from injection with 
EpGFPII-linked region 2, 2-2, 4, 4-1 or 4-2. Brightness and contrast were adjusted 
equally in all images. 
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Region 2 contains a 0.5 kb subregion, 2-2, encompassing sequence conserved at > 
90% with Lv-CycD (Fig. 2.8A; Appendix D, Fig. D.1). Experimental analysis using both 
13-tag and EpGFPII-linked versions of region 2 and subregion 2-2 showed that subregion 
2-2’s temporal activity mirrored region 2’s (Fig. 2.8B, panel 1; Fig. 2.9).  Further analysis 
showed that the activities of each were detected at blastula stage by fluorescence 
microscopy (Figs. 2.8A and 2.8C, panel 1). Together, these findings indicate that 
subregion 2-2 contains a CRM.   
 
Fig. 2.9. Comparison of the temporal activities of region 2 and subregion 2-2 when 
linked to the reporter vector EpGFPII. The plots are from separate experiments 
derived from different embryo cultures, in each of which EpGFPII-linked region 2 or 
subregion 2-2 were separately injected. Activity in each case is with respect to that at the 
time point with the lowest activity. Error bars for region 2 (error bars are small) are 
standard deviations of two technical replicates done on a representative biological 
replicate. Note that error bars are not shown for subregion 2-2, for which 
one technical replicate of one biological replicate is shown. 
Region 4 contains two active subregions (4-1 and 4-2; Fig. 2.8A). Subregion 4-1 
overlaps partly with conserved sequence (Fig. 2.8A; Appendix D, Fig. D.1), and bears a 
potential Runx site (Appendix D, Fig. D.1).  Sequence within subregion 4-1 was 
previously found by chromatin immunoprecipitation to bind the Runx protein SpRunt-1, 
which was shown to regulate Sp-CycD [63].  Subregion 4-2 contains a 22 bp conserved 
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sequence (Fig. 2.8A; Appendix D, Fig. D.1), and a potential Runx site [125] (Appendix 
D, Fig. D.1).   When tested for activity by fluorescence microscopy, subregions 4-1 and 
4-2 were both shown to be active at gastrula stage (Fig. 2.8C, panel 2), suggesting that 
both encompass CRMs.    
Analysis of the intronic regulatory regions, which contain longer stretches of 
sequence conservation than the upstream regions (Fig. 2.8A, red lines), was chiefly 
computational.  In this analysis, a number of sequence elements of interest were 
identified.  Among these, were potential binding sites for TCF and Runx.  Wnt-TCF 
signaling is known to regulate cyclin D expression in a variety of other systems [82, 83, 
87, 126]; and, as noted above, the Sp-Runt-1 protein is known to regulate Sp-CycD.   In 
addition, a search was done for sequences with clustered binding sites for transcription 
factors identified by the program Cluster-Buster, of interest because sequences where 
transcription factor bindings sites cluster are hypothesized to be regulatory [108, 127, 
128].   These areas are highlighted on the sequence for each region in Appendix D, Fig. 
D.1.  Identities of transcription factors identified by Cluster-Buster are in Appendix E, 
Fig. E.1.  In Chapter 3, further analysis of the sequence of each regulatory region is 
presented.  The sequence of each identified regulatory region was also studied to identify 
possible CRMs within each.  One candidate CRM in region 5 was subregion 5-1, found 6 
bp upstream of a potential transcription factor cluster site to 14 bp downstream from a 
potential TCF binding site (Fig. 2.8A, Appendix D, Fig. D.1).  However, subregion 5-1 
showed only background activity (Fig. 2.4, Experiments #5 and 9).  This was surprising 
because within its boundaries, which overlapped with conserved sequence, subregion 5-1 
contains 6 potential TCF and Runx sites, respectively, most of which overlap with the 
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transcription factor cluster site.  Therefore, 5-1 may be necessary but not sufficient for 
region 5’s activity.  Further analysis (presented in Chapter 3) uncovers the possible 
reasons why subregion 5-1 is inactive. 
Within region 6, it was reasoned that the 3’ two-thirds of this region could contain 
a CRM, as most of the potential regulatory elements of interest (discussed further in 
Chapter 3) were found in that portion (Fig. 2.8; Appendices D and E).  This subregion, 6-
1, was verified to be active (Fig. 2.3B, panel 6; Fig. 2.4, Experiments #7, 8 and 9), and its 
temporal activity closely resembled region 6’s (Fig. 2.8B, panel 2).   
Within region 19, a sequence termed subregion 19-1, which bears few of the 
potential regulatory elements of interest highlighted in Appendix D, showed only 
background activity (Fig. 2.4, Experiment #9), indirectly supporting the hypothesis that 
the highlighted sequence elements shown for region 19 likely mark one or more CRMs.  
The hypothesized roles of specific potential transcription factor binding sites in 
regulating the activity of this and all regions are discussed in greater detail in Chapter 3. 
2.2.5  Conclusions 
 The entire Sp-CycD locus was analyzed to identify cis-regulatory regions and 
modules (CRMs) within those regions that mediate expression.  Intronic and upstream 
regions that impart distinct activity patterns were identified, and likely CRMs were found 
in two upstream regions, 2 and 4; and within intronic region 6.  A future aim is to 
determine the specific roles of each regulatory region and candidate CRM by individual 
deletion of each from a BAC bearing Sp-CycD.  Finally, to link Sp-CycD to GRNs that 
control early embryogenesis, the spatial activity of each CRM should be studied and 
compared to that of both endogenous Sp-CycD, Sp-CycD-bearing BAC, and Sp-CycD-
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bearing BAC in which each of the regions in question has been individually deleted.  In 
Chapter 3, further analysis of the sequence of each regulatory region is presented in order 
to gain better insight into how the expression of Sp-CycD could be regulated by 
endomesoderm and ectoderm-specifying transcription factors expressed during 




POSSIBLE LINKAGES OF THE REGULATORY REGIONS OF SP-CYCD 
TO DEVELOPMENTAL SIGNALING PATHWAYS AND LINEAGE 
SPECIFYING TRANSCRIPTION FACTORS 
3.1 Overview 
 During development, cis-regulatory modules (CRMs) carry out their tasks by 
binding to transcription factors that are expressed within the cells as development 
proceeds.  In S. purpuratus, the set of transcription factors that is expressed during 
embryogenesis is well worked out [129].  As presented in Chapter 1, transcription factors 
that regulate development do so via Gene Regulatory Networks (GRNs).   
 In Chapter 2, a cis-regulatory analysis of Sp-CycD during development was 
described.  In addition, the sequence of each active regulatory region was analyzed to 
identify candidate transcription factors that could potentially regulate each region's 
activity (Appendices D and E).  In Chapter 2, only a preliminary discussion of the results 
of this analysis was provided.   The purpose of this Chapter is to provide a more in depth 
analysis.  In addition, at the end of the chapter, how Sp-CycD itself could regulate the 
expression of developmental regulatory genes will be discussed.     
 In addressing how Sp-CycD, through its regulatory regions, could be regulated 
by specific, developmentally-expressed transcription factors, this Chapter discusses a 
number of different groups of transcription factors.  The first group comprises 
transcription factors expressed within the endomesoderm, the lineage that gives rise to 
the endoderm and mesoderm lineages.  This lineage is one of two major lineages in the 
embryo where expression of Sp-CycD becomes confined during and after gastrulation 
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[62].  Insight into how this localized expression is controlled can be gained by identifying 
transcription factors active within that lineage that could bind to the regulatory regions of 
Sp-CycD.  From the large set of transcription factors expressed within the endomesoderm 
GRN [55], focus will be made on a subset of transcription factors that are expressed 
within a conserved subcircuit that plays a central role in the specification of endoderm 
and mesoderm from that lineage [130, 131].  Since the transcription of the genes 
expressed within the endomesoderm is largely induced by two signaling pathways,  the 
Wnt-beta catenin and Delta-Notch pathways [111], available evidence that transcription 
factors activated directly downstream from these two signaling pathways regulate the 
expression of Sp-CycD is given.  This Chapter also presents evidence that Runx 
transcription factors could regulate the transcription of Sp-CycD.  As discussed in 
Chapter 1, Runx transcription factors act in a context-dependent manner to regulate the 
transcription of genes, in part, by inducing the recruitment of other transcription factors 
[132].  Finally, since, along with the endoderm, Sp-CycD becomes confined to the oral 
ectoderm after gastrulation [62], the evidence that the transcription of Sp-CycD could be 
regulated by transcription factors expressed within the GRN that regulates the 
development of the oral ectoderm is discussed.  While this Chapter is essentially 
conjecture, it provides the basis for future work. 
3.2 Comparing the expected and actual number of binding sites for transcription 
factors of interest 
 As described in section 3.1 above, the regulatory regions of Sp-CycD identified 
in Chapter 2 were analyzed for binding sites for transcription factors present in GRNs 
active in developmental lineages where Sp-CycD is expressed during embryogenesis.  
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This current section first describes the statistical calculations done to determine whether 
the actual number of potential binding sites for each transcription factor of interest 
compared to the predicted numbers of each such site was significantly significant, then 
presents the results as a graph.  This graph is then referred to in subsequent sections of 
this Chapter, which discuss which transcription factors of interest could regulate the 
expression of Sp-CycD during embryogenesis. 
 This statistical analysis was performed as follows.  First, the GC and AT 
content of each region was determined using an online GC percent calculator [133], so 
that the probability of finding each nucleotide in the consensus binding site for each 
transcription factor of interest within the regulatory region being examined could be 
determined.  For example, if the GC content was 38.19C%, then the proportion of G or C 
would be 19.095% or 0.19095, and the proportion of A or T would be (100 - 
38.19C)/2/100 = 0.30905.  The probability, P, of finding each consensus sequence and its 
reverse complement in a region of length N was then found using the generalized 
formula:  
2N(P of G or C)
(# of G and C in sequence)
 (P of A or T)
(# of A and T in sequence) 
The purpose of multiplying by 2 was to account for both the forward version and reverse 
complement version of each consensus sequence. The above formula, as noted, is a 
generalized version. In cases where it was possible for a nucleotide within a consensus 
sequence to have more than one identity, the formula was modified.  In Table 3.1 below, 
the consensus binding site sequences of most transcription factors discussed in 
subsequent sections are provided, along with the modified versions of the above formula 
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used to calculate the predicted number of forward and reverse complement binding sites 
for each transcription factor in a regulatory region of sequence length N. 
Table 3.1 Formulas used to determine the expected number of binding sites for the given 
consensus sequences in regulatory regions of length N. 
Note: Lowercase “n” within a sequence denotes any nucleotide; capital “N” in a formula 
denotes sequence length; and “P” in a formula denotes probability.  The consensus 
sequences were determined by examining the references cited below.  These sequences 
are composites of the sequences provided in the references cited in this table.  The figure 
legend of Appendix D, Fig. D.1 shows the original sequences that were used to determine 
the consensus sequences shown in this table. 
 
Bra  
Consensus sequence:  (A/G)(A/T)(A/T)nTn(A/G)CAC(C/T)T 
Formula:  2N(PA+PG)^2(PA+PT)^2(PT or PA)^3(PC)^2(PC+PT)^1 
Reference for consensus sequence:  [134] 
 
FoxA  
Consensus sequence:  (A/G)(A/C)(A/C)T(G/A)TT(A/T/G)(A/T)TT(T/C) 
Formula:  2N(PA+PG)^2(PA+PC)^2(PA or PT)^5(1-PC)^1(PA+PT)^1(PT+PC)^1 




Consensus sequence: (T/G/A)(T/A)(G/C)AGACT(T/A)AGC(T/G) 
Formula: 2N(1-PC)^1(PT+PA)^2(PC+PG)^1(PA or PT)^4(PC or PG)^4(PT+PG)^1 
References for consensus sequence:  Gata-1 binding sites identified by Transfac [135] 
were stated to be GataC sites, because GataC is a homolog of Gata-1 [136]. 
 
Su(H)  
Consensus sequence:  (C/G)(G/A)TG(A/G)GA(A/T/G) 
Formula:  2N(PC+PG)^1(PG+PA)^2(PA or PT)^2(PG)^2(1-PC)^1 
Reference for consensus sequence:  [137] 
 
Runx 
Consensus sequence:  (C/T)G(C/T)GGTn 
Formula: 2N(PC+PT)^2(PG)^3(PT)^1 
References for consensus sequence:  [63, 125] 
 
TCF 
Consensus sequence:  ACAAAG 
Formula:  2N(PA)^4(PA or PG)^2 




 Fig. 3.1 on page 64 presents the predicted and actual numbers of potential 
binding sites in each regulatory region for the transcription factors presented in Table 3.1, 
and indicates whether the difference between predicted and actual values are statistically 
significant, as determined by Goodness of Fit  Tests (G Tests) [138], by providing the p 
values in each case of a statistically significant difference.  The calculations used to 
perform these tests are shown in Appendix F, Fig. F.1  (see separate Excel file provided).  
As described in Robin et al., the Goodness of Fit Test, can be used to determine whether 
a sequence motif is significantly more or less represented in one sequence than another 
[139].  Although Robin et al. were comparing counts of motifs in two different 
sequences, the Goodness of Fit Test was appropriate in the individual analysis of each 
regulatory region of Sp-CycD because the distributions of the predicted numbers of each 
binding site are not normally distributed.  Rather, each starts at zero, rises to a mean that 
is the predicted number of binding sites, then decreases to successively smaller values.  
Each of these distributions is therefore skewed to the left.  As shown in Appendix F (in 
separate Excel file), each G test examined sufficient numbers of binding sites to be 
reliable, because, for each binding site, the G score was calculated by using the predicted 
and actual numbers of not only the binding site in question, but also, its non-version.    
For example, region 2 had 2.4 expected Otx binding sites and about 598.1 expected non-
Otx binding sites.  These non-Otx binding sites would be motifs of the same length as the 
Otx binding site, but with different sequences.  Therefore, information encompassed in 
the whole sequence was taken into account when undertaking the statistical calculation.  
In the current example, the sequence would be considered a population of Otx binding 
sites and non-Otx binding sites, ultimately summing up to all sites of the same length in 
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that sequence. The degrees of freedom for each G test, where N = the number of 
sequence categories being tested (with N designating, in the above example, Otx binding 
sites and non-Otx binding sites) was N -1 = 2-1 = 1.  The statistical analysis was similar 
to that which would be performed to compare the predicted number of offspring bearing 
each phenotype to the observed number in a genetic cross.  In that case, also, one desires 
to know whether the numbers of each phenotype, which ultimately sum up to all the 
phenotypes in the entire population of offspring, are statistically significant [138].   
 In terms of statistical significance, a p value cutoff of 0.10 was considered to be 
statistical significant.  Although this was greater than the customary value of 0.05 [138], 
using a higher cutoff would provide greater assurance that no binding sites of interest, 
whose function could be confirmed or refuted by future experimental analysis, would be 
over-looked.  As shown in Fig. 3.1, Appendix F and in the text below, the actual p values 
for all significantly represented transcription factor binding sites are provided in all cases.   
 The locations of potential binding sites for transcription factors of interest 
within the sequence of each active region are shown in Appendix D, which highlights 
each consensus sequence and also cites references from which these consensus sequences 
were taken.   
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Fig. 3.1.  Number of potential binding sites in regions and subregions of Sp-CycD for 
selected transcription factors discussed in the text.  For each transcription factor 
binding site in each regulatory region, both the predicted number and actual number of 
potential binding sites in each region are provided.  Whether the difference between the 
predicted and actual number of binding sites for each transcription factor in each 
regulatory region was significant, as determined by a Goodness of Fit Test, is indicated in 
each graph by the p values appearing above different comparisons.  If a p value is not 
shown, this indicates that the difference between actual and predicted number of a given 
binding site was not statistically significant.  Statistical calculations were done as 







 The expression profiles of transcription factors that could regulate the 
expression of Sp-CycD have been worked out [124].  The expression profiles of some of 




Fig. 3.2.  Expression profiles of selected transcription factors discussed in the text.  
These expression profile graphs were taken directly from SpBase [3], and the original 
data are from Tu et al [124].  If multiple graphs are shown in a panel, the graph 
corresponding to the gene of interest is labeled. 
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3.3  Are transcription factors directly downstream of Wnt-beta catenin and Delta-
Notch signaling regulators of Sp-CycD expression during embryogenesis? 
 In S. purpuratus, the developmental divergence of the endodermal and 
mesodermal lineages from endomesoderm (one of the two major areas, the other being 
oral ectoderm, where Sp-CycD expression becomes confined as embryogenesis proceeds 
[62]) is primarily directed by the Delta-Notch and Wnt-beta catenin signaling pathways 
[111, 140, 141].   Endodermal and mesodermal fates are attained by gradual activation of 
solely Wnt-beta catenin signaling in presumptive endoderm and Delta-Notch signaling in 
presumptive mesoderm [141].  Within presumptive mesoderm, Delta-Notch signaling 
inhibits expression of Hox 11/13B, which is a key transcription factor in an endoderm-
specific gene regulatory subcircuit that contains the transcription factors Bra, Foxa, and 
Blimp1b.  When allowed to be active, this regulatory subcircuit also leads to the 
maintenance of expression of the Wnt ligand.  Furthermore, in presumptive mesoderm, 
Delta-Notch signaling triggers export of TCF transcription factors from cell nuclei.  This 
makes these cells resistant to Wnt signaling, prevents them from becoming induced to 
become endoderm, and sets them on a developmental trajectory to become mesoderm 
[141]. Therefore, one role for Delta-Notch signaling within presumptive mesoderm is an 
inhibitory one:  inhibiting the expression of genes involved in the specification of 
endoderm.   
 The above description would suggest that mesoderm formation induced through 
Delta-Notch signaling takes place solely through a passive process – the inhibition of 
Wnt signaling.  However, Su(H), the transcription factor induced by Delta-Notch 
signaling, directly activates expression of the transcription factors HesC, Gcm and Gatae 
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in presumptive non-skeletogenic mesoderm [55].  Regarding presumptive endoderm, 
since Hox 11/13B is not inhibited by Delta-Notch signaling in this lineage, expression of 
the Wnt ligand is able to be maintained there. This activates beta-catenin, which interacts 
with the TCF transcription factor, converting it from an inhibitor to an activator of 
transcription of endodermal-specific genes.  This further sets this region on a trajectory to 
become endoderm [141].  
 To gain insight into how the expression of Sp-CycD might be regulated during 
the specification of endoderm and mesoderm, the active regulatory regions within it were 
queried for possible binding sites for the above described transcription factors whose 
expression is regulated by Wnt-beta catenin and Delta-Notch signaling (Fig 3.1; 
Appendix D, Fig. D.1).   
There is evidence, based on sequence analysis of active regions for potential TCF 
binding sites, that Sp-CycD expression is regulated by the Wnt-beta catenin-TCF pathway 
(Fig. 3.1; Appendix D, Fig. D.1; Appendix F, Fig. F.1).  Of the active regulatory regions, 
regions 5 (p<0.01), 6 (p<0.10) and 19 (p<0.10) all have significantly more potential TCF 
binding sites than would be predicted by chance (Fig. 3.1; G-test results in Appendix F, 
Fig. F.1). Potential binding sites for TCF within region 5 all fall within subregion 5-1 
(Appendix D), which, as described in Chapter 2 (Fig. 2.4), is an inactive subregion.  This 
does not mean that these TCF sites are non-functional.  The fact that there are 6 such 
potential sites within a relatively short sequence argues against that idea, as does the fact 
that this number of TCF binding sites in subregion 5-1 compared to the number predicted 
is clearly statistically significant (p value <0.001) (Fig. 3.1; Appendix F).  Rather, it is 
hypothesized based on these findings that TCF is necessary but not sufficient to induce 
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the activity of region 5.   Regarding region 6, all of the potential TCF binding sites fall 
within subregion 6-1, (Appendix D, Fig. D.1).  In addition, like region 6, the number of 
TCF binding sites compared to the number predicted in subregion 6-1 is statistically 
significant (p<0.025; Fig. 3.1 and Appendix F, Fig. F.1). This finding supports the 
proposition that TCF may regulate the activity of region 6, and that of subregion 6-1 
within it. 
Region 19 has the greatest number of potential TCF binding sites of all the active 
regions (Fig. 3.1; Appendix D, Fig. D.1).  In addition, the number of such sites is 
significantly more than would be predicted (p value < 0.10; see Appendix F, Fig. F.1; and 
Fig. 3.1).  Therefore, TCF likely plays a role in regulating the activity of region 19.  This 
hypothesis is further supported based on the locations of the potential TCF binding sites 
within active region 19 and inactive subregion 19-1.  All but one of the 7 potential TCF 
binding sites fall outside of subregion 19-1 (Appendix D, Fig. D.1).  Since region 19 as a 
whole is active, this finding further strengthens the hypothesis that TCF regulates the 
activity of region 19.    As discussed below, region 19 contains binding sites for other 
potentially regulatory transcription factors as well. 
To determine which regulatory regions might be regulated by Delta-Notch 
signaling, potential Su(H) binding sites in the regulatory regions of Sp-CycD were 
searched for based on the sequences of Su(H) binding sites given in a 2006 paper by 
Ransick and Davidson [137].    The only potential Su(H) binding sites were found within 
regions 2 and 17, which each bore one such site.  However, this number was not 
statistically significant for either of these regions, as determined by a G test (Fig. 3.1; 
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Appendix F, Fig. F.1).  Related to this, Region 19, which was predicted, based on its 
length to have ~2 Su(H) binding sites, bore none, significantly less than expected (p < 
0.05).  None of the active regions had any identified binding sites for the transcription 
factors HesC or Gcm, whose transcription within presumptive non-skeletogenic 
mesoderm is directly activated by Su(H) [55].  However, Su(H) also activates the 
expression of Gatae in non-skeletogenic mesoderm [55].  Region 19, which, as discussed 
later in this Chapter, could play an important role during gastrulation, when mesodermal 
cells, such as blastocoelar cells, delaminate from the archenteron [142], has significantly 
over-represented binding sites for Gatae (p < 0.01; see Fig. 3.1 and Appendix F).  
Therefore, Delta-Notch signaling could indirectly regulate the expression of Sp-CycD 
through region 19 by activating expression of Gatae.     
There is additional evidence that Delta-Notch signaling could indirectly regulate 
the temporal transcription of Sp-CycD.  As described near the end of section 3.4, the 
regulatory regions of Sp-CycD all contain many potential binding sites for Gatac at levels 
much greater than would be predicted by chance (see Fig. 3.1; in all cases, p < 0.001).  
Because this transcription factor is activated downstream from Delta-Notch signaling 
[143], Delta-Notch signaling could regulate the expression of Sp-CycD indirectly via this 
transcription factor.    
In addition, Delta-Notch signaling could act in another capacity – an inhibitory 
one.  As described above, Delta-Notch signaling during embryogenesis in sea urchin 
leads, within presumptive mesoderm, to the inhibition of a subcircuit containing the 
transcription factors Bra, Foxa, and Blimp1b that are involved in the specification of 
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endoderm.   Of these, as discussed again below, Foxa is the transcription factor whose 
change in expression mediated by Delta-Notch signaling would most likely affect the 
expression of Sp-CycD, through region 5.  This is because region 5 bears three potential 
Foxa binding sites, a statistically significant number (p < 0.01), since this region was not 
predicted to bear any such sites (Fig. 3.1).  In contrast, Blimp1b binding sites are not 
found within any of the regulatory regions of Sp-CycD discovered in this analysis, and 
Bra is not statistically over or under-represented in any region.   
The explanation for why cyclin D can be expressed in mesoderm may lie partly in 
the fact that, while TCF can act as a transcriptional activator, as it does when beta-catenin 
is triggered by Wnt signaling to translocate to the nucleus, in the absence of such 
signaling, TCF, by complexing with Groucho, acts as a transcriptional repressor [144].  
Delta-Notch signaling can trigger export of TCF from the cell nuclei [141].  It is possible 
that Delta-Notch signaling, by triggering the export of inhibitory TCF from cell nuclei in 
mesoderm, removes this repressive barrier and allows Sp-CycD to be expressed in this 
lineage.   
One way to test if Delta-Notch signaling regulates the expression of Sp-CycD 
would be to compare the transcript levels of cyclin D in control embryos to those in 
which Notch signaling was blocked.  Notch signaling occurs when the binding of Delta 
ligand on one cell binds to the Notch receptor on an adjacent cell, triggering the enzyme 
gamma secretase to cleave an intracellular portion of the Notch receptor [145] . Since this 
signaling can be blocked by administering inhibitors of gamma secretase [145], it is 
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proposed that such inhibitors could be used to test the effect of inhibiting Notch signaling 
on the expression of Sp-CycD during embryogenesis.  
3.4  Does a conserved subcircuit that regulates the specification of endoderm and 
mesoderm contribute to the regulation of Sp-CycD expression during embryogenesis 
in S. purpuratus? 
 In section 3.3, the roles of Delta-Notch and Wnt-beta catenin-TCF signaling in 
possibly regulating the expression of Sp-CycD was discussed.  As noted, these pathways 
are important in inducing the formation of mesoderm and endoderm, respectively.  Based 
on this theme – the relationship between regulation of expression of Sp-CycD and the 
formation of mesodermal and endodermal lineages, this section explores whether a 
conserved subcircuit within the GRN controlling the development of mesoderm and 
endoderm could regulate the expression of Sp-CycD.   The conservation of this subcircuit 
was uncovered through a comparative study of the endomesoderm GRNs of the sea 
urchin S. purpuratus and the sea star A. miniata [130, 131].   This study revealed 
transcription factors of which both their identities and pattern of linkages to other 
transcription factors is conserved.  These transcription factors included Blimp1, Otx, Bra, 
Foxa, Gatae, Gatac, and Bra [130].  The lineage specifying functions of these 
transcription factors were also conserved.  That is, in both sea urchin and sea star, 
Blimp1, Bra and Foxa contribute to the specification of endoderm; Gatac contributes to 
the specification of mesoderm; and Gatae and Otx contribute to the specification of both 
endoderm and mesoderm [130].  An important purpose of the conserved subcircuit 
between sea urchin and sea star is to ultimately allow the expression of Gatae [131].  
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While, as just noted, this transcription factor is expressed in both mesoderm and 
endoderm, its expression is essential for the expression of regulatory genes expressed in 
the endoderm [130, 131].  A direct reproduction of a figure from the 2007 paper by this 
group is given in Fig. 3.3.  Both the transcription factor genes and many of the linkages 
between them by which they regulate each other’s expression are conserved in both sea 




Fig. 3.3. The GRN subcircuit specifying endomesoderm in sea urchin and sea star.  
Taken from [130]. 
 
 Since the sea urchin and sea star last shared a common ancestor ~500 million 
years ago [130], this conservation in terms of identity, linkages and functions of each of 
these transcription factors was considered to be remarkable [130].  Regarding the analysis 
presented in this Chapter, each regulatory region of Sp-CycD was queried for potential 
binding sites for transcription factors expressed in this conserved subcircuit (Fig. 3.1; 
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Appendix F, Fig. F.1).  Within this section, each region is discussed separately for 
potential binding sites for all transcription factors expressed within this conserved 
subcircuit except for Gatac.  Since all the regulatory regions bore significantly more 
potential binding sites for this transcription factor than would be predicted based on their 
lengths (Fig. 3.1; Appendix F, Fig. F.1), and since the number of binding sites were 
statistically significant in all cases (Fig. 3.1; Appendix F, Fig. F.1) the possible roles of 
this transcription factor in regulating the expression of Sp-CycD are discussed primarily 
at the end of this section.  
 Region 2 is notable for bearing 8 potential binding sites for Otx, which is 
expressed in the gut [130] (p < 0.01; Fig. 3.1; Appendix F, Fig. F.1), whereas it would be 
predicted to bear only 2 of these binding sites.   As shown in Moore et al. [62], one of the 
lineages where Sp-CycD becomes confined as development proceeds is the gut.  It is 
hypothesized that one of the regulatory regions responsible for this expression pattern is 
region 2, and that region 2, in part, mediates this through its Otx binding sites.   
 As described in Chapter 2, region 2 also bears within it an active subregion, 2-2, 
whose expression profile is similar in shape to that of region 2 (Chapter 2, Figs. 2.8 and 
2.9).  None of the potential Otx binding sites in region 2 are within the boundaries of 
subregion 2-2.  These potential Otx binding sites in region 2 are likely to be important 
due to their statistical over-representation (Fig. 3.1; Appendix F, Fig. F.1; p < 0.01).  
Binding sites for Otx can also serve as binding sites for the transcriptional repressor Gsc 
[146].   It could be argued that lack of binding sites for a repressor, such as Gsc, may 
explain why subregion 2-2 has a higher activity profile than region 2.  In terms of 
activating the activity of subregion 2-2, Gatac could play an important role, as potential 
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binding sites for this transcription factor are over-represented in region 2 (p < 0.001; Fig. 
3.1; Appendix F, Fig. F.1).  Of note, of the discussed transcription factor binding sites, 
only Gatac binding sites are significantly over-represented in subregion 2-2.  Therefore, 
Gatac may be the only one of the discussed transcription factors that could be activating 
subregion 2-2.   
 Region 4 is most notable for containing an excess of potential Gatac binding 
sites (p < 0.001; Appendix F, Fig. F.1; Fig. 3.1).  Region 4 does not bear an excess of 
actual to predicted binding sites for any other transcription factors conserved within the 
conserved endomesoderm-specifying subcircuit.  This could indicate that the expression 
of this region is controlled primarily by Gatac.   Alternatively, the fact that a regulatory 
region does not bear a statistically significant number of binding sites for a transcription 
factor of interest does not mean that the binding sites it does possess are non-functional.  
Indeed, the number of potential Runx binding sites in region 4 (2 actual vs. ~ 2 predicted; 
see Fig. 3.1; Appendix F, Fig. F.1) was not significant. However, as described in both 
Chapter 2 and section 3.5, one of these Runx binding sites has been confirmed previously 
to be functional.   As described in Chapter 2, region 4 bears two subregions, 4-1 and 4-2, 
which were active (Fig. 2.8), although their temporal activity profiles were not compared 
quantitatively to that of region 4.  It is of interest that two subregions separated by 
intervening sequence, as is the case for subregions 4-1 and 4-2 in region 4 (Appendix D, 
Fig. D.1) could both be functional, indicating that both could be separate CRMs. 
 Region 5 was of strong interest due to it having by far the most robust activity 
of all the active regulatory regions identified in Sp-CycD, showing statistically significant 
activity at all developmental time points examined from when Sp-CycD becomes induced 
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at ~10-12 hours post-fertilization (hpf) through mid-gastrula stage (Chapter 2, Fig. 2.3).  
These results would indicate that region 5 would have many linkages to transcription 
factors expressed in the endomesoderm GRN.  The analysis of region 5’s sequence for 
binding sites for such transcription factors indicates that, indeed, this may be the case.   
Region 5 bears six potential binding sites for Gatae (Fig. 3.1; Appendix D, Fig. D.1), 
although this number was not significantly more than the ~ 7 such sites predicted (Fig. 
3.1; Appendix F, Fig. F.1).  Region 5 also contains three potential binding sites for Foxa 
(Fig. 3.1) compared to none predicted (p value <0.01; Fig. 3.1; Appendix F, Fig. F.1).  
What is especially interesting regarding the potential Foxa binding sites is that region 5 is 
the only region with binding sites for this endoderm-specifying transcription factor (Fig. 
3.1).   The expression of this transcription factor commences at ~10 hpf (as shown at 
SpBase [3]), which would support the hypothesis that it could contribute to the induction 
of region 5’s activity.  The potential binding sites of Foxa are all within subregion 5-1 
(Appendix D, Fig. D.1).  The fact that this subregion is inactive does not mean that these 
Foxa sites are non-functional.  Given their over-representation within this subregion, 
three sites compared to the zero predicted by chance (p < 0.001) (Fig. 3.1; Appendix F, 
Fig. F.1), that hypothesis is unlikely.  Rather, it is proposed that the Foxa sites are 
necessary but not sufficient for the activity of region 5.   
 In a related finding, region 5 bears a potential binding site for the endoderm-
expressed factor Bra.  Although the possession of one such site was not statistically 
significant (Appendix F, Fig. F.1; Fig. 3.1), it could still be of interest.  Along with region 
6 (where the possession of a single potential binding site for Bra is likewise not 
statistically significant as shown in Appendix F, Fig. F.1; and Fig. 3.1), region 5 is one of 
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only two of the six regulatory regions that has a binding site for Bra.    In support of a 
functional role of Bra in regulating the expression of regions 5 and 6, subregion 5-1, 
which is inactive (Chapter 2, Fig. 2.4) lacks a potential binding site for Bra, while 
subregion 6-1, which, like region 6, is active (Fig. 2.8) contains region 6’s potential Bra 
binding site.   
 Region 5 also bears six potential binding site for Otx (Fig. 3.1), a significant 
number (p < 0.01; Fig. 3.1; Appendix F, Fig. F.1).  Of interest, the potential binding sites 
for Bra and Otx fall in the regions located 5’ and 3’ to inactive subregion 5-1 (Appendix 
D, Fig. D.1).  The majority of the other potential transcription factor binding sites in 
region 5 fall within subregion 5-1.  From these findings, it is hypothesized that the 
transcription factor binding sites within region 5 that are within the boundaries of 
subregion 5-1 are necessary but not sufficient to allow the activity of region 5, and, by 
extension, of Sp-CycD.  For region 5 to be activated, the above noted Bra and Otx sites, 
which are outside the boundaries of subregion 5-1, may be critical.    
 It would be informative to compare the spatial expression of region 5 to that of 
the other regions, and to test the effect of mutating the above noted transcription factor 
binding sites on that activity pattern.  It would be predicted, based on its possession of 
binding sites for both Bra and Foxa, both of which are endoderm-specifying transcription 
factors [130], that region 5 would be more strongly expressed in endoderm than the other 
regions, but, due to also containing binding sites of transcription factors Gatac and Otx, 
(Fig. 3.1), that are expressed in mesoderm; and in both mesoderm and endoderm, 
respectively, would also be expressed in mesoderm.  Indeed, region 5 may play an 
especially important role in allowing Sp-CycD to be expressed in both of these lineages. 
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 As has already been partly discussed, region 6 has nearly the same contingent of 
transcription factor binding sites as region 5, with most of these sites falling within 
subregion 6-1, which shows a similar temporal expression profile to the whole of region 
6.  However, unlike region 5, region 6 does not include any site for Foxa.  In addition, 
unlike region 5, which has significantly more than predicted potential binding sites for 
Otx, region 6 does not possess sufficient Otx sites compared to the number predicted to 
reach statistical significance (Fig. 3.1; Appendix F, Fig. F.1). These observations  may 
explain why its expression is much lower, in absolute levels, than that of region 5.  It 
would also be predicted that region 6, along with other regions that lack Foxa, might have 
less of a role in mediating the expression of Sp-CycD in endoderm than would region 5.  
This would be tested by examining spatial activity profiles of region-linked reporters.   
 Region 17, the region with the lowest activity level of all the regulatory regions 
(Chapter 2), is also notable for bearing five potential binding sites for a transcription 
factor from the conserved endoderm-mesoderm specifying subcircuit, Gatae.  However, 
approximately 6 such sites were predicted, and the possession of five such sites was not 
statistically significant (Fig. 3.1; Appendix F, Fig. F.1).   However, other than Gatac, 
Gatae provides the best candidate for functional analysis, simply because binding sites 
for several other candidate regulators were either missing, or were under-represented 
(Fig. 3.1; Appendix F, Fig. F.1).  Otherwise, compared to the other regulatory regions of 
Sp-CycD, region 17 has the least number of potential binding sites for the above 
discussed transcription factors.  This sparseness of binding sites for regulatory 
transcription factors may account for region 17 having the lowest activity of all 
discovered regulatory regions of Sp-CycD.  This does not mean that this region has an 
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unimportant regulatory role.  The fact that its activity continuously rises argues against 
this.  The fact that its activity is low could in fact argue that this region plays an 
important role in mediating the spatial activity of Sp-CycD as this gene’s spatial activity 
becomes increasingly restricted after gastrulation.  This finding may relate to that of a 
cis-regulatory analysis done by Arone and Davidson from 1998 [147], where they 
showed that a cis-regulatory module required for expression of the CyIIa gene, which is 
expressed after most cell types have already been specified, is much simpler in structure 
than that of the cis-regulatory modules controlling the expression of genes that are 
expressed earlier in development, when territories are still being specified (as reviewed in 
a 1997 paper by the same authors) [148].  Region 17 becomes most active (by ~21 hpf, as 
shown in Chapter 2, Fig. 2.6), as Sp-CycD is becoming restricted to cells in well 
established territories, such as the gut and oral ectoderm [62].  Based on the work of 
Arone and Davidson just described, a relatively simple regulatory structure might 
therefore be expected of region 17. 
 Region 19 was most notable for having a distinctive temporal activity profile 
that reproducibly peaked at ~21 hpf, a time point that occurs shortly before gastrulation 
begins (Chapter 2, Fig. 2.6).  As described in Chapter 2, region 19 contains a subregion, 
19-1, which, by itself, is not functional.  Located 3’ with respect to subregion 19-1 is 
sequence that is rich in potential binding sites for various transcription factors of interest 
(Appendix D, Fig. D.1).  Four of these transcription factors have numbers of potential 
binding sites that occur significantly more often than would be predicted by chance 
within the whole of region 19 (Fig. 3.1; Appendix F, Fig. F.1).  It should be noted here 
that although region 19 possesses fewer potential Runx binding sites that would be 
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predicted based on its length (4 actual vs. ~ 5 predicted, a non-significant difference; Fig. 
3.1), one of the potential Runx binding sites overlaps with a potential TCF binding site 
(Appendix D, Fig. D.1, toward 3’ end of region 19).  This finding is of interest because 
region 19 is the only one of the identified regulatory regions of Sp-CycD that shows this 
overlap between a potential Runx and TCF binding site. This overlap could indicate that 
this potential TCF site is functional, for reasons described in the next section.  As 
described in section 3.3, TCF acts directly downstream of Wnt-beta catenin signaling that 
is involved in the specification of endoderm.  Given that the activity of region 19 peaks at 
~21 hpf, which just shortly precedes the beginning of gastrulation [43, 111], the 
overlapping potential Runx and TCF site in region 19 could contribute significantly to 
this temporal activity pattern.   
 A general observation is that none of the regulatory regions of Sp-CycD had any 
potential binding sites for Blimp1 (Fig. 3.1). However, this does not preclude the 
regulation of Sp-CycD transcription by this transcription factor.  This is because within 
the endomesoderm specifying subcircuit conserved between sea urchin and starfish, the 
Otx and Blimp1 genes regulate each others’ expression through a positive feedback loop, 
in which each gene activates transcription of the other [130].  Blimp1 could thus regulate 
the expression of Sp-CycD indirectly by regulating the transcription of Otx, for which, as 
noted, regions 2, 5 and 17 have significantly over-represented potential binding sites (Fig. 
3.1). 
 Of potential binding sites for transcription factors in the conserved GRN 
subcircuit, the most prevalent are those for TRANSFAC 4.0 flagged binding sites for 
Gata1 (Appendix D, Fig. D.1; Fig. 3.1).  All the identified regulatory regions of Sp-CycD 
83 
 
possess statistically significant numbers of potential binding sites for this transcription 
factor (p < 0.001 in all cases; Fig. 3.1; Appendix F, Fig. F.1).    These sites were 
hypothesized to mark potential binding sites for Gatac, since Gatac is a homolog of 
vertebrate Gata1/2/3 [136].  Gatac is expressed strongly in blastocoelar cells, which act as 
immune cells, as shown in unpublished work by Rast, and described in [130] and [142]. 
In addition, the transcription of Gatac is regulated by the Delta-Notch-induced 
transcription factor Gcm, and also, by another transcription factor within the conserved 
endomesoderm-specifying subcircuit, Gatae [130].  Delta-Notch activated Gatac has also 
been shown to be expressed in the non-skeletogenic mesoderm [143] from which the 
blastocoelar cells are derived [142].  Delta-Notch signaling could therefore contribute to 
the regulation of Sp-CycD expression in non-skeletogenic mesodermal-derived cells, such 
as blastocoelar cells, through activation of Gatac.   
 Also of interest, in several instances (Appendix D, Fig. D.1), the potential Gatac 
binding sites overlap with the binding sites for other transcription factors, including TCF, 
Gatae, Otx and Runx, indicating potential cooperative interactions.  Since the marked 
potential Gatac sites are TRANSFAC-identified binding sites for Gata1, they may not all 
correspond to Gatac sites.  However, any region that possesses such sites would have the 
potential to be expressed in blastocoelar cells.  This could be readily tested. 
3.5  Do Runx transcription factors regulate the expression of Sp-CycD during 
embryogenesis in S. purpuratus? 
 Runx transcription factors are developmentally important  proteins that regulate 
transcription by interacting with other developmentally expressed transcription factors 
[132].  Moreover, Runx transcription factors interact with the two signaling pathways – 
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Wnt-beta catenin and Delta-Notch [132] – that, as described in section 3.3, are involved 
in the specification of endoderm and mesoderm.  It was shown by Robertson et al. [63] 
that SpRunt1 binds to and regulates the expression of the Wnt8 gene, which functions 
upstream of TCF.  There is also evidence that Runx transcription factors regulate the 
expression of cyclin D genes.  The embryonically expressed Runx gene SpRunt1 shows 
an expression profile similar to that of Sp-CycD, being globally expressed at 
mesenchyme blastula stage, then becoming restricted mainly to gut and oral ectoderm 
[114].  In addition, as described by Robertson et al. [63], knockdown of  SpRunt1 leads to 
under-expression of Sp-CycD.  Also, as described in Chapter 2, chromatin 
immunoprecipitation experiments indicate that SpRunt1 binds to one of the predicted 
Runx binding sites in region 4, within sequence corresponding to subregion 4-1.   Along 
with this, potential Runx binding sites are distributed among several of the regulatory 
regions of Sp-CycD.   
 Since Runx transcription factors carry out their functions by interacting with 
other transcription factors, the binding sites of strongest interest included those that were 
adjacent to or overlapped for binding sites for other transcription factors discussed in this 
Chapter (see Appendix D).  This is true for region 2, where, toward the 3’ end, a potential 
Runx binding site overlaps with a potential Gatae site; and, as first introduced in the 
previous section, for region 19, where a potential Runx binding site overlaps with a 
potential binding site for TCF.  Regarding the sequence site in region 19 where a 
potential Runx binding site overlaps with a potential TCF binding site (Appendix D, Fig 
D.1), there is reason to propose that this overlap could be functional, based on the 
findings and discussion presented by Robertson et al. [63].  In that study, the transcription 
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of the Wnt8 gene was shown to be regulated by a cis-regulatory element in which a TCF 
binding site overlapped on its 3’ end with a Blimp1 binding site.  Since it was known that 
binding of TCF to can induce looping of that DNA, which in turn can cause nearby 
transcription factors that bind to sites in that loop to functionally interact with each other, 
it had been predicted by Minokawa et al. that just upstream of the TCF binding site, there 
existed the binding site for another transcription factor [63, 101].  Robertson et al. 
showed that this was a Runx binding site, and demonstrated that it was functional using 
site-directed mutagenesis.   
 The 3’ end of the overlapping potential TCF and Runx binding sites in region 
19 ends at position 4186  (Appendix D, Fig. D.1).  Of interest, a potential binding site for 
Gatac was found about 50 bp from the 3’ end of the overlapping potential Runx and TCF 
binding sites.  There were also several other instances of Runx and Gatac binding sites 
being in close proximity, sometimes adjacent or overlapping (Appendix D, Fig. D.1).  In 
addition, analysis of the region 19 sequence with TRANSFAC 4.0 revealed a potential 
binding site for C/EBPalpha from position 4182 to 4191 (data not shown), a position that 
overlapped with this potential Runx binding site. This latter finding was of interest 
because Puig-Kroger et al. (2003) [149] found that Runx and C/EBP transcription factors 
regulated the CD11a integrin gene in myeloid cells by binding to overlapping binding 
sites within the regulatory region of this gene.  In S. purpuratus, blastocoelar cells, 
which, which, like myeloid cells, are immunocytes [142], delaminate from the tip of the 
ingressing gut [142].   Region 19, its activity peaking at ~21 hpf, could, in addition to 
perhaps acting as a switch to contribute to expression during gastrulation, also help 
activate expression during the differentiation of future blastocoelar cells. 
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 It should be noted that the existence of a Runx binding site without any nearby 
binding sites for other transcription factors discussed in this Chapter does not diminish 
the potential importance of these sites.  One example of such a site would be the earlier 
mentioned potential binding site for SpRunt1 in subregion 4-1, which does not overlap 
with or fall adjacent to any binding sites for the transcription factors discussed in this 
Chapter.  There could be other, non-discussed transcription factors with which SpRunt1 
could interact.  In the case of the Runx binding site in region 4, this site extends from 
position 725-731 within this region.  Analysis of the region 4 sequence for TRANSFAC 
4.0 identified transcription factors revealed binding sites for several nearby transcription 
factors, including Sp1 and USF (data not shown). That the Sp1 and Runx binding sites 
could function together is based on the finding that an enhancer active in osteoblasts was 
bound by both of these transcription factors, although the binding sites were separated by 
about 25 bp [150].  From this discussion, it is argued that, although the regulatory regions 
of Sp-CycD each bear less than the predicted number of potential Runx binding sites (Fig. 
3.1), at least some of these sites, including at least one in region 4, and perhaps those that 
may mediate the interaction of Runx with other transcription factors, either are, or could 
be functional. 
   
3.6  Is Sp-CycD transcription during embryogenesis regulated by transcription 
factors involved in the specification of oral ectoderm? 
 During and after gastrulation, as noted, the expression of the cyclin D gene in 
the sea urchin becomes confined to the endomesoderm, oral ectoderm and ciliary band.  
In the previous sections of this Chapter, discussion focused on the transcriptional inputs 
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that might regulate the expression of Sp-CycD in the endomesoderm.  The purpose of this 
section is to identify transcriptional inputs that could regulate the expression of Sp-CycD 
in another region where it becomes confined during and after gastrulation:  the oral 
ectoderm. The structure of the GRN that contributes to the development of the ectoderm 
in S. purpuratus [55, 151] was more recently deciphered than that of the endomesoderm 
GRN [152].  The expression patterns of the transcription factors comprising this GRN are 
regulated by Nodal signaling, the distribution of which along the oral-aboral axis is 
regulated by Lefty and a mitochondrial redox gradient [153-155].  Among the 
transcription factors expressed within this GRN [151] that could regulate the expression 
of Sp-CycD, focus is made on  Pax41 and Gsc.  These two transcription factors may play 
roles in regulating the expression of Sp-CycD by directly binding to its regulatory 
regions.  With respect to Gsc, this transcription factor acts as a transcriptional repressor in 
the oral ectoderm [151], restricting the expression of a number of genes.  In 2001, the 
Angerer lab showed if translation of Gsc was blocked, then both gastrulation and the 
separation of the ectoderm into oral and aboral lineages were blocked or inhibited [146]. 
Related to this finding, this transcription factor was shown to be expressed in some cells 
of the vegetal plate that later ingressed during gastrulation, and to be strongly expressed 
in lineages that became the oral ectoderm [146].  Further study showed that Gsc 
competed for the same binding sites as Otx, a transcription factor expressed throughout 
the ectoderm (along with endomesoderm, as described in section 3.4).  By doing so, Gsc 
interfered with the function of Otx in presumptive oral ectoderm, and contributed to the 
development of this lineage.  Since Otx and Gsc bind to the same sequence, at least some 
of the potential Otx binding sites in regulatory regions can also be hypothesized to be 
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potential Gsc binding sites.  Regions that bear significantly greater than the predicted 
number of binding sites for Otx, and therefore, for Gsc, include regions 2  and 5 (p < 0.01 
in both cases; Fig. 3.1; Appendix F, Fig. F.1).  One observation that requires further 
analysis is that oral ectoderm is one of the areas where Sp-CycD expression becomes 
confined as development proceeds [62].  Given that Otx is a transcriptional activator and 
Gsc is a repressor, further work is needed to determine how each cooperate to regulate 
the expression of Sp-CycD. 
 As noted, another transcription factor involved in the specification of the oral 
ectoderm GRN, Pax4, is likewise a possible candidate for regulating the expression of 
Sp-CycD within the oral ectoderm.  This transcription factor is expressed relatively early 
during development, with it showing its second highest expression level at 10 hpf, before 
peaking at 18 hpf (Fig. 3.2, taken from SpBase [3]).  Related to this finding, a sequence 
within region 5, the region with the highest early activity, identified by Cluster-Buster 
[127] as an area where transcription factors might cluster was shown to have a ten closely 
spaced potential binding sites for mammalian Pax4, with some of these sites overlapping 
(Appendix D, Fig. D.1; Appendix E, Fig. E.1).  Although the transcription factor binding 
sites identified by Cluster-Buster are not from S. purpuratus, human and mouse Pax4 are 
both homologs to Pax4 of S. purpuratus [51].  Therefore, the potential Pax4 binding sites 
identified by Cluster-Buster are putative binding sites for Sp-Pax4, which therefore may, 
by acting through region 5, medidate the expression of Sp-CycD in oral ectoderm.  
Region 5 and 17 have both been described as possibly contributing to the expression of 
Sp-CycD in the oral ectoderm, and they may divide their labor.  Region 5 may function 
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early, as oral ectoderm is being specified, whereas region 17 may function later, as this 
territory becomes a discreet and mature part of the embryo. 
 Table 3.2 summarizes the major findings for each regulatory region discussed in 
both Chapter 2 and the current Chapter.   
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Table 3.2:  Regulatory regions found in Sp-CycD, and their major points of interest  
Note:  This table encompasses three pages. 
 











Potential transcription factor 
binding sites of interest, and 
rationale for that interest 
2 Upstream Begins by 10-
12 hpf, peaks at 















than region 2. 
Otx binding sites are 
significantly over-represented, 
and may mediate activity in 
endoderm and mesoderm. Otx 
sites are also potential binding 
sites for inhibitory Gsc.  
Gatac binding sites, potentially 
activated via Delta-Notch 
signaling, may be responsible 
for activating these regions. 
4 Upstream Increases to 
relatively low 
but stable levels 
by 21-33 hpf, 






4-1 and 4-2 Gatac binding sites are 
significantly over-represented. 
Runx binding sites are not 
statistically over-represented, 
but a Runx site in subregion 4-1 
was previously verified by ChIP 




Table 3.2 continued 
5 Intronic The most active 
region. Most 




















5-1 may be 
inactive due 









represented binding sites for 
Otx, Foxa, Gatac and TCF. 
Region 5 is the only region to 
bear binding sites for 
endoderm-specifying Foxa. All 
these Foxa sites are within 
inactive subregion 5-1, so may 
be necessary but not sufficient 
for region 5’s activity. 
Bra binding sites are not over-
represented but may be required 
for activity, since inactive 
subregion 5-1 lacks a Bra 
binding site. 
Area in need of further 
investigation:  The Otx binding 
sites are also potential binding 
sites for inhibitory Gsc.  Gsc is 
expressed in oral ectoderm, 
where Sp-CycD is also known 
to be expressed.  Sp-CycD may 
be able to be expressed in oral 
ectoderm because region 5’s 
activity has declined by the time 
of specification of this domain.  
See further information 
regarding region 17 in this 
table. 
6 Intronic Has second 
strongest 
activity after 
region 5. Active 
early, when Sp-
CycD is being 
activated, then 
remains stably 












Bears almost the same 
contingent of transcription 
factor binding sites as region 5, 
but lacks Foxa sites.  This could 
explain why this region is less 
active than region 5. 
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Table 3.2 continued 
17 Intronic Has the lowest 
activity of all 
regions but is of 
interest because 
its highest and 
maintained 
activity occurs 
after ~21 hpf 
through at least 




restricted to gut 
and oral 
ectoderm. 
 Has sparsest number of binding 
sites for lineage-specifying 
transcription factors of all active 
regions.  This may relate to this 
region playing a role in 
regulating Sp-CycD expression 
as it becomes spatially 
restricted.  Regions, such as 
region 5, which many more 
transcription factor binding 
sites, may play role in activating 
Sp-CycD expression. 
In contrast to region 5, bears 
significantly fewer than 
predicted number of Gsc 
binding sites.  Region 17 may 
therefore allow Sp-CycD to be 
expressed in oral ectoderm. 
19 Intronic Has 
reproducible 
activity pattern 
that peaks at 







3’ end is rich in binding sites for 
various transcription factors. In 
particular, the TCF binding 
sites may be of interest, 
especially one that overlaps 
with a potential Runx binding 
site.  Although Runx binding 
sites are under-represented, 
region 19 is the only region to 
show an overlap between a 
potential Runx and TCF binding 
site.  This TCF site could 
function to regulate activity just 
before the onset of gastrulation, 
when this region reaches peak 
activity. 
This same Runx site also 
overlaps with potential 
C/EBPalpha site.  Since Runx 
and C/EBPalpha transcription 
factors regulate development of 
myeloid cells, this Runx-
C/EBPalpha site could regulate 
expression in blastocoelar cells, 
which ingress shortly after 




3.7   Some limitations to this study   
 It can be seen that of 22 potential regulatory regions identified by sequence 
conservation (Chapter 2, Fig. 2.3), only 6 were shown to be active during embryogenesis 
through gastrulation.  There could be at least three reasons for this finding.  First, it is 
possible for postulated regulatory regions that are identified computationally to be 
inactive in the analyses carried out here to still be functional [106].  In addition, some of 
the regions identified as inactive might function as repressors.  This possibility was not 
tested during the cis-regulatory analysis of Sp-CycD because the method of Nam et al. 
used to test the activity of potential regulatory regions can only be used to identify 
positively acting regions, but not repressors [120].  Second, it is also possible that some 
of the regions shown to be inactive during embryogenesis could play a role in the 
expression of Sp-CycD in the adult.  A third reason concerns the fact that all regions 
chosen to be tested for analysis were hypothesized, due to possession of various potential 
regulatory elements within their sequences, to be potentially regulatory.  As described in 
Chapter 2, the activity values of all of these regions were used to determine a 
“background” level of region activity.  Regions whose activities were at least 2.5 times 
greater than this background level were considered to have statistically significant 
activity.  This statistical criterion was based on that used by Nam et al. in the 2010 high 
throughput identification of cis-regulatory modules [120].  However, in that study, the 
authors did not pre-select regions that were hypothesized to be active.  Instead, regions to 
be tested for activity were selected at random.  In this dissertation, then, only the most 
active regions in a population of regions already hypothesized to be active were being 
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tested.  Therefore, it is possible that some regions with relatively low activity may have 
been scored as inactive.   
3.8  Potential Future Work:  Testing if Sp-CycD regulates the expression of 
developmental genes  
  Apart from acting as a regulator of the cell cycle, as introduced in Chapter 1, 
there is evidence that genes of the cyclin D family can regulate the transcription of other 
genes.  The weight of the evidence indicates that cyclin D proteins accomplish this by 
undergoing protein-protein interactions with transcription factors and other DNA 
interacting proteins rather than directly binding to DNA.  These interactions can then 
induce the transcription of genes whose regulatory regions are bound by these factors.  
For example, Bienvenu et al. [80] showed that cyclin D1 was associated with the 
promoters of genes that were being expressed in the tissues being examined.  However, 
cyclin D1 was also shown to interact with transcription factors whose consensus binding 
sites were found within the promoters that were shown to be bound by cyclin D1.  From 
this, it would be concluded that, rather than binding to these genes directly, cyclin D1 
bound to these genes through recruitment by these transcription factors.   
 In a recent study by Paulkin and Vallier [156], the protein-protein interactions 
of cyclin D family genes were related to the two, at first thought, disparate roles of cyclin 
D genes in regulating both the cell cycle and development.  Working with pluriopotent 
stem cells, the authors showed that these cells could be coaxed via growth factors to be 
more likely to differentiate into endoderm or into neuroectoderm, depending on the levels 
of cyclin D proteins within those cells.  Moreover, these cyclin D proteins carried out 
their regulatory functions through their “classical” roles of activating cdks 4 and 6 within 
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the cytoplasm.  When active, these SMAD proteins translocated to the nucleus and 
induced the transcription of genes whose protein products led to the development of 
endoderm.  Phosphorylation of these SMAD proteins by the cdks led to their degradation 
and prevented them from translocating to the nucleus to contribute to the formation of 
endoderm.  In this case, the cells would activate transcription factors that led instead 
primarily to the formation of neuroectoderm.  However, if cyclin D protein levels were 
low, then endoderm-specifying transcription factors would be more able to translocate to 
the nucleus, and the stem cells would be more likely to differentiate into endoderm.  
Which developmental program – the formation of neuroectoderm or endoderm – was set 
in motion depended on levels of cyclin D proteins, which in turn, depended on the stage 
of the cell cycle.  Therefore, cyclin D proteins, through protein-protein interactions, can 
function to link the stage of the cell cycle in which cells receive signals to the 
developmental program that those cells undergo.  
 From this summary, a larger theme emerges.  Cyclin D family proteins interact 
with multiple proteins both within the nucleus and in the cytoplasm.  Through these 
interactions, they can modulate the expression of genes, which in turn regulates 
developmental outcome.  In this dissertation, the primary focus was on elucidating the 
inputs into Sp-CycD that regulate its expression.  However, as is suggested from the 
above described studies, this gene, as a member of the cyclin D family of genes, likely 
has regulatory outputs into developmental regulatory genes.  Within S. purpuratus, the 
cyclin D gene Sp-CycD also plays an important developmental role, as shown by Moore 
et al. [62].   
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 It would also be important to identify and confirm the genes whose expression 
was regulated by cyclin D.  This could be accomplished by using morpholino antisense 
oligonucleotides to knockdown Sp-CycD, similar to that done by Moore et al. [62], then 
using either quantitative RT-PCR or the more recently developed Nanostring technology 
[157] to measure the resultant levels of all developmental regulatory genes of the 
endomesoderm GRN.  The data gained from these experiments could be related to those 
gained from the experiments just described where the protein binding partners of Sp-
CycD were determined.  In particular, it could be determined if the regulatory regions of 
genes whose expression was shown to be significantly affected by the knockdown of Sp-
CycD have binding sites for any of the transcription factors shown to interact with Sp-
CycD.  These experiments would further complete our understanding of how Sp-CycD 
fits into the developmental GRNs of S. purpuratus by complementing the cis-regulatory 
analysis that was the primary focus of this dissertation.   
3.9  Conclusions 
 This dissertation presented a cis-regulatory analysis of the Sp-CycD gene during 
embryogenesis in S. purpuratus.  Regulatory regions that were proposed to regulate the 
expression of Sp-CycD during development were identified and characterized.  In this 
chapter, further analysis was done to identify the developmentally regulated transcription 
factors that could mediate the expression of this regulatory gene.  This work and analysis 
presented in this dissertation is pertinent because genes of the cyclin D family are 
developmental regulatory genes, acting as signal-controlled regulators of cell growth, the 
cell cycle, and development (Chapter 1).     
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 This work is the first to provide a comprehensive cis-regulatory analysis across 
the entire locus of a cyclin D gene.  The analysis identified several regions, both 
upstream and downstream of the locus, that were experimentally verified as regulatory 
regions.  In this final Chapter, potential linkages between these regions and the 
developmental lineages where Sp-CycD is expressed were identified.  This provides the 
foundation for experimentally testing each of these linkages in order to integrate this 
developmentally important gene into the GRNs that control embryogenesis in the 
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APPENDIX A:  LIST OF GENES REFERENCED 
Table A.1:  Genes referenced in this dissertation  
Notes:  1. The name used in the text is given, along with the species in which the gene 
being referenced was described, followed by the official name, provided by either NCBI 
Gene [2] for all genes except for those described in Strongylocentrotus purpuratus, or 
SpBase [3] for genes described in S. purpuratus.  2. If the name given in the text is a 
protein, or is written out in full, then that name is not italicized.  Italicized names given 
under Official Names refer to genes rather than proteins.  3. If a gene family containing 
multiple members is mentioned, but the individual members are not individually 
described, then, generally, these are not provided in this table, although one example may 
sometimes be provided. 
 
Name used in text Species  Official name GeneIdentier   
 
AML1 (RUNX1) Mus musculus Runx1  12394  
 
B-MYB  Mus musculus Mybl2  1785     
 




 Mus musculus Cdc25c  12532   
 
C/EBPalpha Mus musculus Cebpa  12606   
 
CLN3  Saccharomyces CLN3  1201   
  cerevisiae 
 
cyclin A  Clam  Not found     
 
 
Cyclin A  S. purpuratus Sp-CycA  SPU_003528  
 
Cyclin A1  Mus musculus Ccna1  12427   
 
Cyclin A2  Mus musculus Ccna2  12428   
 
Cyclin B1  Mus musculus Ccnb1  268697   
 
Cyclin B2  Mus musculus Ccnb2  12442   
 
cyclin B  Lytechinus pictus Not found     
 
Cyclin B  S. purpuratus Sp-Cycb  SPU_015285  
 
Cyclin D  Arabidopsis Not found 
 
Cyclin D  C. elegans  cyd-1  174941   
 
Cyclin D  Drosophila CycD  32551   
 




Table A.1 continued 
 
Name used in text Species  Official name GeneIdentier 
 
Cyclin D1  Chinese Hamster Ccnd1  100689063 
 
Cyclin D1  Mus musculus Ccnd1  12443   
 
Cyclin D1  Xenopus laevis ccnd1-a  379937   
 
Cyclin D2  Mus musculus Ccnd2  12444   
 
Cyclin D3  Mus musculus Ccnd3  12445   
 
Cyclin E  Mus musculus Ccne1  12447   
 
Cyclin E  Drosophila CycE  34924   
 
Cyclin E  C. elegans  cye-1  172399 
 
cyclin dependent  Schizosaccharo-  cdc2  2539869   
kinase 2 (CDK2) myces pombe 
 
Cyclin dependent C. elegans  cdk-2  171911   
kinase 2 (CDK2) 
 
Cyclin dependent Mus musculus Cdk2  12566   
kinase 2 (CDK2) 
 
Cyclin dependent Mus musculus Cdk4  12567   
kinase 4 (CDK4) 
 
Cyclin dependent C. elegans  cdk-4  181472   
kinase 4 (CDK4) 
 
Cyclin dependent Homo sapiens CDK4  1019 
kinase 4 (CDK4) 
 
Cyclin dependent Mus musculus Cdk6  12471   
kinase 6 (CDK6) 
 
Cyclin dependent Homo sapiens CDK6  1021 
kinase 6 (CDK6) 
 
CyIIIa  S. purpuratus Sp-CyIIIa  Not found   
 
DP  Drosophila Dp  36461   
 
Delta  S. purpuratus Sp-Delta  SPU_06128  
 








Table A.1 continued 
 
Name used in text Species  Official name GeneIdentier 
 
E2F1  Mus musculus E2F1  13557 
 
E2F4  Mus musculus E2f4  104394   
 
Endo16  S. purpuratus Sp-Endo16  SPU_011038  
 
ERB2  Mus musculus Esr2  13983 
 
Foxa  S. purpuratus Sp-FoxA  SPU_006676  
 
Gatac  S. purpuratus Sp-GataC  SPU_027015  
 
Gatae  S. purpuratus Sp-Gatae  SPU_010635  
 
GRIP1  Mus musculus Grip1  74053 
 
Gsc  S. purpuratus Sp-Gsc  SPU_015982  
 
HES6  Mus musculus Hes6  55927   
 
Histone deacetylase 1 Mus musculus Hdac1  433759    
 
Lef1  Homo sapiens LEF1  51176   
 
Lef1  Mus musculus Lef1  16842   
 
MEF2C  Mus musculus Mef2c  17260   
 
MTOR  Mus musculus Mtor  56717   
 
MTOR  Homo sapiens MTOR  2475 
 
MYT1  Mus musculus Myt1  17932   
 
Notch1  Homo sapiens NOTCH1  4851   
 
NOTCH1  Mus musculus Notch1  18128 
 
Notch  S. purpuratus Sp-Notchh_11 SPU_015792 (1 of several homologs)  
 
Nodal  S. purpuratus Sp-Nodal  SPU_11064  
 
Otx  S. purpuratus Sp-Otx  SPU_010424  
 
P16INK4a  Mus musculus Cdkn2a  12578   
 
P19ARF  This is derived from same locus as P16INK4A, but has alternative  




Table A.1 continued 
 
Name used in text Species  Official name GeneIdentier 
 
P53  Homo sapiens TP53  7157    
 
P107  Homo sapiens RBL1  5933   
 
P107  Mus musculus Rbl1  19650    
 
P130  Homo sapiens RBL2  5934   
 
P130  Mus musculus Rbl2  19651   
 
Pax4  S. purpuratus Sp-Pax4  Not listed   
 
Retinoblastoma (Rb) Mus musculus Rb1  19645   
 
Retinoblastoma (Rb) Homo sapiens RB1  5925   
 
Runx1  Mus musculus Runx1  12394   
 
Runt1  S. purpuratus Sp-Runt1  SPU_006917  
 
SM50  S. purpuratus Sp-Sm50  SPU_018811  
 
Sp1  Homo sapiens SP1  6667   
 
Stat3  Mus musculus Stat3  20848   
 
STAT5  Homo sapiens STAT5  50695   
 
Su(H)  S. purpuratus Sp-SuH  SPU_021566  
 
TCF  S. purpuratus Sp-Tcf  SPU_009520  
 
Telomerase Homo sapiens TERT  7015 
 
Telomerase Mus musculus Tert  21752 
 
TGFA  Homo sapiens TGFA  7039   
 
WEE  Mus musculus Wee1  22390    
 
Wnt6  S. purpuratus Sp-Wnt6  SPU_13570   
 
Wnt8  S. purpuratus Sp-Wnt8  SPU_020371  
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APPENDIX B:  PRIMER SEQUENCES 
 
Table B.1:  Primer sequences  
 
Notes:  1. In each case, the forward primer is shown before the reverse primer.  2.  The 
primers shown below were those used for linking potential regulatory regions of Sp-CycD 
to 13 tag reporters by fusion PCR.  The nucleotides colored red in each reverse primer do 
not anneal with the Sp-CycD gene, but enable integration with a 13 tag reporter construct 
during fusion PCR.  3.  As noted in Materials and Methods, to generate PCR products for 
incorporation into EpGFPII rather than linkage to 13 tag reporters, the forward primer in 
each case is preceded on its 5’ end with the modification 5’-CTATCGATAGGTACC.  
For the reverse primer, the 5’-TTGAAGTAGCTGGCAGTGACGT modification is 
replaced with 5’-ACAGTTTAACCCGGG. 
 
A. For amplifying the indicated tested regions of Sp-CycD: 
 
1: CAGATAAGATGTGAAGTGATGTTGG and 
TTGAAGTAGCTGGCAGTGACGTAAGTAAATTTTGTTTTGGCCTGA 
14: ACATGCAGTCAGGCCAAAAC and 
TTGAAGTAGCTGGCAGTGACGTTTCCCCTGGCTACCAGTATG 
2: GTAGCCAGGGGAATCGTGT and 
TTGAAGTAGCTGGCAGTGACGTTCTGCAATCTTTGCTCACTTT 
14: ACATGCAGTCAGGCCAAAAC and 
TTGAAGTAGCTGGCAGTGACGTTTCCCCTGGCTACCAGTATG 
15: GGTGTGGAACCATAGCCGTA and 
TTGAAGTAGCTGGCAGTGACGTGAGAGAATGTGAAAGAGATAGAGAAGG 
3: CGTTTCAAATGTACTTTTAATGAAGC and 
TTGAAGTAGCTGGCAGTGACGTATTTGGCCTAGGCAACAGTG 
16: ACAAAATGACGTGATCTATAGGC and 
TTGAAGTAGCTGGCAGTGACGTTCAATATTGGGAGGACTGTGC 
4: TTAATAAATGCGCACAGTCCTC and 
TTGAAGTAGCTGGCAGTGACGTTGGAATGGGTTATTTATTTCTGTTC 
17: AGTATTTTTCACTTTTCTCGGTTTCAA and 
TTGAAGTAGCTGGCAGTGACGTCTGCAGAAAACAAACAAAAAGA 
5: ACTCGTAAGTATTTCCATTTTTGG and 
TTGAAGTAGCTGGCAGTGACGTCTAGGCTATTGAGGGCTTAGAG 
18: AGAACAAAGAGACTGGTTTGTCG and 
TTGAAGTAGCTGGCAGTGACGTAAGCTTTTGCACTTTGTATTTGG 
6: CAGACGGAGTTGTCATAGTT  and 
TTGAAGTAGCTGGCAGTGACGTATTTCTGTGAATTGGGAAGAAAA 
7: ACAGGTAAGCCAAACCCGTCCT and 
TTGAAGTAGCTGGCAGTGACGTAGAGTAGAGGGGGAAAGAG 
8: ATCTTCGGAATGGATTGTGG and 
TTGAAGTAGCTGGCAGTGACGTAGAACCAGTGGAAGCACACC 
19: AACCGTAAGTACATTTTATTTGTT and 
TTGAAGTAGCTGGCAGTGACGTTTTACTTGGTACACTTCCAGCTT 




20: CATCACGGATATCTCCAATTCC and 
TTGAAGTAGCTGGCAGTGACGTCGAACCAGACTCAGAGACTATCAT 
Table B.1 continued 
 
10: TGAAGTCTCAACTTCCCAAGTAGT  and 
TTGAAGTAGCTGGCAGTGACGTTGTAAATGGCGAGAAGAAAAA   
11: ATGTGCCATAATTCTAAAGAGACAA and 
TTGAAGTAGCTGGCAGTGACGTTCGCTATCACCACCATCTTC   
21: TGATTATGGGGATGATGCAC and 
TTGAAGTAGCTGGCAGTGACGTTTCTGACATTCTGACAACGTG 
12: TTAATGCACAAATCTTTGTTAAGTGC and 
TTGAAGTAGCTGGCAGTGACGTCGAGAGGGAGAGAGAGGGAGAGAAAG   
22: TCCCCTTTCTCTCCCTCTCT and 
TTGAAGTAGCTGGCAGTGACGTCCCCTTAACTACGCCACGTC 
13: GTTATCGACGTGGCGTAGTT and 
TTGAAGTAGCTGGCAGTGACGTAACAAATAGAAAAGAAAGAAAGAACGA 
2-2: GCCTTGCCCTAAATATTGAAATT and 
TTGAAGTAGCTGGCAGTGACGTAGTTGACCCGACAAAGGAAG 
4-1: TGAATACACAAATGAACAAAGG and 
TTGAAGTAGCTGGCAGTGACGTCTACTGTACACATCGACCAC 
4-2: GGAGCCTGGGTTGAAAGAA and 
TTGAAGTAGCTGGCAGTGACGTGGGGAACAGCAGACGACCAG 
 










APPENDIX C:  LISTING OF REGULATORY REGIONS TESTED AND THE 13-
TAG REPORTER TO WHICH EACH WAS LINKED 
 
Table C.1:  Listing of regulatory regions tested and the 13-tag reporter to which each was 
linked 
 
Region or subregion  13-tag reporter to which region or subregion was linked 
 
1    1308 
2    1301 
3    1314 
4    1310 
5    1308 
6    1304 
7    1305 
8    1309 
9    1307 
10    1313 
11    1305 
12    1306 
13    1314 
14    1314 
15    1308 
16    1301 
17    1309 
18    1310 
19    1306 
20    1310 
21    1307 
22    1306 
2-2    1306 
6-1    1304 
5-1    1308 




1. Regions linked to the same 13-tag reporter were never analyzed in the same 
experiment.  
2. 13-tag reporters 1303 and 1312 did not show expression when linked to active region 2 




APPENDIX D:  SEQUENCE DETAILS OF ACTIVE REGULATORY REGIONS 
 
Figure D.1.  Sequence details of active regulatory regions of Sp-CycD.   
Each sequence is shown separately in FASTA format, respectively as region 2 (panel A), 
region 4 (panel B), region 5 (panel C), region 6 (panel D), region 17 (panel E) and region 
19 (panel F).  Sequences conserved with Lv-CycD are shown in red font; sequences that 
show at least 90% similarity to Lv-CycD are in red font; and sequences identified by 
Cluster-Buster [127] as having potential binding sites for clusters of transcription factors 
are highlighted in gray.  Within each region, subregions described in the text are shown 
as composites of italic, bold and underlined font.   (Note:  The sequences for upstream 
regions 2 and 4 are from clones.  Those of others are from GBrowse V3.1, at SpBase [3].)
 
Other sites of interest include binding sites for transcription factors found in an 
endomesoderm-specifying subcircuit conserved between sea urchin and sea star [130, 
131], and described in Chapter 3.  These include the following transcription factors, 
whose potential binding sites are highlighted using the indicated colors: Otx (TAATCC, 
TAATCT, and the reverse complements GGATTA, AGATTA ) (consensus binding sites 
provided in [159, 160]); Gatae (C/T)GATA(A/G), and the reverse complement 
(C/T)TATC(A/G) (cited in [161]); and Foxa (reverse complements of 
AAATGTTAATTT,  GCCTATTGATTT, and ACCTATTTTTTC, as identified by 
Cluster-Buster [127] flagging of vertebrate Foxa2 sites but not identified by Transfac 
Public at the site [135]). The original (non-reverse complement) sequence binding sites 
identified by Cluster-Buster were not found in any sequence. There were no identified 
binding sites for Blimp1 (GTTCCCTTT, or its reverse complement AAAGGGAAC) 
(binding site given in 2008 paper by Robertson et al. [63]).  Potential Su(H) binding sites 
were identified by searching for the consensus Su(H) sequences presented in a 2006 
paper by Ransick and Davidson: CGTGAGAA, CGTGGGAA, GGTGGGAT, 
GGTGAGAA, and GATGGGAG [137], along with their reverse complements: 
TTCTCACG, TTCCCACG, ATCCCACC, TTCTCACC, and CTCCCATC.   There were 
no identified potential binding sites for Hesc (CACGCGTG, and its reverse complement 
CACGCGTG) [cited in [123], whose transcription is activated by Su(H), as shown in the 
endomesoderm GRN [55].  There were also no potential binding sites 
((ATGCGG(A/G)(T/C)) and reverse complement ((G/A)(C/T)CCGCAT)) for another 
direct transcriptional target of Su(H), Gcm [cited in [137].  Potential binding sites for 
another transcription factor whose expression is induced by Su(H), Six1/2, were searched 
for by querying for the consensus sequence TCAGGTTTC and its reverse complement 
GAAACCTGA, which is just one of several potential binding sites of this recently found 
to be promiscuous-binding transcription factor [cited in [162].  No such sites were found 
in any regulatory sequences.  Potential binding sites for Bra were identified by searching 
for the consensus sequence (A/G)(A/T)(A/T)NTN(A/G)CAC(C/T)T and its reverse 
complement A(G/A)GTG(T/C)NAN(T/A)(T/A)(T/C)[134].  This consensus sequence 
was searched for using an online consensus sequence finder [163, 164].  The binding site 
TGGGTGGTC and its reverse complement GACCACCCA for  the hedgehog signaling-
induced transcription factor GliA were searched for based on the known binding site of 
the human homolog, Ci (binding sequence provided in [165]).  No such sites were found 
in any active sequences of Sp-CycD.  Transfac-identified [135] binding sites for Gata-1 
((T/G/A)(T/A)(G/C)AGACT(T/A)AGCT(T/G)), and its reverse complement), which is a  
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homolog of Gatac (cited in [136]), are highlighted in dark green.  Potential TCF sites 
(ACAAAG and its reverse complement CTTTGT) (cited in [63]) are highlighted in light 
green.  The following consensus sequences, highlighted in yellow, were considered 
potential Runx binding sites:  TGTGGT and its reverse complement ACCACA (based on 
consensus binding site provided in reference [63]); and (C/T)G(C/T)GGT(C/T) and its 
reverse complement (A/G)ACC(A/G)C(A/G), the consensus binding site for Runx an 
early paper characterizing these transcription factors [125].   Two other transcription 
factors discussed in the text include Gsc and Pax41.  Gsc, a competitor with Otx, binds to 
the same binding sites as Otx [146].  Therefore, Otx binding site can also be considered 
as Gsc binding sites. Binding sites for Pax4 are not shown individually in this figure.  
As shown in Appendix E, analysis of the sequences of the regulatory regions using 
Cluster-Buster [127] yielded potential binding sites for this transcription factor in region 
5, at the following positions within this region:  509-538; 626-655; 1045-1074; 1047-
1076; 1048-1077; 1210-1239; 1214-1243; 1490-1519; 1491-1520; and 1492-1521.  These 
areas are distinguished in the figure by increasing their font sizes to 16 rather 
than 11 used in the rest of the figure.  These areas are also highlighted in the Cluster-
Buster output from the analysis of region 5 in Appendix E.  These regions appear within 
the bp identified by Cluster-Buster as potential areas where transcription factor binding 
sites might cluster, which, as noted above, are highlighted in gray. 
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Fig. D.1 continued 
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Fig. D.1 continued 
D. 















































Fig. D.1 continued 
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Fig. D.1 continued 
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APPENDIX E:  CLUSTER-BUSTER OUTPUT FOR REGIONS 5, 6 AND 19 
 
Fig. E.1. Cluster Buster output for regions 5 (panel A), 6 (panel B) and 19 (panel C).  
Binding sites for Pax4, the significance of which is described in the text, are shown in 
larger font than for the other transcription factors. 
Note:  This figure continues for several pages. 
 
A 
>Cluster-buster output for region 5     
Motif Position Strand Score Sequence 
MA0045 HMG-IY HMG 506 to 521 + 9.95 gttgaaaaggaaaaaa 
MA0013 Broad-complex_4 ZN-FINGER, C2H2 507 to 517 + 6.44 ttgaaaaggaa 
MA0045 HMG-IY HMG 507 to 522 + 7.28 ttgaaaaggaaaaaat 
MA0010 Broad-complex_1 ZN-FINGER, C2H2 508 to 521 + 6.23 tgaaaaggaaaaaa 
MA0120 ID1 ZN-FINGER, C2H2 508 to 519 - 8.95 ttttccttttca 
MA0010 Broad-complex_1 ZN-FINGER, C2H2 509 to 522 + 6.25 gaaaaggaaaaaat 
MA0028 ELK1 ETS 509 to 518 + 6.76 gaaaaggaaa 
MA0050 IRF1 TRP-CLUSTER 509 to 520 + 6.57 gaaaaggaaaaa 
MA0068 Pax4 PAIRED-HOMEO 509 to 538 + 6.42 gaaaaggaaaaaataggtttttagcgcgcc 
MA0120 ID1 ZN-FINGER, C2H2 509 to 520 - 6.12 tttttccttttc 
Ets 510 to 520 + 7.33 aaaaggaaaaa 
MA0039 Klf4 ZN-FINGER, C2H2 510 to 519 + 6.56 aaaaggaaaa 
MA0021 Dof3 ZN-FINGER, DOF 511 to 516 + 6.03 aaagga 
MA0039 Klf4 ZN-FINGER, C2H2 511 to 520 + 6.26 aaaggaaaaa 
MA0081 SPIB ETS 511 to 517 + 7.1 aaaggaa 
MA0013 Broad-complex_4 ZN-FINGER, C2H2 512 to 522 + 6.04 aaggaaaaaat 
MA0026 E74A ETS 512 to 518 + 6.23 aaggaaa 
MA0049 Hunchback ZN-FINGER, C2H2 512 to 521 + 6.95 aaggaaaaaa 
MA0098 c-ETS ETS 513 to 518 - 6.77 tttcct 
MA0039 Klf4 ZN-FINGER, C2H2 516 to 525 + 6.69 aaaaaatagg 
MA0011 Broad-complex_2 ZN-FINGER, C2H2 519 to 526 - 6.1 acctattt 
E2F 528 to 539 + 6.18 tttagcgcgccg 
MA0024 E2F1 Unknown 528 to 535 + 6.5 tttagcgc 
E2F 530 to 541 - 6.14 cgcggcgcgcta 
MA0123 ABI4 AP2 530 to 539 - 7.49 cggcgcgcta 
MA0079 SP1 ZN-FINGER, C2H2 531 to 540 - 8.21 gcggcgcgct 
MA0123 ABI4 AP2 532 to 541 - 6.37 cgcggcgcgc 
MA0028 ELK1 ETS 542 to 551 - 6.9 gcgacggaaa 
GATA 548 to 560 - 6.52 tcatgataagcga 
MA0089 TCF11-MafG bZIP 556 to 561 + 7.31 catgac 
MA0077 SOX9 HMG 567 to 575 - 8.18 aaacaatgg 
MA0040 Foxq1 FORKHEAD 568 to 578 + 8.5 cattgtttatg 
MA0030 FOXF2 FORKHEAD 569 to 582 - 8.05 cacacataaacaat 
MA0084 SRY HMG 569 to 577 - 6.08 ataaacaat 
MA0087 Sox5 HMG 569 to 575 - 6.34 aaacaat 
MA0021 Dof3 ZN-FINGER, DOF 601 to 606 - 6.02 aaagtg 
CCAAT 623 to 638 + 6.32 gttgaccaattacact 
MA0060 NF-Y CAAT-BOX 623 to 638 + 6.57 gttgaccaattacact 
MA0068 Pax4 PAIRED-HOMEO 626 to 655 + 6.02 gaccaattacactcaataatgacggcgcgc 
MA0075 Prrx2 HOMEO 630 to 634 + 7 aatta 
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MA0122 Bapx1 HOMEO 633 to 641 - 7.27 ttgagtgta 
MA0110 ATHB5 HOMEO-ZIP 639 to 647 - 8.13 tcattattg 
MA0008 Athb-1 HOMEO-ZIP 640 to 647 - 6.71 tcattatt 
 
MA0089 TCF11-MafG bZIP 
643 to 648 + 6.88 aatgac 
MA0123 ABI4 AP2 648 to 657 + 6.08 cggcgcgcat 
MA0006 Arnt-Ahr bHLH 669 to 674 + 6.54 tgcgtg 
MA0067 Pax2 PAIRED 670 to 677 - 6.66 agtcacgc 
MA0043 HLF bZIP 690 to 701 - 6.81 cgttacacaaag 
MA0025 NFIL3 bZIP 692 to 702 + 6.22 ttgtgtaacgc 
CCAAT 701 to 716 - 10.6 ttcagccaatcaccgc 
MA0060 NF-Y CAAT-BOX 701 to 716 - 10.8 ttcagccaatcaccgc 
MA0038 Gfi ZN-FINGER, C2H2 702 to 711 - 7.86 ccaatcaccg 
MA0041 Foxd3 FORKHEAD 715 to 726 - 8.81 aaatgttaattt 
MA0047 Foxa2 FORKHEAD 715 to 726 - 6.42 aaatgttaattt 
MA0040 Foxq1 FORKHEAD 716 to 726 - 6.03 aaatgttaatt 
MA0075 Prrx2 HOMEO 716 to 720 + 6.46 aatta 
MA0003 TFAP2A AP2 728 to 736 + 7.03 gcccagggg 
NF-1 729 to 746 - 6.21 atttggcgcgcccctggg 
MA0003 TFAP2A AP2 729 to 737 - 6.91 gcccctggg 
E2F 734 to 745 - 7.83 tttggcgcgccc 
MA0024 E2F1 Unknown 738 to 745 - 10.1 tttggcgc 
MA0082 SQUA MADS 741 to 754 + 7.04 ccaaatataaaact 
E2F 755 to 766 + 6.48 ttcggcgcgcgc 
MA0024 E2F1 Unknown 755 to 762 + 6.29 ttcggcgc 
MA0123 ABI4 AP2 757 to 766 + 7.39 cggcgcgcgc 
MA0017 NR2F1 NUCLEAR RECEPTOR 804 to 817 - 6.11 tgaactgcgccctg 
MA0114 HNF4 NUCLEAR 805 to 817 + 6.5 agggcgcagttca 
MA0049 Hunchback ZN-FINGER, C2H2 820 to 829 + 6.62 tcaaaaaaag 
MA0082 SQUA MADS 820 to 833 + 7.5 tcaaaaaaagtaca 
MA0013 Broad-complex_4 ZN-FINGER, C2H2 836 to 846 - 6.17 atgtaaacaaa 
MA0084 SRY HMG 836 to 844 - 6.32 gtaaacaaa 
MA0031 FOXD1 FORKHEAD 837 to 844 - 8.11 gtaaacaa 
MA0003 TFAP2A AP2 852 to 860 - 6.47 gccccgacg 
TATA 854 to 868 - 6.78 gtacaaaagccccga 
MA0108 TBP TATA-box 854 to 868 - 6.81 gtacaaaagccccga 
MA0020 Dof2 ZN-FINGER, DOF 858 to 863 - 6.12 aaagcc 
MA0078 Sox17 HMG 880 to 888 + 6.58 gctattgtg 
MA0008 Athb-1 HOMEO-ZIP 902 to 909 + 7.36 caatcatt 
MA0110 ATHB5 HOMEO-ZIP 902 to 910 - 7.22 taatgattg 
MA0114 HNF4 NUCLEAR 914 to 926 - 6.33 gcgggagagtgca 
MA0079 SP1 ZN-FINGER, C2H2 917 to 926 - 6.18 gcgggagagt 
MA0039 Klf4 ZN-FINGER, C2H2 918 to 927 - 6.33 tgcgggagag 
MA0062 GABPA ETS 918 to 927 - 6.1 tgcgggagag 
MA0024 E2F1 Unknown 919 to 926 + 6.89 tctcccgc 
TATA 922 to 936 - 8.76 gcatataggtgcggg 
MA0108 TBP TATA-box 922 to 936 - 8.79 gcatataggtgcggg 
MA0103 deltaEF1 ZN-FINGER, C2H2 926 to 931 + 7.36 caccta 
MA0015 CF2-II ZN-FINGER, C2H2 929 to 938 + 6.91 ctatatgcag 
GATA 941 to 953 + 6.04 aagtgataaaaat 
MA0091 TAL1-TCF3 bHLH 992 to 1003 - 8 tgaacatctttt 
MA0121 ARR10 TRP-CLUSTER 1003 to 1010 - 6.11 agattctt 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1045 to 1054 + 7.83 ttaggggcgg 
MA0068 Pax4 PAIRED-HOMEO 1045 to 1074 - 8.91 gaaaagtagaacttcaccccccgcccctaa 
Sp1 1046 to 1058 + 15.3 taggggcgggggg 
MA0039 Klf4 ZN-FINGER, C2H2 1046 to 1055 + 8.63 taggggcggg 
MA0079 SP1 ZN-FINGER, C2H2 1046 to 1055 + 6.54 taggggcggg 
MA0118 Macho-1 ZN-FINGER, C2H2 1046 to 1054 + 7.12 taggggcgg 
Sp1 1047 to 1059 + 7.21 aggggcggggggt 
E2F 1047 to 1058 + 7.38 aggggcgggggg 
MA0039 Klf4 ZN-FINGER, C2H2 1047 to 1056 + 7.36 aggggcgggg 
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MA0068 Pax4 PAIRED-HOMEO 1047 to 1076 - 7.56 aagaaaagtagaacttcaccccccgcccct 
MA0079 SP1 ZN-FINGER, C2H2 1047 to 1056 + 6.73 aggggcgggg 
MA0111 Spz1 bHLH-ZIP 1047 to 1057 + 6.45 aggggcggggg 
MA0123 ABI4 AP2 1047 to 1056 - 8.94 ccccgcccct 
Sp1 1048 to 1060 + 6.27 ggggcggggggtg 
MA0068 Pax4 PAIRED-HOMEO 1048 to 1077 - 13 gaagaaaagtagaacttcaccccccgcccc 
MA0074 RXR-VDR NUCLEAR RECEPTOR 1048 to 1062 + 6.69 ggggcggggggtgaa 
MA0079 SP1 ZN-FINGER, C2H2 1048 to 1057 + 11.5 ggggcggggg 
MA0114 HNF4 NUCLEAR 1048 to 1060 + 6.84 ggggcggggggtg 
MA0118 Macho-1 ZN-FINGER, C2H2 1048 to 1056 + 7.68 ggggcgggg 
Myf 1049 to 1060 + 6.33 gggcggggggtg 
MA0007 Ar NUCLEAR RECEPTOR 1049 to 1070 - 6.67 agtagaacttcaccccccgccc 
MA0079 SP1 ZN-FINGER, C2H2 1049 to 1058 + 7.55 gggcgggggg 
MA0114 HNF4 NUCLEAR 1049 to 1061 + 6.02 gggcggggggtga 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1050 to 1059 + 8.59 ggcggggggt 
MA0079 SP1 ZN-FINGER, C2H2 1050 to 1059 + 9.1 ggcggggggt 
MA0123 ABI4 AP2 1051 to 1060 - 7.83 caccccccgc 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1052 to 1057 + 7.56 cggggg 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1052 to 1061 + 6.98 cggggggtga 
MA0079 SP1 ZN-FINGER, C2H2 1052 to 1061 + 8.68 cggggggtga 
MA0113 NR3C1 NUCLEAR 1052 to 1069 + 6.7 cggggggtgaagttctac 
MA0118 Macho-1 ZN-FINGER, C2H2 1052 to 1060 + 10.3 cggggggtg 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1053 to 1058 + 7.06 gggggg 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1053 to 1062 + 6.57 ggggggtgaa 
MA0079 SP1 ZN-FINGER, C2H2 1053 to 1062 + 7.82 ggggggtgaa 
MA0118 Macho-1 ZN-FINGER, C2H2 1053 to 1061 + 7.6 ggggggtga 
MA0018 CREB1 bZIP 1054 to 1065 + 6.61 gggggtgaagtt 
MA0016 CFI-USP NUCLEAR RECEPTOR 1055 to 1064 + 7.56 ggggtgaagt 
MA0114 HNF4 NUCLEAR 1055 to 1067 + 6.45 ggggtgaagttct 
MA0046 TCF1 HOMEO 1122 to 1135 - 6.16 agttaaatatttta 
GATA 1151 to 1163 + 6.27 tgtagataaagaa 
MA0049 Hunchback ZN-FINGER, C2H2 1154 to 1163 + 6.16 agataaagaa 
MA0020 Dof2 ZN-FINGER, DOF 1158 to 1163 + 6.44 aaagaa 
MA0053 MNB1A ZN-FINGER, DOF 1158 to 1162 + 6.16 aaaga 
MA0075 Prrx2 HOMEO 1162 to 1166 + 6.21 aatta 
MA0019 Chop-cEBP bZIP 1189 to 1200 + 6.08 acatgcaaacct 
Mef-2 1197 to 1208 + 7.1 acctatttttat 
MA0052 MEF2A MADS 1199 to 1208 + 6.36 ctatttttat 
MA0073 RREB1 ZN-FINGER, C2H2 1208 to 1227 - 6.7 ctccccccccccccctcaaa 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1210 to 1219 + 7.55 tgaggggggg 
MA0068 Pax4 PAIRED-HOMEO 1210 to 1239 - 7.97 gaatcgagacagctccccccccccccctca 
Sp1 1211 to 1223 + 6.59 gaggggggggggg 
Sp1 1212 to 1224 + 7.34 agggggggggggg 
Sp1 1213 to 1225 + 7.49 ggggggggggggg 
MA0079 SP1 ZN-FINGER, C2H2 1213 to 1222 + 6.47 gggggggggg 
Sp1 1214 to 1226 + 6.11 gggggggggggga 
MA0068 Pax4 PAIRED-HOMEO 1214 to 1243 - 8.31 aactgaatcgagacagctcccccccccccc 
MA0079 SP1 ZN-FINGER, C2H2 1214 to 1223 + 6.49 gggggggggg 
MA0079 SP1 ZN-FINGER, C2H2 1215 to 1224 + 6.49 gggggggggg 
Sp1 1216 to 1228 + 6.39 ggggggggggagc 
MA0079 SP1 ZN-FINGER, C2H2 1216 to 1225 + 6.49 gggggggggg 
Sp1 1217 to 1229 + 6.7 gggggggggagct 
MA0079 SP1 ZN-FINGER, C2H2 1217 to 1226 + 8.19 ggggggggga 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1221 to 1226 + 6.74 ggggga 
MA0014 Pax5 PAIRED 1228 to 1247 - 6.04 tgctaactgaatcgagacag 
MA0114 HNF4 NUCLEAR 1244 to 1256 - 6.61 tggacaaagtgct 
MA0021 Dof3 ZN-FINGER, DOF 1246 to 1251 - 6.66 aaagtg 
MA0078 Sox17 HMG 1246 to 1254 + 6.03 cactttgtc 
SRF 1253 to 1265 - 7.23 tgccaaggatgga 
MA0095 YY1 ZN-FINGER, C2H2 1253 to 1258 + 6.33 tccatc 
MA0035 Gata1 ZN-FINGER, GATA 1254 to 1259 - 6.53 ggatgg 
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MA0098 c-ETS ETS 1255 to 1260 + 6.11 catcct 
NF-1 1258 to 1275 + 6.91 ccttggcaactcgtaaca 
MA0045 HMG-IY HMG 1276 to 1291 - 6.17 taggaaatcgcagaac 
MA0038 Gfi ZN-FINGER, C2H2 1279 to 1288 - 6.37 gaaatcgcag 
MA0023 Dorsal_2 REL 1280 to 1289 + 6.46 tgcgatttcc 
MA0107 RELA REL 1280 to 1289 + 6.5 tgcgatttcc 
MA0098 c-ETS ETS 1285 to 1290 + 6.09 tttcct 
MA0037 GATA3 ZN-FINGER, GATA 1289 to 1294 - 6.2 tgatag 
Mef-2 1310 to 1321 - 7.34 ggttttatttag 
MA0027 En1 HOMEO 1364 to 1374 - 6.75 aaggagttgtc 
MA0021 Dof3 ZN-FINGER, DOF 1370 to 1375 - 6.04 aaagga 
MA0071 RORA NUCLEAR RECEPTOR 1383 to 1392 + 6.01 gtatgggtca 
AP-1 1384 to 1394 - 7.18 gatgacccata 
MA0089 TCF11-MafG bZIP 1389 to 1394 - 7.54 gatgac 
MA0035 Gata1 ZN-FINGER, GATA 1398 to 1403 - 6.49 ggatgc 
MA0036 GATA2 ZN-FINGER, GATA 1399 to 1403 - 6.09 ggatg 
MA0050 IRF1 TRP-CLUSTER 1412 to 1423 - 6.65 caaagggaagcc 
MA0062 GABPA ETS 1412 to 1421 - 6.59 aagggaagcc 
MA0039 Klf4 ZN-FINGER, C2H2 1413 to 1422 - 6.95 aaagggaagc 
MA0028 ELK1 ETS 1414 to 1423 - 6.22 caaagggaag 
MA0039 Klf4 ZN-FINGER, C2H2 1414 to 1423 - 7.16 caaagggaag 
MA0080 SPI1 ETS 1414 to 1419 - 8.36 gggaag 
MA0098 c-ETS ETS 1414 to 1419 + 6.2 cttccc 
MA0081 SPIB ETS 1415 to 1421 - 6.2 aagggaa 
MA0021 Dof3 ZN-FINGER, DOF 1417 to 1422 - 6.89 aaaggg 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1431 to 1436 + 6.26 tgggga 
MA0070 Pbx HOMEO 1450 to 1461 - 6.77 gcttcaatcaat 
MA0068 Pax4 PAIRED-HOMEO 1490 to 1519 + 6.22 gaaaattgtcctgggccttttgtcatcccc 
MA0068 Pax4 PAIRED-HOMEO 1491 to 1520 + 6.58 aaaattgtcctgggccttttgtcatccccc 
MA0078 Sox17 HMG 1491 to 1499 + 6.03 aaaattgtc 
MA0068 Pax4 PAIRED-HOMEO 1492 to 1521 + 7.03 aaattgtcctgggccttttgtcatcccccc 
MA0078 Sox17 HMG 1505 to 1513 + 6.23 ccttttgtc 
AP-1 1506 to 1516 - 6.57 gatgacaaaag 
MA0010 Broad-complex_1 ZN-FINGER, C2H2 1506 to 1519 - 8.62 ggggatgacaaaag 
MA0045 HMG-IY HMG 1506 to 1521 - 6.89 ggggggatgacaaaag 
NF-1 1507 to 1524 + 6.31 ttttgtcatccccccaaa 
NF-1 1508 to 1525 - 7.38 ctttggggggatgacaaa 
MA0018 CREB1 bZIP 1508 to 1519 - 6.24 ggggatgacaaa 
MA0084 SRY HMG 1508 to 1516 - 6.07 gatgacaaa 
MA0119 Hox11-CTF1 HOMEO/CAAT 1509 to 1522 - 6.77 tggggggatgacaa 
MA0111 Spz1 bHLH-ZIP 1510 to 1520 - 6.43 gggggatgaca 
MA0119 Hox11-CTF1 HOMEO/CAAT 1510 to 1523 + 6.95 tgtcatccccccaa 
Ets 1511 to 1521 - 6.79 ggggggatgac 
MA0089 TCF11-MafG bZIP 1511 to 1516 - 7.2 gatgac 
MA0079 SP1 ZN-FINGER, C2H2 1512 to 1521 - 7.68 ggggggatga 
E2F 1513 to 1524 - 8.32 tttggggggatg 
MA0039 Klf4 ZN-FINGER, C2H2 1513 to 1522 - 6.28 tggggggatg 
MA0098 c-ETS ETS 1513 to 1518 + 6.01 catccc 
MA0118 Macho-1 ZN-FINGER, C2H2 1513 to 1521 - 9.06 ggggggatg 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1514 to 1523 - 6.69 ttggggggat 
MA0079 SP1 ZN-FINGER, C2H2 1514 to 1523 - 7.96 ttggggggat 
MA0118 Macho-1 ZN-FINGER, C2H2 1514 to 1522 - 8.32 tggggggat 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1515 to 1520 - 9.22 ggggga 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1515 to 1524 - 6.99 tttgggggga 
MA0118 Macho-1 ZN-FINGER, C2H2 1515 to 1523 - 7.92 ttgggggga 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1516 to 1521 - 7.85 gggggg 
MA0116 Roaz ZN-FINGER, C2H2 1516 to 1530 + 7.85 ccccccaaagagtcc 
MA0116 Roaz ZN-FINGER, C2H2 1516 to 1530 - 6.34 ggactctttgggggg 
MA0024 E2F1 Unknown 1517 to 1524 - 6.68 tttggggg 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1517 to 1522 - 7.7 tggggg 
MA0047 Foxa2 FORKHEAD 1585 to 1596 - 7.07 gcctattgattt 
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MA0077 SOX9 HMG 1586 to 1594 + 6.82 aatcaatag 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1601 to 1606 + 6.29 tgggga 
Mef-2 1646 to 1657 + 7.06 gggtattttaat 
Tef 1667 to 1678 + 9.99 cacattccttcg 
MA0090 TEAD TEA 1667 to 1678 + 10.1 cacattccttcg 
MA0045 HMG-IY HMG 1677 to 1692 + 6.72 cgtcgaaggggaacat 
MA0066 PPARG NUCLEAR RECEPTOR 1680 to 1699 - 6.07 ccaggtcatgttccccttcg 
MA0120 ID1 ZN-FINGER, C2H2 1680 to 1691 - 6.07 tgttccccttcg 
MA0057 ZNF42_5-13 ZN-FINGER, C2H2 1681 to 1690 + 6.4 gaaggggaac 
MA0066 PPARG NUCLEAR RECEPTOR 1681 to 1700 + 7.97 gaaggggaacatgacctggt 
MA0112 ESR1 NUCLEAR 1681 to 1698 + 6.92 gaaggggaacatgacctg 
MA0113 NR3C1 NUCLEAR 1682 to 1699 + 6.92 aaggggaacatgacctgg 
ERE 1683 to 1696 + 8.14 aggggaacatgacc 
MA0056 ZNF42_1-4 ZN-FINGER, C2H2 1683 to 1688 + 6.44 agggga 
MA0081 SPIB ETS 1683 to 1689 + 6.84 aggggaa 
MA0111 Spz1 bHLH-ZIP 1683 to 1693 + 6.93 aggggaacatg 
ERE 1684 to 1697 - 6.66 aggtcatgttcccc 
MA0080 SPI1 ETS 1685 to 1690 + 6.34 gggaac 
MA0106 TP53 P53 1685 to 1704 + 11 gggaacatgacctggtatgt 
MA0089 TCF11-MafG bZIP 1690 to 1695 + 6.77 catgac 
MA0071 RORA NUCLEAR RECEPTOR 1692 to 1701 - 8.31 taccaggtca 
MA0092 HAND1-TCF3 bHLH 1693 to 1702 + 6.23 gacctggtat 
Tef 1694 to 1705 - 6.97 cacataccaggt 








>Cluster-buster output for region 6 
Motif Position Strand Score Sequence 
MA0073 RREB1 ZN-FINGER, C2H2 2039 to 2058 - 13.4 acccacaacacccccccccc 
MA0079 SP1 ZN-FINGER, C2H2 2040 to 2049 + 7.67 gggggggggt 
MA0079 SP1 ZN-FINGER, C2H2 2042 to 2051 + 6.26 gggggggtgt 
ERE 2082 to 2095 + 6.59 tatacaccatgccc 
MA0074 RXR-VDR NUCLEAR RECEPTOR 2082 to 2096 - 8.16 agggcatggtgtata 
MA0017 NR2F1 NUCLEAR RECEPTOR 2084 to 2097 + 6.33 tacaccatgccctt 
MA0114 HNF4 NUCLEAR 2084 to 2096 - 8.18 agggcatggtgta 
Sp1 2086 to 2098 - 7.05 aaagggcatggtg 
MA0078 Sox17 HMG 2086 to 2094 - 6.67 ggcatggtg 
MA0111 Spz1 bHLH-ZIP 2086 to 2096 - 6.78 agggcatggtg 
MA0079 SP1 ZN-FINGER, C2H2 2087 to 2096 - 10.3 agggcatggt 
MA0095 YY1 ZN-FINGER, C2H2 2087 to 2092 + 6.64 accatg 
MA0039 Klf4 ZN-FINGER, C2H2 2088 to 2097 - 6.93 aagggcatgg 
MA0021 Dof3 ZN-FINGER, DOF 2093 to 2098 - 7.05 aaaggg 
 




>Cluster-buster output for region 19 
 
Motif Position Strand Score Sequence 
MA0022 Dorsal_1 REL 2692 to 2703 - 9.67 tggggtttcccc 
MA0061 NF-kappaB REL 2692 to 2701 + 6.67 ggggaaaccc 
MA0105 NFKB1 REL 2692 to 2702 + 9.39 ggggaaacccc 
MA0105 NFKB1 REL 2692 to 2702 - 10.1 ggggtttcccc 
MA0023 Dorsal_2 REL 2693 to 2702 - 9.95 ggggtttccc 
MA0061 NF-kappaB REL 2693 to 2702 + 8.09 gggaaacccc 
MA0061 NF-kappaB REL 2693 to 2702 - 10.1 ggggtttccc 
MA0101 REL 2693 to 2702 - 6.41 ggggtttccc 
MA0105 NFKB1 REL 2693 to 2703 + 7.52 gggaaacccca 
MA0105 NFKB1 REL 2693 to 2703 - 7.98 tggggtttccc 
MA0107 RELA REL 2693 to 2702 - 8.06 ggggtttccc 
MA0023 Dorsal_2 REL 2694 to 2703 - 7.43 tggggtttcc 
MA0101 REL 2694 to 2703 - 9.28 tggggtttcc 
MA0107 RELA REL 2694 to 2703 - 9.75 tggggtttcc 
MA0095 YY1 ZN-FINGER, C2H2 2722 to 2727 - 6.6 gccatc 
MA0092 HAND1-TCF3 bHLH 2733 to 2742 + 6.17 tggctggctt 
MA0020 Dof2 ZN-FINGER, DOF 2738 to 2743 - 6.39 aaagcc 
MA0021 Dof3 ZN-FINGER, DOF 2738 to 2743 - 6.06 aaagcc 
Ets 2751 to 2761 - 7.25 ttcaggaaatg 
MA0026 E74A ETS 2753 to 2759 - 6.52 caggaaa 
MA0081 SPIB ETS 2754 to 2760 - 6.44 tcaggaa 
MA0044 HMG-1 HMG 2770 to 2778 + 6.56 gttgtgatc 
NF-1 2772 to 2789 - 7.11 ttttggccgaggatcaca 
SRF 2782 to 2794 + 6.35 ggccaaaaatgac 
MA0051 IRF2 TRP-CLUSTER 2801 to 2818 - 6.58 gcaaggcgaaacgatgaa 
MA0004 Arnt bHLH 2819 to 2824 + 6.42 aacgtg 
MA0029 Evi1 ZN-FINGER, C2H2 2830 to 2843 + 10.8 gagaaaagataaaa 
GATA 2833 to 2845 + 6.12 aaaagataaaaaa 
MA0010 Broad-complex_1 ZN-FINGER, C2H2 2838 to 2851 + 9.46 ataaaaaacaagtg 
MA0044 HMG-1 HMG 2841 to 2849 - 6.14 cttgttttt 
MA0012 Broad-complex_3 ZN-FINGER, C2H2 2842 to 2852 + 6.14 aaaacaagtgg 
MA0016 CFI-USP NUCLEAR RECEPTOR 2849 to 2858 + 6.8 gtggtcacca 
MA0110 ATHB5 HOMEO-ZIP 2867 to 2875 + 6.06 cgatgattg 
MA0051 IRF2 TRP-CLUSTER 2879 to 2896 - 6.74 agaaatcgaaagtctcac 
MA0050 IRF1 TRP-CLUSTER 2884 to 2895 - 9.2 gaaatcgaaagt 
MA0082 SQUA MADS 2885 to 2898 - 7.14 acagaaatcgaaag 
MA0076 ELK4 ETS 2908 to 2916 + 6.37 actggaagt 
MA0058 MAX bHLH-ZIP 2918 to 2927 - 9.35 aatcacgtga 
MA0093 USF1 bHLH-ZIP 2918 to 2924 - 8.49 cacgtga 
MA0004 Arnt bHLH 2919 to 2924 + 8.17 cacgtg 
MA0004 Arnt bHLH 2919 to 2924 - 8.17 cacgtg 
MA0093 USF1 bHLH-ZIP 2919 to 2925 + 8.36 cacgtga 
MA0104 Mycn bHLH-ZIP 2919 to 2924 + 8.25 cacgtg 
MA0104 Mycn bHLH-ZIP 2919 to 2924 - 8.25 cacgtg 
 




>Cluster-buster output for subregion 5-1 
Motif Position Strand Score Sequence 
MA0045 HMG-IY HMG 7 to 22 + 11 gttgaaaaggaaaaaa 
MA0013 Broad-complex_4 ZN-
FINGER, C2H2 
8 to 18 + 7.12 ttgaaaaggaa 
MA0045 HMG-IY HMG 8 to 23 + 8.74 ttgaaaaggaaaaaat 
MA0010 Broad-complex_1 ZN-
FINGER, C2H2 
9 to 22 + 7.41 tgaaaaggaaaaaa 
MA0120 ID1 ZN-FINGER, C2H2 9 to 20 - 9.82 ttttccttttca 
MA0010 Broad-complex_1 ZN-
FINGER, C2H2 
10 to 23 + 7.4 gaaaaggaaaaaat 
MA0028 ELK1 ETS 10 to 19 + 7.31 gaaaaggaaa 
MA0030 FOXF2 FORKHEAD 10 to 23 + 6.12 gaaaaggaaaaaat 
MA0050 IRF1 TRP-CLUSTER 10 to 21 + 7.44 gaaaaggaaaaa 
MA0068 Pax4 PAIRED-HOMEO 10 to 39 + 6.8 gaaaaggaaaaaataggtttttagcgcgcc 
MA0120 ID1 ZN-FINGER, C2H2 10 to 21 - 6.99 tttttccttttc 
Ets 11 to 21 + 8.44 aaaaggaaaaa 
MA0039 Klf4 ZN-FINGER, C2H2 11 to 20 + 7.52 aaaaggaaaa 
MA0120 ID1 ZN-FINGER, C2H2 11 to 22 - 6.71 ttttttcctttt 
MA0013 Broad-complex_4 ZN-
FINGER, C2H2 
12 to 22 + 6.23 aaaggaaaaaa 
MA0020 Dof2 ZN-FINGER, DOF 12 to 17 + 6.07 aaagga 
MA0021 Dof3 ZN-FINGER, DOF 12 to 17 + 6.28 aaagga 
MA0039 Klf4 ZN-FINGER, C2H2 12 to 21 + 7.18 aaaggaaaaa 
MA0081 SPIB ETS 12 to 18 + 7.52 aaaggaa 
MA0013 Broad-complex_4 ZN-
FINGER, C2H2 
13 to 23 + 7.05 aaggaaaaaat 
MA0026 E74A ETS 13 to 19 + 6.64 aaggaaa 
MA0049 Hunchback ZN-FINGER, 
C2H2 
13 to 22 + 7.83 aaggaaaaaa 
MA0120 ID1 ZN-FINGER, C2H2 13 to 24 - 6.28 tattttttcctt 
MA0049 Hunchback ZN-FINGER, 
C2H2 
14 to 23 + 6.17 aggaaaaaat 
MA0098 c-ETS ETS 14 to 19 - 6.99 tttcct 
MA0049 Hunchback ZN-FINGER, 
C2H2 
15 to 24 + 6.03 ggaaaaaata 
MA0047 Foxa2 FORKHEAD 16 to 27 - 6.13 acctattttttc 
MA0033 FOXL1 FORKHEAD 17 to 24 + 7.2 aaaaaata 
MA0039 Klf4 ZN-FINGER, C2H2 17 to 26 + 7.59 aaaaaatagg 
MA0011 Broad-complex_2 ZN-
FINGER, C2H2 
20 to 27 - 6.57 acctattt 
MA0024 E2F1 Unknown 29 to 36 + 6.29 tttagcgc 
MA0123 ABI4 AP2 31 to 40 - 6.34 cggcgcgcta 
MA0079 SP1 ZN-FINGER, C2H2 32 to 41 - 6.72 gcggcgcgct 
MA0028 ELK1 ETS 43 to 52 - 6.62 gcgacggaaa 
GATA 49 to 61 - 6.53 tcatgataagcga 
MA0089 TCF11-MafG bZIP 57 to 62 + 7.12 catgac 
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MA0077 SOX9 HMG 68 to 76 - 8.25 aaacaatgg 
MA0040 Foxq1 FORKHEAD 69 to 79 + 8.68 cattgtttatg 
MA0030 FOXF2 FORKHEAD 70 to 83 - 8.31 cacacataaacaat 
MA0084 SRY HMG 70 to 78 - 6.38 ataaacaat 
MA0087 Sox5 HMG 70 to 76 - 6.58 aaacaat 
MA0021 Dof3 ZN-FINGER, DOF 102 to 107 - 6.02 aaagtg 
CCAAT 124 to 139 + 6.32 gttgaccaattacact 
MA0060 NF-Y CAAT-BOX 124 to 139 + 6.57 gttgaccaattacact 
MA0068 Pax4 PAIRED-HOMEO 127 to 156 + 6.02 gaccaattacactcaataatgacggcgcgc 
MA0075 Prrx2 HOMEO 131 to 135 + 7 aatta 
MA0122 Bapx1 HOMEO 134 to 142 - 7.27 ttgagtgta 
MA0110 ATHB5 HOMEO-ZIP 140 to 148 - 8.13 tcattattg 
MA0008 Athb-1 HOMEO-ZIP 141 to 148 - 6.71 tcattatt 
MA0089 TCF11-MafG bZIP 144 to 149 + 6.88 aatgac 
MA0123 ABI4 AP2 149 to 158 + 6.08 cggcgcgcat 
MA0006 Arnt-Ahr bHLH 170 to 175 + 6.54 tgcgtg 
MA0067 Pax2 PAIRED 171 to 178 - 6.66 agtcacgc 
MA0043 HLF bZIP 191 to 202 - 6.81 cgttacacaaag 
MA0025 NFIL3 bZIP 193 to 203 + 6.22 ttgtgtaacgc 
CCAAT 202 to 217 - 10.6 ttcagccaatcaccgc 
MA0060 NF-Y CAAT-BOX 202 to 217 - 10.8 ttcagccaatcaccgc 
MA0038 Gfi ZN-FINGER, C2H2 203 to 212 - 7.86 ccaatcaccg 
MA0041 Foxd3 FORKHEAD 216 to 227 - 8.81 aaatgttaattt 
MA0047 Foxa2 FORKHEAD 216 to 227 - 6.42 aaatgttaattt 
MA0040 Foxq1 FORKHEAD 217 to 227 - 6.03 aaatgttaatt 
MA0075 Prrx2 HOMEO 217 to 221 + 6.46 aatta 
MA0003 TFAP2A AP2 229 to 237 + 7.03 gcccagggg 
NF-1 230 to 247 - 6.21 atttggcgcgcccctggg 
MA0003 TFAP2A AP2 230 to 238 - 6.91 gcccctggg 
E2F 235 to 246 - 7.83 tttggcgcgccc 
MA0024 E2F1 Unknown 239 to 246 - 10.1 tttggcgc 
MA0082 SQUA MADS 242 to 255 + 7.04 ccaaatataaaact 
E2F 256 to 267 + 6.48 ttcggcgcgcgc 
MA0024 E2F1 Unknown 256 to 263 + 6.29 ttcggcgc 
MA0123 ABI4 AP2 258 to 267 + 7.39 cggcgcgcgc 
MA0017 NR2F1 NUCLEAR 
RECEPTOR 
305 to 318 - 6.11 tgaactgcgccctg 
MA0114 HNF4 NUCLEAR 306 to 318 + 6.5 agggcgcagttca 
MA0049 Hunchback ZN-FINGER, 
C2H2 
321 to 330 + 6.62 tcaaaaaaag 
MA0082 SQUA MADS 321 to 334 + 7.5 tcaaaaaaagtaca 
MA0013 Broad-complex_4 ZN-
FINGER, C2H2 
337 to 347 - 6.17 atgtaaacaaa 
MA0084 SRY HMG 337 to 345 - 6.32 gtaaacaaa 
MA0031 FOXD1 FORKHEAD 338 to 345 - 8.11 gtaaacaa 
MA0003 TFAP2A AP2 353 to 361 - 6.47 gccccgacg 
TATA 355 to 369 - 6.78 gtacaaaagccccga 
MA0108 TBP TATA-box 355 to 369 - 6.81 gtacaaaagccccga 
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MA0020 Dof2 ZN-FINGER, DOF 359 to 364 - 6.12 aaagcc 
MA0078 Sox17 HMG 381 to 389 + 6.58 gctattgtg 
MA0008 Athb-1 HOMEO-ZIP 403 to 410 + 7.36 caatcatt 
MA0110 ATHB5 HOMEO-ZIP 403 to 411 - 7.22 taatgattg 
MA0114 HNF4 NUCLEAR 415 to 427 - 6.33 gcgggagagtgca 
MA0079 SP1 ZN-FINGER, C2H2 418 to 427 - 6.18 gcgggagagt 
MA0039 Klf4 ZN-FINGER, C2H2 419 to 428 - 6.33 tgcgggagag 
MA0062 GABPA ETS 419 to 428 - 6.1 tgcgggagag 
MA0024 E2F1 Unknown 420 to 427 + 6.89 tctcccgc 
TATA 423 to 437 - 8.76 gcatataggtgcggg 
MA0108 TBP TATA-box 423 to 437 - 8.79 gcatataggtgcggg 
MA0103 deltaEF1 ZN-FINGER, C2H2 427 to 432 + 7.36 caccta 
MA0015 CF2-II ZN-FINGER, C2H2 430 to 439 + 6.91 ctatatgcag 
GATA 442 to 454 + 6.04 aagtgataaaaat 
MA0091 TAL1-TCF3 bHLH 493 to 504 - 8 tgaacatctttt 
MA0121 ARR10 TRP-CLUSTER 504 to 511 - 6.11 agattctt 
MA0057 ZNF42_5-13 ZN-FINGER, 
C2H2 
546 to 555 + 7.83 ttaggggcgg 
MA0068 Pax4 PAIRED-HOMEO 546 to 575 - 8.91 gaaaagtagaacttcaccccccgcccctaa 
Sp1 547 to 559 + 15.3 taggggcgggggg 
MA0039 Klf4 ZN-FINGER, C2H2 547 to 556 + 8.63 taggggcggg 
MA0079 SP1 ZN-FINGER, C2H2 547 to 556 + 6.54 taggggcggg 
MA0118 Macho-1 ZN-FINGER, C2H2 547 to 555 + 7.12 taggggcgg 
Sp1 548 to 560 + 7.21 aggggcggggggt 
E2F 548 to 559 + 7.38 aggggcgggggg 
MA0039 Klf4 ZN-FINGER, C2H2 548 to 557 + 7.36 aggggcgggg 
MA0068 Pax4 PAIRED-HOMEO 548 to 577 - 7.56 aagaaaagtagaacttcaccccccgcccct 
MA0079 SP1 ZN-FINGER, C2H2 548 to 557 + 6.73 aggggcgggg 
MA0111 Spz1 bHLH-ZIP 548 to 558 + 6.45 aggggcggggg 
MA0123 ABI4 AP2 548 to 557 - 8.94 ccccgcccct 
Sp1 549 to 561 + 6.27 ggggcggggggtg 
MA0068 Pax4 PAIRED-HOMEO 549 to 578 - 13 gaagaaaagtagaacttcaccccccgcccc 
MA0074 RXR-VDR NUCLEAR 
RECEPTOR 
549 to 563 + 6.69 ggggcggggggtgaa 
MA0079 SP1 ZN-FINGER, C2H2 549 to 558 + 11.5 ggggcggggg 
MA0114 HNF4 NUCLEAR 549 to 561 + 6.84 ggggcggggggtg 
MA0118 Macho-1 ZN-FINGER, C2H2 549 to 557 + 7.68 ggggcgggg 
Myf 550 to 561 + 6.33 gggcggggggtg 
MA0007 Ar NUCLEAR RECEPTOR 550 to 571 - 6.67 agtagaacttcaccccccgccc 
MA0079 SP1 ZN-FINGER, C2H2 550 to 559 + 7.55 gggcgggggg 
MA0114 HNF4 NUCLEAR 550 to 562 + 6.02 gggcggggggtga 
MA0057 ZNF42_5-13 ZN-FINGER, 
C2H2 
551 to 560 + 8.59 ggcggggggt 
MA0079 SP1 ZN-FINGER, C2H2 551 to 560 + 9.1 ggcggggggt 
MA0123 ABI4 AP2 552 to 561 - 7.83 caccccccgc 
MA0056 ZNF42_1-4 ZN-FINGER, 
C2H2 
553 to 558 + 7.56 cggggg 
MA0057 ZNF42_5-13 ZN-FINGER, 
C2H2 
553 to 562 + 6.98 cggggggtga 
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MA0079 SP1 ZN-FINGER, C2H2 553 to 562 + 8.68 cggggggtga 
MA0113 NR3C1 NUCLEAR 553 to 570 + 6.7 cggggggtgaagttctac 
MA0118 Macho-1 ZN-FINGER, C2H2 553 to 561 + 10.3 cggggggtg 
MA0056 ZNF42_1-4 ZN-FINGER, 
C2H2 
554 to 559 + 7.06 gggggg 
MA0057 ZNF42_5-13 ZN-FINGER, 
C2H2 
554 to 563 + 6.57 ggggggtgaa 
MA0079 SP1 ZN-FINGER, C2H2 554 to 563 + 7.82 ggggggtgaa 
MA0118 Macho-1 ZN-FINGER, C2H2 554 to 562 + 7.6 ggggggtga 
MA0018 CREB1 bZIP 555 to 566 + 6.61 gggggtgaagtt 
MA0016 CFI-USP NUCLEAR 
RECEPTOR 
556 to 565 + 7.56 ggggtgaagt 
MA0114 HNF4 NUCLEAR 556 to 568 + 6.45 ggggtgaagttct 
MA0046 TCF1 HOMEO 623 to 636 - 6.16 agttaaatatttta 
GATA 652 to 664 + 6.27 tgtagataaagaa 
MA0049 Hunchback ZN-FINGER, 
C2H2 
655 to 664 + 6.16 agataaagaa 
MA0020 Dof2 ZN-FINGER, DOF 659 to 664 + 6.44 aaagaa 
MA0053 MNB1A ZN-FINGER, DOF 659 to 663 + 6.16 aaaga 
MA0075 Prrx2 HOMEO 663 to 667 + 6.21 aatta 
MA0019 Chop-cEBP bZIP 690 to 701 + 6.08 acatgcaaacct 
Mef-2 698 to 709 + 7.1 acctatttttat 
MA0052 MEF2A MADS 700 to 709 + 6.36 ctatttttat 
MA0073 RREB1 ZN-FINGER, C2H2 709 to 728 - 6.7 ctccccccccccccctcaaa 
MA0057 ZNF42_5-13 ZN-FINGER, 
C2H2 
711 to 720 + 7.55 tgaggggggg 
MA0068 Pax4 PAIRED-HOMEO 711 to 740 - 7.97 gaatcgagacagctccccccccccccctca 
Sp1 712 to 724 + 6.59 gaggggggggggg 
Sp1 713 to 725 + 7.34 agggggggggggg 
Sp1 714 to 726 + 7.49 ggggggggggggg 
MA0079 SP1 ZN-FINGER, C2H2 714 to 723 + 6.47 gggggggggg 
Sp1 715 to 727 + 6.11 gggggggggggga 
MA0068 Pax4 PAIRED-HOMEO 715 to 744 - 8.31 aactgaatcgagacagctcccccccccccc 
MA0079 SP1 ZN-FINGER, C2H2 715 to 724 + 6.49 gggggggggg 
MA0079 SP1 ZN-FINGER, C2H2 716 to 725 + 6.49 gggggggggg 
Sp1 717 to 729 + 6.39 ggggggggggagc 
MA0079 SP1 ZN-FINGER, C2H2 717 to 726 + 6.49 gggggggggg 
Sp1 718 to 730 + 6.7 gggggggggagct 
MA0079 SP1 ZN-FINGER, C2H2 718 to 727 + 8.19 ggggggggga 
MA0056 ZNF42_1-4 ZN-FINGER, 
C2H2 
722 to 727 + 6.74 ggggga 
MA0014 Pax5 PAIRED 729 to 748 - 6.04 tgctaactgaatcgagacag 
MA0114 HNF4 NUCLEAR 745 to 757 - 6.61 tggacaaagtgct 
MA0021 Dof3 ZN-FINGER, DOF 747 to 752 - 6.66 aaagtg 
MA0078 Sox17 HMG 747 to 755 + 6.03 cactttgtc 
SRF 754 to 766 - 7.23 tgccaaggatgga 
MA0095 YY1 ZN-FINGER, C2H2 754 to 759 + 6.33 tccatc 
MA0035 Gata1 ZN-FINGER, GATA 755 to 760 - 6.53 ggatgg 
MA0098 c-ETS ETS 756 to 761 + 6.11 catcct 
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NF-1 759 to 776 + 6.91 ccttggcaactcgtaaca 
MA0045 HMG-IY HMG 777 to 792 - 6.17 taggaaatcgcagaac 
MA0038 Gfi ZN-FINGER, C2H2 780 to 789 - 6.37 gaaatcgcag 
MA0023 Dorsal_2 REL 781 to 790 + 6.46 tgcgatttcc 
MA0107 RELA REL 781 to 790 + 6.5 tgcgatttcc 
MA0098 c-ETS ETS 786 to 791 + 6.09 tttcct 
MA0037 GATA3 ZN-FINGER, GATA 790 to 795 - 6.2 tgatag 
Mef-2 811 to 822 - 7.34 ggttttatttag 
MA0027 En1 HOMEO 865 to 875 - 6.75 aaggagttgtc 
MA0021 Dof3 ZN-FINGER, DOF 871 to 876 - 6.04 aaagga 
MA0071 RORA NUCLEAR 
RECEPTOR 
884 to 893 + 6.01 gtatgggtca 
AP-1 885 to 895 - 7.18 gatgacccata 
MA0089 TCF11-MafG bZIP 890 to 895 - 7.54 gatgac 
MA0035 Gata1 ZN-FINGER, GATA 899 to 904 - 6.49 ggatgc 
MA0036 GATA2 ZN-FINGER, GATA 900 to 904 - 6.09 ggatg 
MA0050 IRF1 TRP-CLUSTER 913 to 924 - 6.65 caaagggaagcc 
MA0062 GABPA ETS 913 to 922 - 6.59 aagggaagcc 
MA0039 Klf4 ZN-FINGER, C2H2 914 to 923 - 6.95 aaagggaagc 
MA0028 ELK1 ETS 915 to 924 - 6.22 caaagggaag 
MA0039 Klf4 ZN-FINGER, C2H2 915 to 924 - 7.16 caaagggaag 
MA0080 SPI1 ETS 915 to 920 - 8.36 gggaag 
MA0098 c-ETS ETS 915 to 920 + 6.2 cttccc 
MA0081 SPIB ETS 916 to 922 - 6.2 aagggaa 
MA0021 Dof3 ZN-FINGER, DOF 918 to 923 - 6.89 aaaggg 
MA0056 ZNF42_1-4 ZN-FINGER, 
C2H2 
932 to 937 + 6.26 tgggga 
MA0070 Pbx HOMEO 951 to 962 - 6.77 gcttcaatcaat 
MA0068 Pax4 PAIRED-HOMEO 991 to 1020 + 6.22 gaaaattgtcctgggccttttgtcatcccc 
MA0068 Pax4 PAIRED-HOMEO 992 to 1021 + 6.58 aaaattgtcctgggccttttgtcatccccc 
MA0078 Sox17 HMG 992 to 1000 + 6.03 aaaattgtc 
MA0068 Pax4 PAIRED-HOMEO 993 to 1022 + 7.03 aaattgtcctgggccttttgtcatcccccc 
MA0078 Sox17 HMG 
1006 to 
1014 









- 8.62 ggggatgacaaaag 
MA0045 HMG-IY HMG 
1007 to 
1022 








- 7.38 ctttggggggatgacaaa 
MA0018 CREB1 bZIP 
1009 to 
1020 
- 6.24 ggggatgacaaa 
MA0084 SRY HMG 1009 to - 6.07 gatgacaaa 




MA0119 Hox11-CTF1 HOMEO/CAAT 
1010 to 
1023 
- 6.77 tggggggatgacaa 
MA0111 Spz1 bHLH-ZIP 
1011 to 
1021 
- 6.43 gggggatgaca 
MA0119 Hox11-CTF1 HOMEO/CAAT 
1011 to 
1024 




- 6.79 ggggggatgac 
MA0089 TCF11-MafG bZIP 
1012 to 
1017 
- 7.2 gatgac 
MA0079 SP1 ZN-FINGER, C2H2 
1013 to 
1022 




- 8.32 tttggggggatg 
MA0039 Klf4 ZN-FINGER, C2H2 
1014 to 
1023 
- 6.28 tggggggatg 
MA0098 c-ETS ETS 
1014 to 
1019 
+ 6.01 catccc 
MA0118 Macho-1 ZN-FINGER, C2H2 
1014 to 
1022 
- 9.06 ggggggatg 




- 6.69 ttggggggat 
MA0079 SP1 ZN-FINGER, C2H2 
1015 to 
1024 
- 7.96 ttggggggat 
MA0118 Macho-1 ZN-FINGER, C2H2 
1015 to 
1023 
- 8.32 tggggggat 




- 9.22 ggggga 




- 6.99 tttgggggga 
MA0118 Macho-1 ZN-FINGER, C2H2 
1016 to 
1024 
- 7.92 ttgggggga 




- 7.85 gggggg 
MA0116 Roaz ZN-FINGER, C2H2 
1017 to 
1031 
+ 7.85 ccccccaaagagtcc 
MA0116 Roaz ZN-FINGER, C2H2 
1017 to 
1031 
- 6.34 ggactctttgggggg 
MA0024 E2F1 Unknown 
1018 to 
1025 
- 6.68 tttggggg 




- 7.7 tggggg 
MA0047 Foxa2 FORKHEAD 
1086 to 
1097 
- 7.07 gcctattgattt 
MA0077 SOX9 HMG 1087 to + 6.82 aatcaatag 
















+ 9.99 cacattccttcg 
MA0090 TEAD TEA 
1168 to 
1179 
+ 10.1 cacattccttcg 
MA0045 HMG-IY HMG 
1178 to 
1193 
+ 6.72 cgtcgaaggggaacat 




- 6.07 ccaggtcatgttccccttcg 
MA0120 ID1 ZN-FINGER, C2H2 
1181 to 
1192 
- 6.07 tgttccccttcg 




+ 6.4 gaaggggaac 




+ 7.97 gaaggggaacatgacctggt 
MA0112 ESR1 NUCLEAR 
1182 to 
1199 
+ 6.92 gaaggggaacatgacctg 
MA0113 NR3C1 NUCLEAR 
1183 to 
1200 




+ 8.14 aggggaacatgacc 




+ 6.44 agggga 
MA0081 SPIB ETS 
1184 to 
1190 
+ 6.84 aggggaa 
MA0111 Spz1 bHLH-ZIP 
1184 to 
1194 




- 6.66 aggtcatgttcccc 
MA0080 SPI1 ETS 
1186 to 
1191 
+ 6.34 gggaac 
MA0106 TP53 P53 
1186 to 
1205 
+ 11 gggaacatgacctggtatgt 
MA0089 TCF11-MafG bZIP 
1191 to 
1196 
+ 6.77 catgac 




- 8.31 taccaggtca 
MA0092 HAND1-TCF3 bHLH 
1194 to 
1203 




- 6.97 cacataccaggt 
MA0090 TEAD TEA 1195 - 1206 - 6.89 cacataccagg 
Appendix F:  G-test to determine statistical significance of number of binding sites for each indicated transcription factor in each discussed regulatory region
Notes:
1.  "Non_versions" of each transcription factor binding site are calculated because at least 1 degree of freedom is needed to determine if a G value is significant. Deg of freedom = N - 1, where N = number of each transcription factor binding site + its non_version.
2.  If the value  of either observed or predicted number of binding sites was zero, the number zero was not used in calculations, since the G value would then be undefined. Instead, a very small number, approaching zero, was used, e.g. 10^-100.
3. To achieve the most accurate values for G, the expected number of binding sites for each transription factor were not rounded up or down to the nearest whole number.
4. The p value cutoffs for statistically significant differences are shown only for p values of 0.10 and lower.  G tests yielding p values of >0.10 were considered to yield non-significant results.
4. Sometimes, it could be determined without calculations that the difference between observed and expected values of transcription factors bindings sites was not significant, for example, if both values were the same number, or could be rounded to the same number. 
It was also sometimes able to be determined, based on comparison to preceeding calculations in this file, if a p value was <0.001.
6. Abbreviation:  rc = reverse complement
Calculations for significance
Expected frequencies
How often both orientations are predicted to occur in each region and subregion (click on each cell to determime formula used to obain each value)
2 2_2 4 4_1 4_2 5 5_1 6 6_1 17 19 19_1
Otx TAATCC  TAATCT plus reverse complements 2.39689 0.31521 1.39546 0.4885 0.25942 1.60379 1.01358 1.83805 1.29655 1.4236 3.11002 0.99176
Gatae (C/T)GATA(A/G) plus reverse complemement 10.1541 1.27622 5.90635 2.13804 1.05332 6.80313 4.25044 8.13051 5.64469 6.3208 13.2553 4.23741
Bra (A/G)(A/T)(A/T)NTN(A/G)CAC(C/T)T  plus rev comp 0.37038 0.04373 0.21532 0.07898 0.03638 0.24835 0.15391 0.30084 0.20826 0.23397 0.48516 0.15528
Foxa (A/G)(A/C)(A/C)T(G/A)TT(A/G/T)(A/T)TT(T/C) + rc 0.31748 0.0238 0.18333 0.08423 0.02065 0.21496 0.12187 0.34168 0.21495 0.27149 0.4347 0.14157
Gatac  (T/G/A)(T/A)(G/C)AGACT(T/A)AGC(T/G) +rc 0.00516 0.00083 0.00301 0.00093 0.00067 0.00343 0.00227 0.00335 0.00251 0.00256 0.00653 0.00206
Su(H) (C/G)(G/A)TG(A/G)GA(A/T/G) + rc 1.93846 0.35424 1.13389 0.33977 0.28258 1.28825 0.86687 1.22506 0.92214 0.93522 2.43858 0.76831
Runx (C/T)G(C/T)GGTN +rc 3.87634 0.82113 2.27201 0.63811 0.64553 2.56864 1.77576 2.26166 1.74762 1.71667 4.81279 1.50863
TCF ACAAAG + rc 2.39689 0.31521 1.39546 0.4885 0.25942 1.60379 1.01358 1.83805 1.29655 1.4236 3.11002 0.99176
GC percentage 38.19 44.51 38.28 35.33 43.91 38.06 39.26 34.53 35.75 34.26 37.6 37.37
G or C proportion 0.19095 0.22255 0.1914 0.17665 0.21955 0.1903 0.1963 0.17265 0.17875 0.1713 0.188 0.18685
A or T proportion 0.30905 0.27745 0.3086 0.32335 0.28045 0.3097 0.3037 0.32735 0.32125 0.3287 0.312 0.31315
Sequence length(bp) 3603 537 2100 716 435 2407 1546 2685 1905 2078 4643 1477
Observed frequencies 2 2_2 4 4_1 4_2 5 5_1 6 6_1 17 19 19_1 #bp/site (for excel calcs)
Otx TAATCC  TAATCT plus reverse complements 8 0 2 0 0 6 3 3 2 0 5 1 6 otx
Gatae (C/T)GATA(A/G) plus reverse complemement 12 3 3 2 2 6 5 7 4 5 4 2 6 gatae
Bra (A/G)(A/T)(A/T)NTN(A/G)CAC(C/T)T  plus rev comp 0 0 0 0 0 1 0 1 1 0 0 0 12 bra
Foxa (A/G)(A/C)(A/C)T(G/A)TT(A/G/T)(A/T)TT(T/C) + rc 0 0 0 0 0 3 3 0 0 0 0 0 12 foxa
Gatac  (T/G/A)(T/A)(G/C)AGACT(T/A)AGC(T/G) +rc 14 2 13 5 3 16 11 9 9 6 20 8 13 gatac
Su(H) (C/G)(G/A)TG(A/G)GA(A/T/G) + rc 1 0 0 0 0 0 0 0 0 1 0 0 8 su(H)
Runx (C/T)G(C/T)GGTN +rc 2 0 2 1 1 2 2 4 4 2 4 0 6 Runx
TCF ACAAAG + rc 2 1 2 2 0 6 6 5 5 1 7 1 6 TCF
G test calculations to determine if observed numbers of each potential binding site in each region is significant.  (For each region, G values for both each transcription factor binding site of interest, plus its non-version, were calculated, as shown in the columns designated "G." 
These values were summed, and the resultant "Sum of G's" calculated in each case was compared to P values in the table below that starts at line 179.  From this result, a level of statistical significance could be determined in each case).
Reg 2 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 8 2.39689 19.2843 Gatae 12 10.1540705 4.00877 Bra 1E-133 0.37038 -6E-131 Foxa 0 0.31748 Gatac 14 0.00516 221.374 Su(H) 1 1.93846 -1.32378 Runx 2 3.87634 -2.64698 Otx 2.39689
Non Otx 592.5 598.103 -11.1536 Non Gatae 588.5 590.34593 -3.68608 Non Bra 300.25 299.88 0.74122 NonGatac 263.154 277.149 -27.2708 NonSu(H) 449.375 448.437 1.87888 NonRunx 598.5 596.624 3.75858 Gatae 10.1541
Sum of G's 8.13073 Sum of G's 0.32269 Sum of G's 0.74122 Sum of G's 194.103 Sum of G's 0.55509 Sum of G's 1.1116 Bra 0.37038
Foxa 0.15874
P<0.01 Not significant Not significant Not significant P<0.001 Not significant in either tail. Not significant. Gatac 0.00516
Su(H) 1.93846
Observed Expected G Runx 3.87634
TCF 2 2.39689 -0.7241 TCF 2.39689
NonTCF 598.5 598.103 0.79405
Sum of G's 0.06994
Not significant
Reg 2_2 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 1E-114 0.31521 -5E-112 Gatae 3 1.27622156 5.12825 Bra 0 0.04373 FoxA 0 0.0238 Gatac 2 0.00083 31.1406 Su(H) 0 0.35424 Runx 1E-111 0.82113 -5E-109 Otx 0.31521
Non Otx 89.5 89.1848 0.63153 Non Gatae 86.5 88.2237784 -3.41365 NonGatac 39.3077 41.3069 -3.89998 NonSu(H) NonRunx 89.5 88.6789 1.64984 Gatae 1.27622
Sum of G's 0.63153 Sum of G's 1.7146 Sum of G's 27.2406 Sum of G's 1.64984 Bra 0.04373




Observed Expected G TCF 0.31521
TCF 1 0.31521 2.30904
NonTCF 88.5 89.1848 -1.36431
Sum of G's 0.94473
Not significant
Reg 4 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 2 1.39546 1.4397 Gatae 3 5.90634754 -4.06449 Bra 0 0.21532 FoxA 0 0.18333 Gatac 13 0.09167 128.818 Su(H) 1E-97 1.13389 -4.5E-95 Runx 2 2.27201 -0.51008 Otx 1.39546
NonOtx 348 348.605 -1.20803 NonGatae 347 344.093652 5.83717 NonBra NonGatac 148.538 161.447 -24.7559 262.5 261.366 2.27269 NonRunx 348 347.728 0.54424 Gatae 5.90635
Sum of G's 0.23166 Sum of G's 1.77268 Sum of G's Sum of G's 104.062 Sum of G's 2.27269 Sum of G's 0.03416 Bra 0.21532
Not significant Not significant in either tail Not significant Not significant P<0.001 Not significant Not significant in either tail Foxa 0.09167
Observed Expected G Gatac 0.09167
TCF 2 1.39546 1.4397 Su(H) 1.13389
NonTCF 348 348.605 -1.20803 Runx 2.27201
Sum of G's 0.23166 TCF 1.39546
Not significant
Reg 4_1 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 1E-101 0.4885 -5E-99 Gatae 2 2.13803723 -0.26696 Bra 0 0.07898 FoxA 0 0.08423 Gatac 5 0.00093 85.9273 Su(H) 0 0.33977 Runx 1 0.63811 Otx 0.4885
NonOtx 119.33333 118.845 0.979 NonGatae 117.333 117.195296 0.27624 NonBra NonGatac 49.0769 55.076 -11.3196 Gatae 2.13804
Sum of G's 0.979 Sum of G's 0.00927 Sum of G's 74.6077 Bra 0.07898
Not significant Not significant Not significant Not significant p<0.001 Not significant Not significant Foxa 0.04211
Gatac 0.00093
Observed Expected G Su(H) 0.33977
TCF 2 0.4885 5.63828 Runx 0.63811
NonTCF 117.33333 118.845 -3.0037 TCF 0.4885
2.63458
Not significant
Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Observed Expected G Gatae 2 1.05331686 2.56481 Bra 0 0.03638 FoxA 0 0.02065 Gatac 3 0.00067 50.4045 Su(H) 0 0.28258 Runx 1 0.64553 Otx 0.25942
Reg 4_2 0 0.25942 NonGatae 70.5 71.4466831 -1.88077 NonGatac 30.4615 33.4609 -5.72139 NonSu(H) Gatae 1.05332
Otx 0.68405 44.6831 Bra 0.03638
Not significant Not significant Not significant Not significant P<0.001 Not significant. Not significant. Foxa 0.01032
Gatac 0.00067
Observed Expected G Su(H) 0.28258
TCF 0 0.25942 Runx 0.64553
Not significant TCF 0.25942
Observed Expected G G tests checked, ok
Reg 5 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 6 1.60379 15.8327 Gatae 6 6.80312576 -1.50747 Bra 1 0.24835 2.78585 FoxA 3 0.21496 15.8155 Gatac 16 0.00343 Su(H) 1E-82 1.28825 -3.8E-80 Runx 2 2.56864 -1.00092 Otx 1.60379
NonOtx 395.16667 399.563 -8.74386 NonGatae 395.167 394.363541 1.60789 199.583 200.335 -1.50048 NonFoxA 197.583 200.368 -5.53119 NonSu(H) 300.875 299.587 2.58202 NonRunx 399.167 398.598 1.1381 Gatae 6.80313
Sum of G's 7.08879 0.10041 1.28537 10.2843 2.58202 0.13717 Bra 0.24835
p<0.01 Not significant. Not significant. p<0.01 p<0.001 Not significant. Not signficant. Foxa 0.10748
Gatac 0.00343
Observed Expected G Su(H) 1.28825
TCF 6 1.60379 15.8327 Runx 2.56864
NonTCF 395.16667 399.563 -8.74386 TCF 1.60379
Sum of G's 7.08879
p<0.01
Reg5_1 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 3 1.01358 6.51073 Gatae 5 4.25044273 1.62415 Bra 0 0.15391 FoxA 3 0.12187 19.2207 Gatac 11 0.00227 186.657 Su(H) 1E-160 0.86687 -7E-158 Runx 2 1.77576 0.47567 Otx 1.01358
NonOtx 254.66667 256.653 -3.95742 NonGatae 252.667 253.416224 -1.4969 NonFoxA 125.833 128.711 -5.69142 NonGatac 107.923 118.921 -20.9455 193.25 192.383 1.73764 NonRunx 255.667 255.891 -0.44828 Gatae 4.25044
Sum of G's 2.5533 Sum of G's 0.12725 13.5293 165.711 1.73764 0.02739 Bra 0.15391
Not significant Not significant Not significant p<0.001 p<0.001 Not significant Not significant Foxa 0.06093
Gatac 0.00227
Observed Expected G Su(H) 0.86687
TCF 6 1.01358 21.3392 Runx 1.77576
NonTCF 251.66667 256.653 -9.87532 TCF 1.01358
11.4639
p<0.001
Reg6 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 3 1.83805 2.93945 Gatae 7 8.13051233 -2.09599 Bra 1 0.30084 2.40234 FoxA 0 0.34168 Gatac 9 0.00335 Su(H) 1E-186 1.22506 -9E-184 Runx 4 2.26166 4.56158 Otx 1.83805
444.5 445.662 -2.32087 NonGatae 440.5 439.369488 2.26393 NonBra 222.75 223.449 -1.39613 NonSu(H) 335.625 334.4 2.45461 NonRunx 443.5 445.238 -3.46989 Gatae 8.13051
Sum of G's 0.61858 Sum of G's 0.16794 Sum of G's 1.00621 Sum of G's 2.45461 Sum of G's 1.09169 Bra 0.30084
Not significant. Not significant. Not significant Not significant p<0.001 Not significant. Not significant Foxa 0.17084
Gatac 0.00335
Observed Expected G Su(H) 1.22506
TCF 5 1.83805 10.0073 Runx 2.26166
NonTCF 442.5 445.662 -6.30142 TCF 1.83805
Sum of G's 3.70592
p<0.10
Reg 6_1 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 2 1.29655 1.73376 Gatae 4 5.64469452 -2.75537 Bra 1 0.20826 3.13795 FoxA 0 0.21495 Gatac 9 0.00251 147.321 Su(H) 1E-191 0.92214 -9E-189 Runx 4 1.74762 6.62433 Otx 1.29655
Non Otx 315.5 316.203 -1.40533 Non Gatae 313.5 311.855305 3.29805 NonBra 157.75 158.542 -1.57952 NonGatac 137.538 146.536 -17.4309 NonSu(H) 238.125 237.203 1.84785 NonRunx 313.5 315.752 -4.48866 Gatae 5.64469
Sum of G's 0.32843 Sum of G's 0.54267 Sum of G's 1.55843 Sum of G's 129.891 Sum of G's 1.84785 Sum of G's 2.13567 Bra 0.20826
Not significant. Not significant. Not significant Not significant p<0.001 Not significant Not significant Foxa 0.10748
Observed Expected G Gatac 0.00251
TCF 5 1.29655 13.4973 Su(H) 0.92214
NonTCF 312.5 316.203 -7.36335 Runx 1.74762
Sum of G's 6.13395 TCF 1.29655
p<0.025
Reg 17 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 1E-258 1.4236 -1E-255 Gatae 5 6.32079962 -2.34408 Bra 0 0.23397 FoxA 0 0.27149 Gatac 6 0.00256 93.1009 Su(H) 1 0.93522 Runx 2 1.71667 0.61104 Otx 1.4236
NonOtx 346.33333 344.91 2.85308 NonGatae 341.333 340.012534 2.64672 NonGatac 153.846 159.844 -11.767 NonRunx 344.333 344.617 -0.56642 Gatae 6.3208
Sum of G's 2.85308 Sum of G's 0.30265 Sum of G's 81.3339 Sum of G's 0.04462 Bra 0.23397
p<0.10 Not significant. Not significant. Not significant. p<0.001 Not significant. Not significant. Foxa 0.13574
Gatac 0.00256
TCF Observed Expected G Su(H) 0.93522
1 1.4236 Runx 1.71667
TCF 1.4236
Not significant.
Reg19 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 5 3.11002 4.7481 Gatae 4 13.2553231 -9.58484 Bra 0 0.48516 FoxA 0 0.4347 Gatac 20 0.00653 Su(H) 1E-215 2.43858 -1E-212 Runx 4 4.81279 -1.47986 Otx 3.11002
NonOtx 768.83333 770.723 -3.77533 NonGatae 769.833 760.57801 18.6228 NonSu(H) 580.375 577.936 4.88744 NonRunx 769.833 769.021 1.62644 Gatae 13.2553
Sum of G's 0.97277 Sum of G's 9.03798 Sum of G's 4.88744 Sum of G's 0.14658 Bra 0.48516
Not significant p<0.01 Not significant Not significant p<0.001 p<0.05 Not significant. Foxa 0.21735
Gatac 0.00653
Observed Expected G Su(H) 2.43858
TCF 7 3.11002 11.3579 Runx 4.81279
NonTCF 766.83333 770.723 -7.7603 TCF 3.11002
Sum of G's 3.59765
p<0.10
Reg19_1 Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Observed Expected G Site Expected
Otx 1 0.99176 Gatae 2 4.23741354 -3.00322 Bra 0 0.15528 FoxA 0 0.14157 Gatac 8 0.00206 Su(H) 1E-216 0.76831 -1E-213 Runx 1E-185 1.50863 -9E-183 Otx 0.99176
NonGatae 244.167 241.929253 4.49546 NonSu(H) 184.625 183.857 1.53982 NonRunx 246.167 244.658 3.02654 Gatae 4.23741
Sum of G's 1.49223 Sum of G's 1.53982 Sum of G's 3.02654 Bra 0.15528
Not significant Not significant Not significant Not significant P<0.001 Not significant p<0.10 Foxa 0.07079
Gatac 0.00206
Observed Expected G Su(H) 0.76831
TCF 1 0.99176 Runx 1.50863
Not significant TCF 0.99176
P value tables
Upper-tail critical values of chi-square distribution with ν  degrees of freedom Taken from http://www.itl.nist.gov/div898/handbook/eda/section3/eda3674.htm
                Probability less than the critical value
  ν            0.90      0.95     0.975      0.99     0.999
  1          2.706     3.841     5.024     6.635    10.828
  2          4.605     5.991     7.378     9.210    13.816
  3          6.251     7.815     9.348    11.345    16.266
  4          7.779     9.488    11.143    13.277    18.467
  5          9.236    11.070    12.833    15.086    20.515
  6         10.645    12.592    14.449    16.812    22.458
  7         12.017    14.067    16.013    18.475    24.322
  8         13.362    15.507    17.535    20.090    26.125
  9         14.684    16.919    19.023    21.666    27.877
 10         15.987    18.307    20.483    23.209    29.588
 11         17.275    19.675    21.920    24.725    31.264
 12         18.549    21.026    23.337    26.217    32.910
 13         19.812    22.362    24.736    27.688    34.528
 14         21.064    23.685    26.119    29.141    36.123
 15         22.307    24.996    27.488    30.578    37.697
 16         23.542    26.296    28.845    32.000    39.252
 17         24.769    27.587    30.191    33.409    40.790
 18         25.989    28.869    31.526    34.805    42.312
 19         27.204    30.144    32.852    36.191    43.820
 20         28.412    31.410    34.170    37.566    45.315
 21         29.615    32.671    35.479    38.932    46.797
 22         30.813    33.924    36.781    40.289    48.268
 23         32.007    35.172    38.076    41.638    49.728
 24         33.196    36.415    39.364    42.980    51.179
 25         34.382    37.652    40.646    44.314    52.620
 26         35.563    38.885    41.923    45.642    54.052
 27         36.741    40.113    43.195    46.963    55.476
 28         37.916    41.337    44.461    48.278    56.892
 29         39.087    42.557    45.722    49.588    58.301
 30         40.256    43.773    46.979    50.892    59.703
 31         41.422    44.985    48.232    52.191    61.098
 32         42.585    46.194    49.480    53.486    62.487
 33         43.745    47.400    50.725    54.776    63.870
 34         44.903    48.602    51.966    56.061    65.247
 35         46.059    49.802    53.203    57.342    66.619
 36         47.212    50.998    54.437    58.619    67.985
 37         48.363    52.192    55.668    59.893    69.347
 38         49.513    53.384    56.896    61.162    70.703
 39         50.660    54.572    58.120    62.428    72.055
 40         51.805    55.758    59.342    63.691    73.402
 41         52.949    56.942    60.561    64.950    74.745
 42         54.090    58.124    61.777    66.206    76.084
 43         55.230    59.304    62.990    67.459    77.419
 44         56.369    60.481    64.201    68.710    78.750
 45         57.505    61.656    65.410    69.957    80.077
 46         58.641    62.830    66.617    71.201    81.400
 47         59.774    64.001    67.821    72.443    82.720
 48         60.907    65.171    69.023    73.683    84.037
 49         62.038    66.339    70.222    74.919    85.351
 50         63.167    67.505    71.420    76.154    86.661
 51         64.295    68.669    72.616    77.386    87.968
 52         65.422    69.832    73.810    78.616    89.272
 53         66.548    70.993    75.002    79.843    90.573
 54         67.673    72.153    76.192    81.069    91.872
 55         68.796    73.311    77.380    82.292    93.168
 56         69.919    74.468    78.567    83.513    94.461
 57         71.040    75.624    79.752    84.733    95.751
 58         72.160    76.778    80.936    85.950    97.039
 59         73.279    77.931    82.117    87.166    98.324
 60         74.397    79.082    83.298    88.379    99.607
 61         75.514    80.232    84.476    89.591   100.888
 62         76.630    81.381    85.654    90.802   102.166
 63         77.745    82.529    86.830    92.010   103.442
 64         78.860    83.675    88.004    93.217   104.716
 65         79.973    84.821    89.177    94.422   105.988
 66         81.085    85.965    90.349    95.626   107.258
 67         82.197    87.108    91.519    96.828   108.526
 68         83.308    88.250    92.689    98.028   109.791
 69         84.418    89.391    93.856    99.228   111.055
 70         85.527    90.531    95.023   100.425   112.317
 71         86.635    91.670    96.189   101.621   113.577
 72         87.743    92.808    97.353   102.816   114.835
 73         88.850    93.945    98.516   104.010   116.092
 74         89.956    95.081    99.678   105.202   117.346
 75         91.061    96.217   100.839   106.393   118.599
 76         92.166    97.351   101.999   107.583   119.850
 77         93.270    98.484   103.158   108.771   121.100
 78         94.374    99.617   104.316   109.958   122.348
 79         95.476   100.749   105.473   111.144   123.594
 80         96.578   101.879   106.629   112.329   124.839
 81         97.680   103.010   107.783   113.512   126.083
 82         98.780   104.139   108.937   114.695   127.324
 83         99.880   105.267   110.090   115.876   128.565
 84        100.980   106.395   111.242   117.057   129.804
 85        102.079   107.522   112.393   118.236   131.041
 86        103.177   108.648   113.544   119.414   132.277
 87        104.275   109.773   114.693   120.591   133.512
 88        105.372   110.898   115.841   121.767   134.746
 89        106.469   112.022   116.989   122.942   135.978
 90        107.565   113.145   118.136   124.116   137.208
 91        108.661   114.268   119.282   125.289   138.438
 92        109.756   115.390   120.427   126.462   139.666
 93        110.850   116.511   121.571   127.633   140.893
 94        111.944   117.632   122.715   128.803   142.119
 95        113.038   118.752   123.858   129.973   143.344
 96        114.131   119.871   125.000   131.141   144.567
 97        115.223   120.990   126.141   132.309   145.789
 98        116.315   122.108   127.282   133.476   147.010
 99        117.407   123.225   128.422   134.642   148.230
100        118.498   124.342   129.561   135.807   149.449
100        118.498   124.342   129.561   135.807   149.449
Lower-tail critical values of chi-square distribution with ν  degrees of freedom 
                Probability less than the critical value
  ν            0.10     0.05     0.025      0.01     0.001
  1.          .016      .004      .001      .000      .000
  2.          .211      .103      .051      .020      .002
  3.          .584      .352      .216      .115      .024
  4.         1.064      .711      .484      .297      .091
  5.         1.610     1.145      .831      .554      .210
  6.         2.204     1.635     1.237      .872      .381
  7.         2.833     2.167     1.690     1.239      .598
  8.         3.490     2.733     2.180     1.646      .857
  9.         4.168     3.325     2.700     2.088     1.152
 10.         4.865     3.940     3.247     2.558     1.479
 11.         5.578     4.575     3.816     3.053     1.834
 12.         6.304     5.226     4.404     3.571     2.214
 13.         7.042     5.892     5.009     4.107     2.617
 14.         7.790     6.571     5.629     4.660     3.041
 15.         8.547     7.261     6.262     5.229     3.483
 16.         9.312     7.962     6.908     5.812     3.942
 17.        10.085     8.672     7.564     6.408     4.416
 18.        10.865     9.390     8.231     7.015     4.905
 19.        11.651    10.117     8.907     7.633     5.407
 20.        12.443    10.851     9.591     8.260     5.921
 21.        13.240    11.591    10.283     8.897     6.447
 22.        14.041    12.338    10.982     9.542     6.983
 23.        14.848    13.091    11.689    10.196     7.529
 24.        15.659    13.848    12.401    10.856     8.085
 25.        16.473    14.611    13.120    11.524     8.649
 26.        17.292    15.379    13.844    12.198     9.222
 27.        18.114    16.151    14.573    12.879     9.803
 28.        18.939    16.928    15.308    13.565    10.391
 29.        19.768    17.708    16.047    14.256    10.986
 30.        20.599    18.493    16.791    14.953    11.588
 31.        21.434    19.281    17.539    15.655    12.196
 32.        22.271    20.072    18.291    16.362    12.811
 33.        23.110    20.867    19.047    17.074    13.431
 34.        23.952    21.664    19.806    17.789    14.057
 35.        24.797    22.465    20.569    18.509    14.688
 36.        25.643    23.269    21.336    19.233    15.324
 37.        26.492    24.075    22.106    19.960    15.965
 38.        27.343    24.884    22.878    20.691    16.611
 39.        28.196    25.695    23.654    21.426    17.262
 40.        29.051    26.509    24.433    22.164    17.916
 41.        29.907    27.326    25.215    22.906    18.575
 42.        30.765    28.144    25.999    23.650    19.239
 43.        31.625    28.965    26.785    24.398    19.906
 44.        32.487    29.787    27.575    25.148    20.576
 45.        33.350    30.612    28.366    25.901    21.251
 46.        34.215    31.439    29.160    26.657    21.929
 47.        35.081    32.268    29.956    27.416    22.610
 48.        35.949    33.098    30.755    28.177    23.295
 49.        36.818    33.930    31.555    28.941    23.983
 50.        37.689    34.764    32.357    29.707    24.674
 51.        38.560    35.600    33.162    30.475    25.368
 52.        39.433    36.437    33.968    31.246    26.065
 53.        40.308    37.276    34.776    32.018    26.765
 54.        41.183    38.116    35.586    32.793    27.468
 55.        42.060    38.958    36.398    33.570    28.173
 56.        42.937    39.801    37.212    34.350    28.881
 57.        43.816    40.646    38.027    35.131    29.592
 58.        44.696    41.492    38.844    35.913    30.305
 59.        45.577    42.339    39.662    36.698    31.020
 60.        46.459    43.188    40.482    37.485    31.738
 61.        47.342    44.038    41.303    38.273    32.459
 62.        48.226    44.889    42.126    39.063    33.181
 63.        49.111    45.741    42.950    39.855    33.906
 64.        49.996    46.595    43.776    40.649    34.633
 65.        50.883    47.450    44.603    41.444    35.362
 66.        51.770    48.305    45.431    42.240    36.093
 67.        52.659    49.162    46.261    43.038    36.826
 68.        53.548    50.020    47.092    43.838    37.561
 69.        54.438    50.879    47.924    44.639    38.298
 70.        55.329    51.739    48.758    45.442    39.036
 71.        56.221    52.600    49.592    46.246    39.777
 72.        57.113    53.462    50.428    47.051    40.519
 73.        58.006    54.325    51.265    47.858    41.264
 74.        58.900    55.189    52.103    48.666    42.010
 75.        59.795    56.054    52.942    49.475    42.757
 76.        60.690    56.920    53.782    50.286    43.507
 77.        61.586    57.786    54.623    51.097    44.258
 78.        62.483    58.654    55.466    51.910    45.010
 79.        63.380    59.522    56.309    52.725    45.764
 80.        64.278    60.391    57.153    53.540    46.520
 81.        65.176    61.261    57.998    54.357    47.277
 82.        66.076    62.132    58.845    55.174    48.036
 83.        66.976    63.004    59.692    55.993    48.796
 84.        67.876    63.876    60.540    56.813    49.557
 85.        68.777    64.749    61.389    57.634    50.320
 86.        69.679    65.623    62.239    58.456    51.085
 87.        70.581    66.498    63.089    59.279    51.850
 88.        71.484    67.373    63.941    60.103    52.617
 89.        72.387    68.249    64.793    60.928    53.386
 90.        73.291    69.126    65.647    61.754    54.155
 91.        74.196    70.003    66.501    62.581    54.926
 92.        75.100    70.882    67.356    63.409    55.698
 93.        76.006    71.760    68.211    64.238    56.472
 94.        76.912    72.640    69.068    65.068    57.246
 95.        77.818    73.520    69.925    65.898    58.022
 96.        78.725    74.401    70.783    66.730    58.799
 97.        79.633    75.282    71.642    67.562    59.577
 98.        80.541    76.164    72.501    68.396    60.356
 99.        81.449    77.046    73.361    69.230    61.137
100.        82.358    77.929    74.222    70.065    61.918
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